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Using Multiwavelength UV-Visible Spectroscopy for the Characterization of Red Blood 
Cells:  An Investigation of Hypochromism 
 
Akihisa Nonoyama 
 
ABSTRACT 
 
Particle analysis using multiwavelength UV-visible spectroscopy provides the 
potential for extracting quantitative red blood cell information, such as hemoglobin 
concentration, cell size, and cell count.  However, if there is a significant presence of 
hypochromism as a result of the concentrated hemoglobin (physiological value of 33%), 
successful quantification of red cell values would require a correction.   
Hypochromism has been traditionally defined as a decrease in absorption relative 
to the values expected from the Beer-Lambert Law due to electronic interactions of 
chromophores residing in close proximity of one another.  This phenomenon has been 
suggested to be present in macroscopic systems composed of strong chromophores such 
as nucleic acids, chlorophyll, and hemoglobin.  The study presented in this dissertation 
examines the presence of hypochromism in red blood cells as a part of a larger goal to 
qualitatively and quantatively characterize red blood cells using multiwavelength UV-
visible spectroscopy.   
 The strategy of the study was three-fold:  1) to determine the instrumental 
configuration that would provide the most complete information in the acquired spectra, 
 xviii
2) to develop an experimental model system in which the hemoglobin content in red 
blood cells could be modified to various concentrations, and 3) to implement an 
interpretation model based on light scattering theory (which accounts for both the 
scattering and absorption components of the optical density spectrum) to provide 
quantitative information for the experimental system.  By this process, hypochromicity 
was redefined into two categories with molecular hypochromicity representing the 
traditional definition and macroscopic hypochromicity being an attenuation of the 
absorption component due to a scattering-related effect.  Successful simulations of 
experimental red cell spectra containing various amounts of hemoglobin were obtained 
using the theoretical model.  Furthermore, successful quantitative interpretation of the red 
blood cell spectra was achieved in the context of corpuscular hemoglobin concentration, 
corpuscular volume, and cell count solely by accounting for the scattering and absorption 
effects of the particle, indicating that molecular hypochromicity was insignificant in this 
macroscopic system.   
 
 
 1
 
 
 
Chapter 1:  Introduction 
Multiwavelength ultraviolet-visible (UV-vis) spectrophotometry is a powerful 
tool for the characterization of particles in suspension.  With the acquisition of one 
spectrum, it is possible to obtain information on parameters such as particle count, size, 
shape, and chemical composition.1,2  Application of this technology coupled with spectral 
interpretation using the theory of light scattering allows for the analysis of particles in a 
large range of sizes (10-9 – 10-6 m).  The method proves particularly useful in the 
examination of micron-sized particles due to their significant scattering properties, 
especially if they exhibit a high optical contrast (high refractive index) in relation to the 
background medium.  For such particles, light scattering theory provides the means to 
interpret the combined scattering and absorption components of the spectrum to extract a 
wealth of information about the suspension system.  Furthermore, the opportunity to 
examine the spectrum over a large wavelength range (190 – 1100 nm) allows for 
redundant analysis through mathematical corroboration of all wavelengths, providing a 
high level of reliability of the elucidated values.  
 
1.1  Blood 
The capabilities of multiwavelength UV-visible spectrophotometry offers the 
potential for the characterization of whole blood.  Whole blood is a complex system with 
 2
the major components being red blood cells (RBC, or erythrocytes), white blood cells 
(WBC, or leukocytes), platelets, and plasma, each making a contribution to the whole 
blood spectrum (Figure 1.1).  Each individual component exhibits unique spectral 
features based on their physical characteristics that impact their optical behavior.  The 
combination of important parameters (size, shape, chemical composition) that influence 
the cumulative spectral attributes of the particle is referred to as the joint property 
distribution (JPD).3,4   
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Figure 1.1:  Blood components and their spectral contributions to the whole blood 
spectrum.  The spectrum of each major component (red blood cells, platelets, plasma, and 
white blood cells) is unique to their individual physical properties such as size and 
chemical composition.   
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 The objective of the study reported in this dissertation is to obtain a 
multiwavelength characterization of red blood cells.  In whole blood, red cells dominate 
in number and in its contribution to the overall spectrum; hence it is important to achieve 
an accurate spectral depiction of the red cells as a necessary step to obtaining information 
on the other major components of whole blood such as white blood cells, platelets, and 
plasma.  In the context of spectral analysis, the red cell suspension can be broken down 
into three pathlengths, each of which offers different levels of particle information as 
indicated in Figure 1.2.  Each pathlength denotes a different type of hypochromism, with 
observed hypochromism representing the most general definition:  a decrease in the 
optical density (and extinction coefficient) as a result of the increase in concentration of a 
strong chromophore relative to the value expected by the Beer-Lambert Law.5  
Macroscopic hypochromism is a type of observed hypochromism where a decrease in the 
optical density (relative to Beer-Lambert) is seen due to the combined effects of 
absorption and scattering of chromophores in aggregated and encapsulated systems.  
Moreover, molecular hypochromism is another category of observed hypochromism 
where molecular charge interaction among closely packed chromophores causes a 
decrease in the absorption spectrum.5  Since red blood cells contain a highly absorbing 
species, hemoglobin, it is necessary to account for the possibility of hypochromicity to 
attain a qualitative optical characterization of RBCs.  The study clearly establishes two 
subcategories of hypochromism and identifies the level of significance of each to the 
spectral analysis of red cells.   
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Figure 1.2:  Three important pathlengths to consider in the spectral analysis of red cells.  
Each pathlength accounts for a different set of information reflected in the spectrum of 
the suspension. 
 
 
The issue of hypochromism was addressed by closely examining two paradigms:  
measurement variables including instrumental configuration and the combined effect of 
the scattering and absorption components on the red cell spectrum.  The instrumental 
configuration of the optical arrangement of commercially available spectrophotometers 
may reflect differences in the design of the optics, particularly in the angle of acceptance, 
which can result in different spectral features that can mislead the interpretation of the 
optical density spectrum.  Some studies that have disregarded the importance of the 
detection angle on the spectrum have attempted to explain the observed hypochromism in 
ways other than to consider the instrumental configuration.6,7  
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The second method of investigating hypochromism in red cells was to examine 
the absorption and scattering components of the red cell spectrum in an effort to interpret 
the spectrum using the theory of light scattering.  To this end, any hypochromic effect 
present in the spectrum would have to be accounted for to achieve a good interpretation 
of the particle parameters (eg. size, number and chemical composition).  The 
investigation was extended beyond physiological red cell values by developing a protocol 
to modify the hemoglobin composition.  A procedure using hypotonic shock (with 
varying incubation times) was developed to control the final cellular hemoglobin 
concentration.  Observing cells with varying hemoglobin content allowed for the 
inspection of spectral features and trends in relation to their changing optical 
characteristics. 
 
1.2  Theoretical Modeling 
Theoretical modeling and interpretation of the red cells were performed using the 
Mie theory, which provides analysis for spherical particles.8  This approach has already 
proven successful in offering good spectral interpretation for particle systems such as 
polymers,1 molecular aggregates,2 platelets,9 and microorganisms.10  In the case of the red 
cells, the capabilities of the Mie theory were extended to obtain good values for  RBC 
number, size, and hemoglobin concentration.  The success of this interpretation model 
helped to identify the two categories of hypochromism and their influence, if any, on the 
transmission spectrum of purified and modified red blood cells. 
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Chapter 2:  Whole Blood, Red Blood Cells and Hemoglobin 
 
2.1 Whole Blood 
 Whole blood is a complex system of regenerating cells and physiologically 
essential molecules which work to sustain life in various ways.  It is responsible for 
transporting nutrition, oxygenating tissues, removing waste products, controlling body 
temperature, and maintaining hemostasis.11,12  Whole blood is composed of four major 
components:  plasma, thrombocytes (platelets), leukocytes (white blood cells), and 
erythrocytes (red blood cells).  It has a viscosity approximately 1.5 times that of water, 
maintains a specific gravity of 1.050 – 1.060, and has a physiologic pH of 7.35 – 7.45.12  
The cell-to-plasma ratio is on the order of 45%:55% and a normal adult sustains 70 – 75 
milliliters of blood per kilogram of body weight, which constitutes 7 – 8% of total body 
weight.11 
   The components of blood have been well characterized and baseline normal 
values have been established for each constituent (Table 2.1).  Such accepted values are 
typically represented as ranges or statistical averages due to the fact that the physiological 
abundances of cells and proteins vary according to age, sex, race, geographic locations, 
and pathologies.  Typically, 95% of all normal individuals fall within + 2 standard 
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deviations of the reported reference values, with only the remaining 5% normal 
individuals being outside of this range.11 
 
Blood 
Component 
Size 
(µm) 
Volume 
(fl) 
Count 
(number/µl) 
Role 
Erythrocytes 7 – 8  80 – 100  Male: 4.7 - 6.1x106  
Female: 4.2 - 5.4x106 
O2 and CO2 transport 
Leukocytes   4 – 11x103   
Granulocytes     
Neutrophils 10 – 15  -- 4,420 Phagocytose small organisms 
Basophils 10 – 15  -- 40 Mediate inflammatory events 
Eosinophils 10 – 15  -- 200 Allergic inflammatory 
response 
Monocytes 15 – 22 -- 300 Phagocytose organisms 
Lymphocytes 10 --  2,500 Cellular and humoral 
immunity 
Thrombocytes 1 – 2  7.4 - 10.4 1.5 - 4.5x105 Maintain hemostasis 
Plasma -- -- -- Fluid medium in blood 
 
Table 2.1:11,13,14,15,16,17  Normal values of major blood components.   
   
Leukocytes 
 Leukocytes, or white blood cells (WBC) contribute only about one percent of the 
total blood volume, yet plays an important role in defense against infections and 
phagocytosis of cell debris.11,13  Leukocytes are classified under two major categories:  
granulocytes and mononuclear cells (non-granulated cells).  As the name implies, the 
granulocytes exhibit a granular cytoplasm when stained and can be further organized into 
three subcategories:  neutrophils, eosinophils, and basophils.  The mononuclear cells 
include lymphocytes and monocytes.12  The abundance of each leukocyte type in a 
healthy individual is illustrated in Table 2.2. 
 
 
 8
 
 
 
  
 
 
Table 2.2:12  Percent abundances of leukocyte sub-types. 
 
 Among the granulocytes, neutrophils are the primary line of defense owing to 
their functional characteristics and large nucleus.  They will destroy foreign agents 
mainly by means of phagocytosis, and are a major contributor to inflammatory responses.  
Neutrophils are approximately 10 to 14 µm in diameter and contain a lobulated nucleus 
(two to five lobes) with condensed chromatin.  The cytoplasm contains granules of sizes 
ranging from 200 to 500 nm.  These granules are classified as peroxidase-positive and 
peroxidase-negative, with the latter typically being smaller in size (~ 200 nm diameter).  
An electron micrograph will show on the average, 200 to 300 granules, with 
approximately one third being peroxidase-positive granules (Figure 2.1).14 
Eosinophils, which are the second most abundant of the granulocytes, have the 
capacity to secrete toxic granules to help eradicate invading cells.  They also aid in 
digesting old clots.  Eosinophils are usually slightly larger than neutrophils and contain a 
nucleus with two lobes.  The granules in the cytoplasm are larger than those in the 
Leukocyte 
Type 
Percent 
Abundance 
Neutrophil 62.0% 
Eosinophil 2.3% 
Basophil 0.4% 
Lymphocyte 30.0% 
Monocyte 5.3% 
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neutrophils and are more uniform in size.  Moreover, the granules contain crystalline 
structures that are readily seen in the electron microscope picture in Figure 2.2. 
Basophils, normally low in concentration, increase in number during the healing 
phase of an inflammation.  Furthermore, they release histamine, heparin, bradykinin and 
serotonin to help mediate the inflammatory response.12  The size of the basophils are 
slightly smaller than the neutrophils.  The nucleus is larger than those of the other 
granulocytes, and typically are not as segmented as they are in neutrophils.  They contain 
large granules that are less uniform in size compared to those of the eosinophils (Figure 
2.3).14 
 
Figure 2.1:14  An electron microscopy picture of a mature neutrophil using peroxidase 
staining.  The picture shows multiple lobes of nuclei (n), peroxidase-positive granules 
(p+), and peroxidase-negative granules (p-).  
 
 
 10
 
Figure 2.2:14  An electron microscopy picture of an eosinophil using peroxidase staining.  
The nuclei has two lobes, and the granules (g) contains crystalline structures (arrow). 
 
 
 
 
 
 
Figure 2.3:14  An electron microscopy picture of a basophil using peroxidase staining.  
The granules stain lightly and are irregular in size.   
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Lymphocytes compose the major non-granulocyte component with a lifespan of 
100-300 days and are differentiated into three types:  B-lymphocytes, T-lymphocytes and 
natural killer (NK) cells.  All are principal contributors to the immune response.  The B-
lymphocyte recognizes antigens that cause the cells to proliferate and release large 
amounts of immunoglobulins (antibodies).  The T-lymphocytes aids in B-lymphocyte 
function as well as exhibiting cytotoxic effects such as lysing virus-infected cells.12,13  
Upon activation, T-cells (T-lymphocytes) can proliferate into one of four types of cells:  
memory T-cells (memory for previously encountered antigens), helper T-cells (help 
enhance the activities of lymphocytes and phagocytes and stimulate proliferation and 
maturation of B-cells), suppressor T-cells (suppress over-activity of lymphocytes and 
phagocytes), and cytotoxic T-cells (kill cells targeted by specific antigen).12  The NK 
cells provide immunity against infectious agents and transformed cells.  Morphologically,  
 
 
Figure 2.4:14  An electron microscopy picture of a lymphocyte.  The nucleus dominates 
the cellular space.   
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the three types of lymphocytes share similarities, with sizes ranging from 6 to 15 µm 
(Figure 2.4).  The nucleus is round or kidney-shaped ad occupies ~ 90% of the cell.14 
 
 
 
 
 
Figure 2.5:14  An electron microscopy picture of a monocyte.  It contains a relatively 
large nucleus (N) along with visible organelles such as the ER (thin arrow), mitochondria 
(thick arrow), and lysosomes (empty arrow).   
 
 
Monocytes ( Figure 2.5) constitute two to eight percent of whole blood cells and 
are released from the marrow as immature cells.  Once in tissues, they differentiate into 
the larger macrophages to fight infections and remove debris from blood through 
phagocytosis.  They are more resilient than neutrophils and they can also endocytose 
larger particles.12  In terms of size, the monocytes large blood cells with diameters 
ranging from 12 to 15 µm.  The shapes of the nucleus vary form round to oval and 
lobulated.  The cytoplasm contains frequently vacuolated granules (~ 50 to 200 nm). 
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Figure 2.6:14  An electron microscopy picture of macrophage.  Internal contents include 
the nucleus (N), ER (thin arrow), Golgi zone (G), mitochondria (thick arrow), and 
lysosomes (empty arrow).   
 
Monocytes will differentiate into macrophages in tissue, an event characterized by an 
increase in cellular size up to 22 µm accompanied by an increase in the granules (Figure 
2.6).14   
 
Thrombocytes 
Thrombocytes, or platelets, are derived from megakaryocytes in the bone marrow 
and play a crucial role in maintaining hemostasis.  Mature megakaryocytes are released 
from the marrow and subsequently fragment into platelets, which survive in the 
vasculature for approximately ten days.12,14  Through receptor-mediated signaling, 
platelets converge at the site of vascular injury and activate, allowing for aggregation, 
which is part of the clotting process.  Furthermore, they will release granules and 
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cytoplasmic contents containing essential hemostatic components such as clotting factors 
and serotonin which promote the clotting cascade.14   
 
Erythrocytes 
 Erythrocytes (red blood cells – RBC) are biconcave discoid cells containing the 
protein hemoglobin.  Its primary function is to transport molecular oxygen (O2) from the 
lungs to the tissues and to carry carbon dioxide (CO2) from the tissues to the lungs.  The 
composition and functions of RBCs will be discussed in detail in section 2.2.   
 
Plasma 
 Plasma is the liquid medium of whole blood through which the blood cells are 
circulated.  While the cells make up approximately 45% of the volume of blood, plasma 
constitutes the complementary 55%.  It is primarily composed of water and it accounts 
for roughly six liters of blood in a normal human body.11     Aside from the cells, plasma 
also contains a multitude of proteins, ions, lipids, and carbohydrates, many of which are 
responsible for maintaining the integrity of the vascular system.  Some major proteins 
include albumin, γ-globulins, and fibrinogen, with albumin being the most abundant.   
Important ions include H+, Na+, K+, Mg2+, Ca2+, and Cl-.11,18,19   
 The plasma-enabled fluidity of whole blood helps the heart deliver essential 
biological components to all body tissues with great efficiency.  It allows for the body to 
maintain hemostasis, protect against infections, deliver oxygen to tissues, transport lipids 
via water soluble proteins, and remove catabolites, among other functions.14  This 
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intricate network of components is maintained in a delicate balance of functions in the 
vascular system of a healthy individual.  Advances in clinical and research-oriented 
diagnoses have helped to identify the numerous abnormalities currently seen in whole 
blood. 
 
Serum Albumin 
Human serum albumin (HSA) is the most abundant protein in plasma at a 
concentration of 42 g/L and serves several important biological functions within the 
vascular system.20  Synthesized predominantly in the liver, HSA exhibits dimensions of 
134 x 41 angstroms and has a molecular weight of 66,439 da.  At physiological pH, the 
protein displays a net charge of approximately -17 and is composed of 585 amino acid 
residues.20,21   
Albumin possesses the unique capacity to bind numerous endogenous and 
exogenous compounds, making it a vital transport protein.  It binds mainly water 
insoluble substances, such as lipids and also potentially toxic compounds such as 
bilirubin, giving its transport mechanism a multi-purpose role.20, 22  Its abundance also 
provides the vasculature with 80% of the osmotic pressure needed to maintain the 
integrity of cell structure in whole blood.   
Human serum albumin is composed of the following chromophoric amino acid 
residues:  1 tryptophan, 1 cysteine, 17 cystines (disulfide bridges), 18 tyrosines, and 31 
phenylalanines.20  The structure consists of a series of three identical domains with each 
of the domains connected to each other by a hinge region and a disulfide bond.  Each 
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domain is predominantly characterized by helices and the three domains are arranged in a 
trough-like tertiary structure.  Bovine serum albumin has a slightly smaller number of 
amino acids with 583 and possesses a molecular weight of 66,267 da.  It is structurally 
similar to the human isoform, and chromophoric residues include 19 tyrosines, 26 
phenylalanines, 18 cystines and 2 tryptophans.20,23 
Albumin is an extensively studied molecule which has been well characterized in 
many different aspects and it has proven to be a useful model molecule in our research 
(See Appendices C and H).   Our studies revolve around UV-visible spectroscopy and 
albumin has been analyzed in terms of its optical behavior based on its size and chemical 
composition.24 
 
2.2  The Erythrocyte 
 Erythrocytes, or red blood cells (RBC), are dark red, flexible, biconcave cells that 
carry O2 and CO2 to and from tissues respectively.14  In the early 1800’s, Francois 
Magendie did not heed colleague William Hewson’s recommendation to dilute blood in  
 
Component Concentration (mg/ml) 
Total protein 371.0 
Hemoglobin 361.8 
Non-hemoglobin protein 9.2 
Insoluble stroma protein 6.3 
Protein from enzymes 2.9 
 
Table 2.3:14  Protein content of human erythrocytes 
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serum when studying them.  He instead used water, and through his microscopy studies, 
reported that red blood cells were air bubbles.25  Since then, scientific knowledge of 
erythrocytes has soared as a result of advances in research technology.   
 Red blood cells generally exhibit a diameter of approximately 7.5 – 8.7 µm, 
(Figure 2.1) and are found at a concentration of 5 x 106 cells per microliter of blood.13,14  
They owe their deep red color to the presence of the iron-containing molecule 
hemoglobin (33% m/v).14  In fact, roughly 97% of all total protein in erythrocytes is 
hemoglobin, as illustrated in Table 2.3.  That is, approximately 95% of the total cell 
weight can be attributed to the chromophoric molecule.12  Furthermore, mature human 
erythrocytes lack a nucleus and mitochondria and exhibit minimal metabolism yet 
maintain their existence for an average of 100-120 days.14,26   
 
 
 
Figure 2.7:26  A cartoon and micrograph representations of the erythrocyte. 
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The biconcave discoid has a thickness of approximately 2 µm (Figure 2.7), a 
surface area of 136 µm2, and a volume of ~90 fl.26  Its flat shape keeps the hemoglobin 
molecules closer to the membrane which allows for a more efficient transfer of oxygen.  
The resourceful functionality of the cell is attributed to the composition of the membrane 
and the underlying cytoskeleton.   
 
The Erythrocyte Membrane and Cytoskeleton 
 The membrane of the red blood cell is a phospholipid bilayer (75 angstroms in 
thickness) in which the non-polar, hydrophobic tails orient to form the internal region of 
the membrane, while the polar, hydrophilic heads of the phospholipids face out into the 
aqueous plase.26,27  The density of the membrane alone is reported to be 1.15 g/cm3.27  
The contents of the red cell membrane can be broken down by mass into the following:  
52% protein, 40% lipid and 8% carbohydrate.27   
The major types phospholipids present in the membrane include phosphatidylcholine 
(28% of total phospholipids), phosphatidylserine (13%), phosphatidylethanolamine 
(27%), and sphingomyelin (26%).14  Known generally as glycerophospholipids or 
phosphoglycerides, phosphatidylcholine, phosphatidylserine, and 
phosphatidylethanolamine are derivatives of glycerol-3-phosphate, with the R1 and R2 
groups being fatty acids which are associated with the first two carbons of the 3-carbon 
backbone via an ester linkage (Figure 2.8).  The R1 group typically represents C16 and C18 
fatty acids while R2 is often C16-C20 unsaturated fatty acids.28  The third carbon is linked 
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to the R3 group by a phosphodiester bond with the variations of R3 defining the type of 
phosphoglyceride (Figure 2.9).   
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Figure 2.8:  The general chemical structure of a phosphoglyceride.  R1 and R2 represent 
hydrophobic fatty acid chains and R3 defines the specific type of phospholipid. 
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Figure 2.9:  R3 groups for major types of phosphoglycerides:  phosphatidylcholine, 
phosphatidylethanolomine, and phosphatidylserine.  
  
 20
Sphingomyelin is derived from a long chain amino alcohol sphingosine and is 
classified as a sphingolipid.  The derivative contains a ceramide group which is 
characterized by a fatty acid linked to the second carbon by an amide bond.  The head 
carbon is attached to a phosphocholine (Figure 2.10). 
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Figure 2.10:  A structural formula of sphingomyelin showing the ceremide and 
phosphocholine moieties. 
 
Unesterified cholesterol is also found in the membrane in a 1:1 molar ratio with 
the phospholipids.  Cholesterol (Figure 2.11) is a bulky ring system that modulates the 
membrane by hindering the movements of the fatty acid side chains and decreasing their 
fluidity.  The presence of the cholesterol also obstructs the potential crystallization of the 
phospholipids if they become packed too closely.28  Furthermore, it creates openings in 
the membrane which allow for the passive transport of certain cations.11  Hence, the diet 
of an individual can influence the lipid and cholesterol concentrations in the blood stream 
which in turn could affect the quality of the erythrocyte membranes.   
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Figure 2.11:  The structural formula of cholesterol. 
  
The membrane phospholipid contents exhibit a characteristic asymmetry.  
Phosphatidylserine and phosphatidylethanolamine are found in larger quantities in the 
inner leaflet of the bilayer whereas phosphatidylcholine and sphingomyelin are mostly 
located in the outer layer.  An enzyme, aminophospholipid translocase (flipase), has been 
identified to execute an ATP-dependent translocation of phosphatidylserine and 
phosphatidylethanolamine from the outside to the inner layer.  The asymmetry can be 
maintained on the most part due to the slow fluidity of the membrane, and the 
electrostatic attractions of skeletal proteins to the phosphatidylserine.  Alterations in the 
phospholipids distributions may have a significant effect on vascular normalcy.  For 
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example, a substantial amount of phosphatidylserine on the external layer may incite the 
activation of blood clotting.14 
The characteristic and functional shape of the red blood cell is maintained by a 
network of proteins in the skeletal matrix.  The erythrocyte also owes its deformability to 
this intricate matrix and internal viscosity, allowing the cell (~8 µm in diameter) to 
squeeze through capillary openings as small as 3 µm, or increase its volume from 90 fl up 
to 150 fl.11,14  
The supporting network of proteins (Figure 2.12) in the membrane skeleton 
consists of spectrin and actin, among others.  Spectrin, the most abundant protein of the 
skeleton, is a heterodimer composed of two non-identical subunits (α and β) with 
molecular weights of 240 kD and 220 kD respectively.29  The two subunits are 
intertwined in a linear fashion, measuring approximately 1000 angstroms.  Furthermore, 
the heterodimer will interact head-to-head to form a heterotetramer, which will be the 
core of the meshwork in the membrane skeleton.28,30  Five to eight spectrin heteromer 
tails come together at a junctional complex composed of a combination of actin, protein 
4.1 (band 4.1), tropomyosin, adducin, and protein 4.9 (dematin).11,31,32  The spectrin tails 
are directly associated with actin and protein 4.1.  The junctional complex itself is 
anchored down via protein 4.1 to the membrane by its association to glycophorin C, an 
integral membrane glycoprotein which carries an antigen on its extracellular domain.11  A 
deficiency in glycophorin C shows a deficit of protein 4.1 and a disruption in membrane 
stability that leads to a mild case of elliptocytosis.33  In between two junctional 
complexes, ankyrin (protein 2.1) attaches to the spectrin tetramer, and through the aid of 
 23
protein 4.2 (pallidin), the complex is anchored to the integral membrane protein, band 3 
(protein 3).33  This elaborate meshwork of the membrane skeleton maintains the 
erythrocyte’s biconcave discoid shape as well as its flexibility which allows it to pass 
through small openings. 
 
Figure 2.12:11  The figure depicts the organization of the membrane and membrane 
skeleton.  The spectrin heterotetramer attaches to both the junctional complex (actin, 
tropomyosin, adducing, protein 4.9 and protein 4.1) and the ankyrin/protein 4.2 complex.  
The junctional complex is attached to the membrane by way of glycophorin C and the 
ankyrin/protein 4.2 is attached via band 3. 
 
The Erythrocyte Surface 
 The outer surface of the red blood cell has an overall negative charge due to its 
richness in neuraminic acid residues primarily located on the glycophorin A 
transmembrane protein.14  More importantly, it is the different blood group determinants 
on the surface that comprise about 22 different blood group systems.  Two systems, the 
ABO and rhesus (Rh) blood groups have the largest clinical implications.28   
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The antigenic determinants for the ABO blood group system are oligosaccharides 
of type A, B, and H attached on surface sphingoglycolipids.  The three subtypes differ in 
sugar residues at their non-reducing ends with all three sharing the same base 
polysaccharide sequence.  The A and B variants each exhibit a unique sugar residue 
attached to the base whereas the H antigen has none.  The H antigen is therefore 
considered to the precursor to the A and B types, and in the absence of A or B antigens, 
the individual is deemed type O.  A type A individual bears A antigens on the red cell 
surface while the blood plasma contains antibodies to the B antigen.  A type B person 
would show the opposite phenotype.  If anti-A serum is introduced to type A red cells, 
the antibodies would cause the cells to agglutinate, illustrating the importance of 
matching up blood types for clinical transfusions.28  AB individuals carry both types of 
antigens on the cell surface but do not express either antibody in their plasma. 
 
The Life of an Erythrocyte 
 Hematopoiesis is the formation of cells in the vascular system, and erythropoiesis 
is specifically the process by which red blood cells are developed.  In post-birth 
individuals, cells are generated from the bone marrow, where all blood cells are 
differentiated from a pool of common stem cells.11,12,14,15  Although less than five percent 
of the stem cells are dividing at one time, approximately 1x1011 cells are generated per 
day from a stem cell pool of around 2x106 by constant division and proliferation.11   
 Figure 2.13 shows the lineage of the different blood cells.  The stem cell (CFU-S), 
deemed “pluripotential” due to its capacity to differentiate, can be stimulated into 
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becoming CFU-GEMM (colony-forming unit-granulocyte, erythrocyte, monocyte, 
megakaryocyte) or CFU-L (colony-forming unit-lymphocyte).  The CFU-GEMM will 
then be differentiated into one of the committed progenitor cells (with the aid of specific 
hematopoietic growth factors) for neutrophils, eosinophils, basophils, monocytes, 
platelets, or erythrocytes.  The CFU-L will either become the B- or the T-lymphocyte.11 
 
 
 
Figure 2.13:11  The figure illustrates the cell lineage of each of the blood cells generated 
from the pluripotential stem cell (CFU-S).  The CFU-GEMM (colony-forming unit-
granylocyte, erythrocyte, monocyte, megakaryocyte) will differentiate into committed 
progenitor cells, eventually producing neutrophils, monocytes, eosinophils, basophils, 
platelets, and erythrocytes.  The CFU-L (colony-forming unit-lymphocyte) will 
differentiate into T- and B-lymphocytes. 
 26
As indicated in figure 2.13, erythropoiesis shares the CFU-S to CFU-GEMM 
lineage with the granulocytes, monocytes, and platelets.  From the CFU-GEMM stage, 
however, differentiation into the early progenitor cell blast-forming unit-erythrocyte 
(BFU-E), the late progenitor cell colony-forming unit-erythrocyte (CFU-E) and 
subsequent proliferation are initiated by combinations of the granulocyte-macrophage 
colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), interleukin-4 (IL-4), and 
erythropoietin.11  Proliferation of CFU-E leads to maturation stages in the following 
order:  pronormoblast (rubriblast), basophilic normoblast (prorubricyte), 
polychromatophilic normoblast (rubricyte), orthochromatic normoblast (metarubricyte), 
reticulocyte, and erythrocyte.11,15,26  The pronormoblasts and basophilic normoblasts are 
large in size and volumes (up to 20 µm and 300-800 fl respectively) and have clumped 
nuclear chromatin.  Polychromatophilic normoblasts show early signs of hemoglobin 
production (blue-green in color) and a smaller size (10-12 µm).  The hemoglobin content 
is visibly increased in the orthochromatic normoblast as demonstrated by the cell’s pink 
color and it contains 2/3 of the total erythrocyte hemoglobin.  The nucleus is gradually 
pushed out of the cell for it to become a marrow reticulocyte.  Residual mitochondria and 
RNA will help synthesize the remaining hemoglobin before they are eliminated.  The size 
of the reticulocyte continues to decrease in size and lose RNA for approximately 24 hours 
post release into circulation.  Once the reticulocytes are released via the sinuses, they will 
mature within a day into erythrocytes.11,26  One CFU-E will produce 16-32 adult 
erythrocytes.26 
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Metabolic Pathways in the Erythrocyte 
 Although the red cell is devoid of many common cellular activities, it still exhibits 
metabolic pathways essential to maintaining its viability for its lifetime in circulation.  
Briefly, the Embdon-Meyerhof pathway, or glycolysis, accounts for 90-95% of the cell’s 
glucose consumption.  The glucose, which is harvested externally (due to the fact that 
erythrocytes lack glycogen reserves), is converted to lactate producing two moles of 
adenosine triphosphate (ATP) for every mole of glucose reacted.  The ATP is then used 
to maintain everything from membrane integrity to active ion pumps (Na+ and Ca2+ out; 
K+ and Mg2+ in).  Two subsidiaries of the glycolysis pathway are the methemoglobin 
reductase pathway and the Rapoport-Leubering shunt.  The methemoglobin reductase 
keeps hemoglobin iron in a reduced state (Fe2+) and maintains the oxidized form, 
methemoglobin (Fe3+) to about two percent.  The Rapoport-Leubering shunt takes the 
1,3-bisphosphoglycerate (1,3-BPG) from the glycolysis pathway and catalyzes it to 2,3-
bisphosphoglycerate (2,3-BPG).  2,3-BPG is important for the release of oxygen by the 
hemoglobin molecule.  The hexose-monophosphate shunt produces nicotinamide adenine 
dinucleotidephosphate (NADPH) and glutathione (GSH) both in their reduced forms.  
When the sulfhydryl groups (-SH) of hemoglobin become oxidized, GSH will work to 
reduce these groups, and in turn will become oxidized (GSSG).  GSSG will then be 
reduced to back GSH with the aid of NADPH.  Deterring the oxidation of the hemoglobin 
–SH groups is important since such an event would lead to denaturation and precipitation 
of the oxygen-carrier.  Furthermore, GSH/NADPH are responsible for maintaining 
reduced sulfhydryl groups on the membrane.11,34 
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Morphology of the Red Cell 
 The characteristic biconcave shape of an erythrocyte is referred to as a 
discocyte.14  There have been many speculations as to why and how the cell is able to 
maintain this unique shape.  One hypothetical model showed that the discocyte shape has 
lowest bending energy due to the reduced surface curvature.35  From a biochemical 
standpoint, the shape could be explained as an effect due to the interactions between the 
molecules which make up the membrane and membrane skeleton.  Regardless of the 
cause of the shape, it cannot be argued that it is an efficient design to carry out its task. 
 Aside from its discocyte shape, erythrocytes may take on alternate shapes, usually 
due to an abnormality.  Such variant forms include, but are not limited to, echinocyte, 
elliptocyte, and drepanocyte.14  The echinocytes are spherical, crenated cells 
characterized by spicule projections, not unlike a sea urchin (Figure 2.14).  The 
echinocytes will form under circumstances such as prolonged storage or uremia.  
Elliptocytes are oval-shaped red cells and are commonly seen in types of anemias and 
thallassemias.  Finally, the drepanocyte (Figure 2.15) is the sickling of the cell as seen in 
sickle cell anemia patients.14,35   
 
Figure 2.14:35  An electron micrograph of a discocyte (A) and an echinocyte (B). 
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Figure 2.15:35  An electron micrograph of a drepanocyte. 
 
2.3  Hemoglobin 
Erythrocytes can generally be considered as sacks of hemoglobin, the oxygen 
carrying molecule which gives the cell its red color.  As previously mentioned, 
approximately 97% of the total red cell protein is hemoglobin with a cell mass fraction of 
approximately 0.33.14  The protein is found in different subtypes such as A1 (most 
common, ~95%), A2 (~2-4%), and F (fetal).36,37  It is one of the most well-studied 
proteins due to its elegant complexities as well as its availability.  It can also exhibit a 
multitude of abnormalities, leading to various clinical pathologies.  Moreover, its optical 
characteristics provide a means for the spectrophotometric analysis of blood quality.   
 
Hemoglobin Structure and Function: 
 Simple organisms can sustain life by depending on the diffusion or oxygen, but 
with tissues thicker than ~1 mm, the rate is too slow to support life.  Additionally, oxygen 
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solubility in blood plasma is around 1 x 10-4 M, which is too low for the metabolic needs 
of animals.  Whole blood, which contains 150 g Hb/L can carry O2 at concentrations up 
to 0.01 M.36 
With the average man containing approximately 1 kg of hemoglobin, its major 
functions aside from O2 transport include CO2 transport and buffering the blood to 
maintain its homeostatic environment.38  It has a molecular weight of 64,458 kD and 
overall dimensions of 64 x 55 x 50 Å.28,38  Its tetrameric nature allows for its complex yet 
efficient oxygen binding properties.   
Hemoglobin (Hb) contains two distinct entities:  the globular portion of the 
protein and the heme group.  The apoprotein of adult hemoglobin A1 consists of two α- 
and two β-subunits (α2β2), whereas subtype A2 is designated α2δ2 and F is α2γ2.38  The 
heme group consists of the reduced form of iron (Fe2+) which binds to the molecular 
oxygen for transport.  The discussion on Hb characteristics will focus on the most 
common subtype, A1.   
The α-chain contains 141 amino acid residues and the β-chain has 146 residues, 
with approximately 70 – 75% of both chains arranged as a series of α-helices (7 in the α-
chain and 8 in the β-chain with the helices named A-H and A-G respectively starting 
from the amino-terminus).14,38,39  A heme (ferroprotoporphyrin IX) is noncovalently 
associated with each subunit in the space created between helices E and F (Figure 2.16).  
The heme is tucked into a hydrophobic pocket, which acts as the stabilizer to the binding 
of the molecule to the protein subunit.  That is, specific hydrophobic amino acid residues 
are within proximity of the heme for van der Waals contact.  The hydrophobicity also  
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Figure 2.16:40  The β chain of hemoglobin shows the globular tertiary structure 
consisting of eight α-helices.  The heme group is tucked in the crevice between helices E 
and F.   
 
 
Figure 2.17:28  A structural depiction of the heme molecule.  The protoporphyrin IX 
consists of four pyrrole rings linked in a heterocyclic ring system.  The Fe(II) center is 
chelated to the four nitrogen groups.  The proximal histidine (F8) can be seen coordinated 
to the iron from the bottom of the plane and the molecular oxygen binds to the iron on the 
opposite side. 
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repels any small polar molecules away from the ligand binding site.  Furthermore, a 
nonpolar crevice makes the oxidation of Fe2+ to Fe3+ more difficult.14 
The heme consists of an iron (II) coordinated to the nitrogens of four pyrrole rings 
in a heterocyclic ring system named protoporphyrin IX (Figure 2.17).  When the heme is 
situated in a hemoglobin subunit, the iron is also coordinated covalently to the imidazole 
 
 
 
Figure 2.18:28  An illustration of the heme pocket in the deoxygenated state.  The 
proximal histidine (F8) is coordinated to the iron center as a part of a square pyramidal 
geometry.  In the pocket, the heme is surrounded by mostly hydrophobic residues, which 
keeps out small polar molecules.  The distal histidine (E7) stabilized the ligand in the 
oxygenated state.  In the absence of a ligand, the heme adopts a domed shape.   
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nitrogen of the proximal histidine (histidine F8) to form a square pyramidal geometry in 
the deoxygenated state (Figure 2.18).  When a molecular oxygen associates to the Fe in 
an octahedral geometry, a distal histidine (E7) will hydrogen-bond to the ligand to 
stabilize it.36,38  Moreover, in the deoxygenated form, the iron center is pulled by the 
proximal histidine approximately 0.6Å out of the plane of the heme (Figure 2.19) to form 
a slightly domed structure.  However, when an oxygen binds, the iron is pulled back into 
the heme plane, causing strain in the ring structure.  The movement of the iron center 
repositions the proximal histidine and alters the distance between certain residues, such 
as Val FG5, and the heme (they become closer).  Additionally, the proximal histidine is 
tilted with respect to the heme plane in the deoxygenated state, but becomes more  
 
 
 
Figure 2.19:36  When deoxygenated, the iron is pulled out of the heme plane ~0.6Å 
whereas the iron resides in the plane in the presence of a ligand.  The shift affects the 
tertiary structure, and ultimately, the quarternary structure of the tetrameric hemoglobin 
molecule. 
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perpendicular when the iron is retracted into the plane (in the oxygenated state), 
subsequently affecting the positioning of certain neighboring residues.41  Such shifts 
within the subunit will cause the globular structure to reorganize, resulting in a 
conformational change.36,41  A shift in one subunit will affect the conformation of the 
juxtaposed hemoglobin subunits, and such is the basis for its cooperative properties 
(discussed later in this chapter). 
The quarternary structure involves the subunits of the tetramer being held together 
by a combination of direct hydrogen bonds, solvent mediated hydrogen bonds, 
hydrophobic contacts and salt bridges.14   The deoxygenated form is typically known as 
the T (tense) state and the oxygenated form is considered the R (relaxed) state.36,38,41  
While the R state is stabilized by ligand binding, the T state is a more rigid form and it is 
stabilized by a series of salt bridges that involve the C-terminal residues of each subunit; 
residues which are otherwise free.38  Furthermore, the T state has a Val E11 in the β 
subunits positioned on the distal side of the heme, hindering ligand binding.41  The α-β 
interface also shows two stable positions that switch between the states.  In the T state, 
Tyr αC7 hydrogen bonds with Asp βG1, but upon oxygenation, the R state causes a shift 
in the interface, which is now stabilized by a hydrogen bond between Asp αG1 and Asn 
βG4 (Figure 2.20).  In both conformations, the hills and valleys on the surfaces of 
subunits complement each other well, such that any intermediate positioning is not 
energetically favorable.36     
Another factor that favors the deoxygenated state of hemoglobin is the presence 
of the compound 2,3-diphosphoglycerate (2,3-DPG) (Figure 2.21).  2,3-DPG binds  
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Figure 2.20:36  This figure illustrates the dynamics in the α-β interface between the T 
and R forms of hemoglobin.  In the T form, Tyr αC7 hydrogen bonds with Asp βG1.  
The R form sees a shift in the interface and a new interaction between Asp αC1 and Asn 
βG4.  The hills and valleys of the surfaces complement each other  in both conformations 
such that any intermediate would be unstable.   
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Figure 2.21:  Structural formula for 2,3-diphosphoglycerate (2,3-DPG).   
 
tightly to the central cavity created by the four subunits by way of electrostatic attractions 
and hydrogen bonding.  The molecule has an important function for the following reason.  
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In arterial blood, where oxygen is abundant (pO2 ~100 torr), approximately 95% of the 
hemoglobin is saturated with oxygen.  As it circulates, the red cells release ~40% of the 
oxygen.  Due to hemoglobin’s high affinity for O2, it is the presence of 2,3-DPG that 
allows for the efficient delivery of oxygen.28 
 
Hemoglobin Cooperativity 
  The complex series of conformational dynamics that stems from the interaction of  
O2 to the heme and ultimately affecting the quarternary structure plays an important role 
in the hemoglobin’s ability to effectively deliver oxygen.  This allosteric behavior of 
hemoglobin can be seen in an oxygen dissociation curve of fractional oxygen saturation 
(Y) as a function of partial pressure of oxygen (pO2).  Figure 2.22 shows a sigmoidal 
curve for hemoglobin compared with myoglobin (a single subunit oxygen carrier similar 
in structure to one of Hb’s subunits) which shows a hyperbolic curve reflecting its lack of 
allostericity.  The myoglobin curve suggests that it will not release its bound oxygen until 
the partial pressure of O2 in the surrounding environment drops below 20 torr.  Although 
a single hemoglobin subunit has similar affinity to oxygen as myoglobin, the cooperative 
feature of the tetrameric structure of hemoglobin helps lower its attraction to O2 with 
every subsequent O2 it loses.  As noted before, this is due to the conformational change 
experienced by each subunit from the loss (or gain) of a ligand.36  The sigmoidal curve of 
isolated hemoglobin in itself is a significant reflection of the regulatory feature of oxygen 
delivery.  However, in its native environment (in erythrocytes), the presence of such 
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factors as 2,3-BPG further modifies the profile of the oxygen dissociation curve.  Hence, 
red cells show a more reduced oxygen-binding capacity than hemoglobin by itself.   
 
 
Figure 2.22:28  Oxygen binding curves of hemoglobin and myoglobin, with the 
hemoglobin curve showing a sigmoidal shape denoting its allosteric behavior. 
 
 
Hemoglobin Derivatives 
 In its primary function as an effective oxygen-carrier, hemoglobin houses its iron 
atoms in the reduced state.  The molecule, however, can exist in small quantities with the 
iron in an altered oxidation state.  Additionally, hemoglobin exhibits the capacity to bind 
to ligands other than molecular oxygen.   
 Methemoglobin is the form of hemoglobin that exists with oxidized irons.14  In 
this state, the molecule loses its ability to reversibly bind molecular oxygen, hence it is 
not the preferred physiological form.  As oxyhemoglobin is converted to methemoglobin, 
the color changes from bright red to a dark brown color, corresponding to shifts in the 
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absorption peaks at ~410 nm and 500-600 nm.14,42  Although the mostly hydrophobic 
pocket in which the heme resides prevents the oxidation of the iron to a degree, it cannot 
prevent it completely.  In vivo, methemoglobin reductase (also known as cytochrome B5 
reductase) is present to reduce the methemoglobin in order to maintain normal 
concentrations at <1.5% of the total hemoglobin.43,44  Methemoglobin’s affinity for 
cyanide (CN) has been exploited in the development of a standard assay for total 
hemoglobin quantification.  All forms of hemoglobin with the exception of 
sulfhemoglobin is converted into the stable cyanohemoglobin form and assayed at 540 
nm with respect to a standard curve.45,46,47 
 Hemoglobin in its reduced state also has potential ligand alternatives beyond O2.  
Carboxyhemoglobin involves carbon monoxide (CO) binding to the heme center with an 
affinity that is approximately 200 times stronger than that of oxygen.  This is due to the 
fact that the rate of dissociation of CO is significantly slower that O2.14  The presence of 
0.1% atmopheric CO would convert 50% of the hemoglobin into its carboxy derivative 
and prove to be fatal within one hour as a result of oxygen deprivation to the body.48 
Sulfhemoglobin is a form in which sulfur is bound to the porphyrin group of the heme 
and lowers the iron’s affinity to oxygen ~100 times.14  It is typically caused by, but not 
limited to, the ingestion of drugs, such as sulfonamides and phenacetin.14  
 
2.4  Current Methods of Red Cell Analysis 
 Red cells are typically analyzed for transfusion viability at blood banks by 
monitoring such parameters as cell counts and hemoglobin concentrations.  A common 
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automated method for obtaining such values is electric impedance-based hematologic 
analyzers like the Coulter counters.49  In these instruments, the cells are passed into an 
aperture and through a constant electric current.  The impedance caused by the cells as 
they pass through the current results in a voltage spike which is converted into the 
volume of the cell.  Thus, the volume of the cell is proportional to its induction of current 
change as it travels through the aperture.49,50   
 Cell types (erythrocytes, leukocytes, platelets) are identified based on size cutoffs 
of their known physiological distributions, hence the counts and mean cell volume are 
obtained.  Knowing these two values, the % hematocrit, or the packed red cell volume 
can be calculated by the relationship: 
 
Mean corpuscular volume (MCV)51 =         %  hematocrit (HCT)      x  10    (Eq 2.1) 
                 erythrocyte count (x106/µl)  
 
The erythrocytes are then lysed and the hemoglobin is allowed to disperse in free 
solution.  Quantification of the hemoglobin involves the standard Drabkin’s method 
where all forms of hemoglobin are converted to the cyanomethemoglobin derivative and 
compared against standards.  The resulting concentration of the diluted hemoglobin (Hb) 
is reported in g/dL.  The mean corpuscular hemoglobin concentration (MCHC) is 
calculated by the following equation. 
 
        MCHC (%)51 =        hemoglobin (g/dl)      x 100                                       (Eq 2.2) 
                         % packed cell volume  
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Mean corpuscular hemoglobin (MCH) is another interpretation of MCHC and is 
expressed in picograms of Hb/cell.  The above parameters, as the names imply, are all 
average values and they may or may not reflect an abnormality in the donor unit. 
 
2.5  Erythrocytes and Multiwavelength UV-Visible Analysis 
In the context of clinical settings, the need for quality red cells for transfusion 
purposes is immeasurable.  For this reason, blood banks must adopt the latest technology 
in quality control for donated blood to insure that transfusion recipients are getting viable 
blood units and not ones that are infected or incompatible.  The current blood banking 
system implements multiple methods and instrumentations for different analyses 
including cell counts, blood typing, and screening of infections, among others.  Efforts to 
improve upon current technologies in the area of efficiency, accuracy and cost are 
constantly underway.   
Our proposed entry into clinical whole blood analysis revolves around 
multiwavelength ultraviolet-visible (uv-vis) spectroscopic analysis.  Based on the 
knowledge of the optical properties of whole blood components (erythrocytes, 
leukocytes, thrombocytes, plasma), it is possible to obtain size, shape, number, and 
chemical composition information from a single scan.  The spectrograph can be modeled 
as a mathematical representation based on the Mie theory to corroborate with the 
experimental data.  This method has been demonstrated with certain types of blood 
analyses.  The first was a blood typing method in which blood groups were determined 
by changes seen in the spectra when red cells were introduced to agglutinating 
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antibodies.52,53  That is, the spectra showed their sensitivity to changes in particle size and 
number.  Secondly, uv-vis spectroscopy was used for the quantitative analysis for platelet 
quality.9  The multiwavelength analysis successfully estimated the particle size 
distribution (PSD) for platelets and also showed the potential for monitoring platelet 
activation.   
In terms of erythrocyte analysis, the implications of this technology span from the 
routine screening of whole blood to diagnosis of certain types of diseases to online 
monitoring of blood oxygenation during surgeries.  It is important to establish a spectral 
baseline for normal erythrocytes so that any anomalous conditions could be immediately 
detected.  A simple scan of a patient’s whole blood could produce information about his 
or her cell counts, MCV, MCH, MCHC, and the ability to detect any morphology 
variations associated with red blood cells, such as sickle cell anemia (which produces 
sickle-shaped red cells as a result of hemoglobin polymerization).14  Infections may 
potentially be revealed as it has been suggested by data (Garcia-Rubio, L. H. et al., 
unpublished) that blood from individuals infected with the malaria parasite show 
characteristic spectrophotometric features.  Furthermore, the ability to screen transfusable 
units for proper leuko-depletion, or the capacity to confirm the viability of 5-day-old 
blood could enhance the effectiveness of quality control in blood banks.54,55  In this quest 
to spectrally characterize the norm in whole blood, it is necessary to separate the optical 
behavior of each component.  An accurate depiction and the defining of the spectral 
limits of normal erythrocytes are particularly important for a few reasons:  1) it is the 
most abundant cell in the vascular system, 2) it contains hemoglobin, a protein with a 
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high absorptivity (extinction) coefficient, and 3) the majority of the spectral fingerprint of 
whole blood is due to the contribution of red cells.   
In order to use this technology as a multifunctional analytical tool for red blood 
cell quality, it is necessary to establish the optical properties of normal red cells and how 
they affect the absorption and scattering of light.  It is well known that erythrocytes 
contain hemoglobin at a physiologic concentration of 33%.  At such elevated 
concentrations, it has been suggested by using similarly chromophoric compounds 
(chlorophyll, nucleic acids) that the absorbance component experiences an observed 
hypochromism.  In this context, hypochromism refers to a decrease in the absorbance 
(and hence the absorption coefficient) due to an increase in the concentration of a 
strongly absorbing species.56  The phenomenon has been documented in free solution as 
well as the absorbing species being stacked in the form of micelles.57,58  It is proposed in 
this study that the UV-visible characterization of red blood cells be approached from the 
context of a combined scattering and absorption effect based on light scattering theory.  
In the process of using this technology to solve the optical behavior red cells, the problem 
of hypochromism will be addressed. 
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Chapter 3:  Multiwavelength Spectrophotometry and Its Application for the 
Characterization of Red Blood Cells 
 
3.1  Features of Spectrophotometry 
Spectrophotometry is widely used for various types of chemical and biological 
analysis, and by its nature spans a broad range of wavelengths.  This dissertation focuses  
on applying the significant potential of multiwavelength ultraviolet-visible (UV-vis) 
spectrophotometry to characterize erythrocytes.  The spectrophotometer used for 
experiments, the Hewlett Packard/Agilent 8453, outputs data in the wavelength range of 
190 – 1100 nm, which covers the near UV (200 – 380 nm), the visible (380 – 780 nm), 
and part of the near infrared (IR) region (780 – 1100 nm) (Figure 3.1).59,60   
 
 
Figure 3.1:59  Diagram of electromagnetic radiation in the UV, visible, and IR regions. 
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Particle analysis requires both the acquisition of spectral data and the ability to 
understand and interpret the absorption and scattering components of the optical density 
spectrum.  The optical density is often referred to as absorbance; however this is typically 
under the assumption that the absorption dominates and that the molecule under analysis 
is small in size on the order of proteins (usually < 10 nm) with negligible scattering.  
Even in this size range, light scattering occurs in the Rayleigh regime and must be 
accounted for interpretation purposes.24  While the absorption component dominates in 
solutions or pure liquids and solids, light scattering still makes a contribution.8  Hence a 
more specific terminology will be established where all raw spectra will be referred to as 
optical density (OD) in this dissertation. 
 
Absorption Component 
 Electromagnetic radiation is a two-component field consisting of an electric (E) 
and magnetic (B) fields (Figure 3.2).  Both constituents are oscillating waves and are 
oriented perpendicular to each other as well as to the direction of propagation.  The rate 
of propagation of the radiation in a vacuum, more commonly referred to as the speed of 
light (c) is equal to 3 x 108 m/s.  The unit energy of the emitted radiation is a wavelength-
dependent function 
   E = hc/λ   (Eq 3.1) 
where h is Planck’s constant (6.62 x 10-34 J-s) and λ is the wavelength.  When the 
radiation travels through a medium and interacts with a chromophoric molecule, the 
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energy is absorbed in a quantized manner.  That is, the light energy must equal the energy 
required to allow for a specific electronic transition.60 
 
Figure 3.2:61  A depiction of a wave of electromagnetic radiation where the magnetic 
field (B) and electric field (E) are perpendicular to each other as well as to the direction 
of propagation.  The wavelength is the distance of one full wave oscillation. 
 
 As inferred above, the energies of UV and visible light absorbed by a molecule 
result in electrons changing energy levels.  Not all electrons can make such transitions as 
is the case with σ-bonds, which requires too high an excitation energy to effectively be 
transitioned.  The allowed transitions that arise as absorbances are n?σ*, n?π*, and 
π?π*, where n is a non-bonding orbital and π are orbitals found in double and triple 
bonds.  The asterisks denote anti-bonding energy levels.  The n?σ* occurs with non-
bonding electrons adjacent to saturated bonds and require energies of short wavelengths 
typically below 200 nm.  The n?π* occurs when a non-bonding electron is elevated to a 
low lying π anti-bonding orbital, such as in the case of the carbonyl moiety in Figure 3.3, 
and it is characterized by relatively a low absorptivity coefficient.  The π?π* transitions 
(Figure 3.4) are usually seen in conjugated systems and show the highest absorptivity 
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coefficients.  In the context of absorbance spectroscopy in the UV and visible wavelength 
range, the n?π* and π?π* transitions are the most relevant.59,60   
 
C O C O
 
Figure 3.3:60  A representation of an n?π* electronic transition in a carbonyl moiety. 
 
C O C O
 
Figure 3.4:60  A representation of an π?π* electronic transition in a carbonyl moiety. 
 
 Inorganic chelates, such as the heme group of hemoglobin, are sources of high 
absorption.  Metals are strongly chelated by moieties like nitrogen that possesses an  
unshared pair of electrons.  Hence there is the possibility for the excitation of these 
unshared pairs of electrons.  The metal atoms themselves typically have high lying 
energy shells and orbitals and they have the capacity for electronic transitions.  Finally, 
the chelate is capable of a charge transfer, or the movement of electrons from the ligand 
to the metal, or vice versa.  These transfers show intense absorbance, owing to the ability 
of the electrons to transition to unoccupied orbitals of the metal ions.60 
 When light travels through a vessel (cuvette) containing a solution of an optically 
absorbing substance, the incident, or source light is attenuated as it exits the vessel.  In a 
particle suspension, the transmitted radiation is a combination of non-absorbed incident 
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light and forward scattered light.  In a solution, where the absorbing species are 
sufficiently smaller than the wavelength and the refractive index of the species compared 
to that of the medium is close to unity, it is categorized in the Rayleigh scattering regime, 
where the contribution of the absorption dominates over that of the scattering.8 
 Considering the above assumption, the Beer-Lambert law is a limit of the Mie 
theory as the particles become infinitely small and the medium-to-particle refractive 
index ratio approaches one.62  Under these conditions, the scattering is negligible and the 
transmitted light exclusively describes absorbance.   The Beer-Lambert relationship, 
typically used for solutions, can be used to calculate a wavelength-dependant absorptivity 
(extinction) coefficient 
A(λ) = ε(λ)lc    (Eq 3.2) 
where A(λ) is the absorbance value at a given wavelength, l is the pathlength of the 
cuvette (typically 1 cm or 0.1 cm), c is the concentration of the solution (moles/L or 
g/ml), and ε(λ) is the extinction coefficient at the given wavelength.63  The extinction 
coefficient is defined by Bouger’s Law,  
    λ
λπκλε )(4)( =     (Eq 3.3) 
where κ(λ) is the imaginary part of the complex refractive index representing the 
chromophore’s absorptive characteristics (complex refractive index is defined in the 
Optical Properties section of this chapter).  Absorbance in this context can be further 
defined as  
    A = log (I0/It)    (Eq 3.4) 
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where I0 is the incident light from the radiation source and It is the transmitted light seen 
by the detector of the spectrophotometer.   
 The measured data obtained by the spectrophotometer is collected first as percent 
(%) transmission.  The relationship between absorbance and transmission is63  
    A = -log (1/T)    (Eq 3.5) 
where T is transmission, and when converted in terms of % transmission,  
    A = 2 – log (%T)   (Eq 3.6) 
 
Absorption in Proteins 
 Biological systems contain proteins, many of which possess multiwavelength UV-
visible fingerprints from their chemical composition.  This is due to the presence of 
chromophoric amino acids.  The major contributing amino acids are:  aromatic residues 
tyrosine, tryptopan, and phenylalanine, thiol containing cysteine, and its derivative 
cystine (Figure 3.5).64,65,66   
Tryptophan, phenylalanine and tyrosine are all relatively hydrophobic residues 
that have conjugated ring systems and their absorption peaks correspond to the π?π* 
transition.  Tryptophan’s high level of conjugation in its indole side chain results in the 
most intensely absorbing bands.  It is a bulky residue that occurs less frequently in 
proteins than other residues.   Phenylalanine is a chemically non-reactive aromatic 
residue that can participate in hydrophobic pockets.  Tyrosine is slightly more polar due 
to the hydroxyl (-OH) group and has the capability of hydrogen bonding for stability.  
Furthermore, the hydroxyl group can ionize at a basic pH and change its 
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spectrophotometric profile from its protonated state.  Cysteine contains a polar thiol        
(-SH) group and is able to undergo a redox reaction to form a disulfide bond with the 
sulfur of another cysteine residue to forming cystine.  This bond is integral in the folding 
of proteins as it stabilizes tertiary and quarternary structures.67 
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Figure 3.5:  Chemical structures of the chromophoric amino acids that contribute to the 
absorbances of proteins.   
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Scattering Component 
 In a complex heterogeneous mixture such as whole blood, the scattering 
component has a significant presence in the optical density spectra.  This is because of 
the abundance of particles with diameters on the order of micrometers and having 
refractive indices greater than that of the medium.  When incident light encounters one of 
these scattering bodies, the electric component of the electromagnetic radiation induces 
dipole moments within different regions of the particles, exciting them into an oscillatory 
motion.  These accelerated charges reradiate the energy in all directions and it is this 
radiation that is referred to as scattered light.8  
 Although all media scatter light to some extent through events such as density 
fluctuations, the scattering caused by particles in suspension is the most profound.  
Understanding how to translate the data will allow the investigator to obtain size, shape, 
and orientation information on the particles, given that the chemical composition of the 
particles is known.   
 
3.2  Light Scattering Theory 
Scattering Trends 
 When the particle is small compared to the wavelength of analysis, the scattered 
waves are approximately in phase.  This will scatter the light in a relatively uniform 
manner in all directions (Figure 3.6).  However, as the particle increases in size, the 
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scattered waves tend to dominate in the forward direction.  The shape and the orientation 
 
Figure 3.6:8  Scattering patterns for a spherical particle that is small relative to the 
wavelength (Rayleigh scattering) where A is scattering due to a polarized incident light 
perpendicular to the scattering plane, B is unpolarized incident light, and C is polarized 
incident light parallel to the scattering plane.  The source beam originates from the left 
(180o) and the detector resides at 0o. 
 
of the particle with respect to the incident beam will further determine the scattering 
pattern.  Figure 3.7 shows scattering models of a few representative shapes and 
orientations.  The top left is a sphere of significant diameter (~1.24 µm) and it is easy to 
see the dissymmetry of the profile along the plane perpendicular to the unpolarized 
incident beam.  An elliptical particle of equivalent volume (top right) maintains its axis of 
symmetry parallel to the beam similar to the sphere, but the scattering lobes contain more 
oscillations.  When the spheroids are oriented in various angles with respect to the 
incident light, the dissymmetry is evident on all planes.68  To add to the complexity, the 
 52
chemical composition of the particle will determine its refractive index which will have a 
bearing on the magnitude of reradiation.8  
Another important parameter that affects the direction and magnitude of scattered 
light is the size of the particle.  It has previously been discussed that particles small 
compared to the wavelength exhibit Rayleigh scattering and produce symmetrical 
scattering patterns in the forward and backward directions.  As the size of the particle 
increases to be larger than the wavelength of the incident light, the profile becomes 
biased in the direction of forward scattering.8   
 
Figure 3.7:8,68  Scattering profiles of large particles (~1.24 µm) as a sphere, and ellipses 
in various orientations.  The refractive index (m) of the particles is 1.05 and the 
wavelength is 500 nm.   
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 A simulation model based on angular formulations of the Mie theory was used to 
predict angular scattering profiles of large particles.  The model accepted wavelength, 
diameter of sphere, the real and imaginary part of the refractive index of the particle, and 
the refractive index of the medium as inputs.  Holding all parameters  constant except for 
size, Figure 3.8 shows the predicted scattering profile for the optical properties of  
 
 
Figure 3.8:  Calculated scattering patterns of spherical particles increasing in size 
generated using the Mie theory, where λ = 500 nm, the medium is water, and the optical 
properties are that of bacteria.69  With increasing size, the scattering shifts in the forward 
direction. 
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bacteria at λ = 500 nm.  A bacterium is considered a “soft particle” that exhibits a small 
refractive index close to that of the medium compared to particles like erythrocytes that 
show a larger refractive index and a higher visual contrast to the medium.  Results show 
that with an increase in size, there is a noticeable change in favor of forward scattering.  
Analysis of particles with larger refractive indices, polystyrene and alumina, yield a 
similar trend.   
Understanding this phenomenon is advantageous to our work with erythrocytes 
which are approximately 8 µm in diameter, or ~5.5 µm in diameter in terms of an 
equivalent sphere.  Reynolds (1975) showed the forward scattering trend to be true for 
erythrocytes using the Rayleigh-Gans-Debye approximation which accounts for the shape 
of the scattering particle.70  A log polar plot of the scattering intensities (at 800 nm) 
predicts the strong forward scattering of the erythrocytes.70  Our calculations based on the 
Mie theory yields similar results (Figure 3.9).  The figure suggests that approximately 
97% of the total scattered light is scattered in the forward direction within a 5o angle.  
The inset shows a semi-logarithmic plot elucidating the oscillatory features of the 
scattering at larger angles.  It is evident by the inset that at an angle of approximately 4o, 
there is an intensity decrease of nearly three orders of magnitude. Thus we can take 
advantage of the forward scattering property of macroscopic particles to effectively 
interpret data captured by varying acceptance angles. 
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Figure 3.9:  Angular scattering prediction for an equivalent sphere red cell.  The large 
plot is a linear plot and the inset is represented as a semi-logarithmic scale.  A majority of 
the scattered light is directed in the forward direction within five degrees.  
 
Mie Theory 
 First published in 1907, Mie theory provides an exact solution to Maxwell’s 
equations for spherical particles and contains information on the refractive index and the 
absorption coefficient of the materials constituting the particles, as well as, on the 
absorption and scattering components of the transmitted light.8,71,72  The optical density 
(OD), sometimes referred to as turbidity, contains various information about the 
particulate system being characterized.  Given enough information about the system, Mie 
theory can provide a general solution for its extinction properties with the assumption 
that the particles in question are isotropic spheres.  Mie theory is widely used because of 
its lack of limitations in two important areas:  1) it is applicable for any size and 2) there 
are no refractive index constraints.8,72  The same cannot be said for related 
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approximations although they are simpler in execution.  For example, Rayleigh scattering 
is limited to particles with diameter (D) << λ (more specifically, it is typically defined as 
being effective for particles < λ/20) and the refractive index of the particle to be close to 
that of the medium (n/n0 ~ 1).8  The Rayleigh-Debye-Gans (RDG) approximation 
perceives the particle as a body containing multiple scattering centers and allows for the 
implementation of particle form factors.  However, this theory limits analysis to particles 
where D ≥ λ and n/n0 ~ 1.8  
 The turbidity (τ) is defined by the equation 
 dDDfmQDN extp )())(,(4
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λαπτ ∫∞=   (Eq 3.7) 
where Np is particle number per unit volume, D is the particle diameter, Qext(α,m) is the 
extinction efficiency which can be evaluated using the appropriate approximation (in our 
case, Mie theory), α is the size parameter, m is the complex refractive index, and f(D) is 
the particle size distribution (PSD).  The size parameter is a function of wavelength (λ) 
and is defined as  
λ
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and the complex refractive index (m(λ)) is 
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where n(λ) is the refractive index of the particle, n0(λ) is the refractive index of the 
medium, and κ is the absorption coefficient of the particle.  (See Appendix A for further 
details of the Mie equations.)  
 The Mie extinction coefficient (Qext) is an important term that defines the sum 
effect of the scattering and absorption components of the particle.  Hence,  
    Qext = Qsca + Qabs   (Eq 3.10) 
where Qsca and Qabs represent the scattering and absorption constituents respectively.  
Thus Equation 3.8 can be separated into two independent terms: 
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Furthermore, the absorption coefficient of chromophores in solution ε(λ), or Beer-
Lambert absorption coefficient is directly related to the Mie absorption coefficient κ(λ)  
through Bouger’s law 
     λ
λπκλε )(4)( =    (Eq 3.12) 
enabling direct comparison of the magnitude of the absorption coefficients for 
encapsulated chromophores and chromophores in solution.8   
 Through the understanding of the turbidity equation, it is possible to use it in a 
constructive manner depending on the available information.  If an experimental 
spectrum of a single population particle system is available and the optical properties are 
known, the size of the particles could be calculated.  Conversely, if enough information 
about the system is obtained through an alternative analysis, it would be feasible to 
construct a spectrum that would correspond closely with the experimental.  The latter 
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case is considered the “direct problem”, where if the particle size, shape, PSD, and 
composition are given, it is possible to predict the intensity of the irradiance in a given 
direction.  The opposite predicament or the “inverse problem” is far more complex as it 
demands the elucidation of particle parameters in an experimental spectrum.8  
 
Optical Properties 
 The complex refractive index (Eq 3.9) of a particle is also referred to as its optical 
properties.  The real part of the refractive index, n(λ), is the component which describes 
the scattering capacity of the particle.  In order for it to be meaningful, it must be 
observed against a reference, which in this case is the refractive index of the medium 
(n0(λ)).  The imaginary part of m(λ), κ(λ), is the absorption coefficient and is prominent 
in strong chromophores such as hemoglobin.  Consideration of the two parts in 
combination with complementary parameters helps paint an optical picture of the particle.  
For example, small spheres absorb proportionally to their volume, whereas large metallic 
spheres absorb only about half of the radiation striking their surface implying that it is a 
strong scatterer.72   
 Furthermore, the ratio of the refractive index to that of the medium dictates the 
sensitivity of the measurement.  A high ratio of n(λ)/n0(λ) implies a high level of visual 
contrast of the particle.  Erythrocytes contain a significant physiological concentration of 
highly chromophoric hemoglobin (33%) that account for its prominent visibility under 
the microscope and also its intense spectra.  Additionally, the medium itself is 
instrumental in the outcome of the spectral data of a suspension.  It has been 
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demonstrated by Garcia-Rubio (1992) that a change in the refractive index of the solvent 
will cause shifts in optical density peaks, a phenomenon that can be readily corrected 
for.73 
 As the notation indicates, the complex refractive index is a function of 
wavelength, thus it is not the same throughout when dealing with multiwavelength 
spectrographs.  Obtaining a full frequency range of reliable optical properties dictates the 
accuracy of the mathematical estimations.  One way is to acquire dependable optical 
density data on the particle being characterized.  In the case of hemoglobin, absorbance 
spectrum over the entire wavelength (190 – 1100 nm) is obtained experimentally and the 
extinction coefficient (ε(λ)) is generated.  Through Bouger’s Law (Eq 3.12), κ(λ) can be 
calculated.  Using the Kramers-Kronig transform, the full multiwavelength complex 
refractive index can be obtained.  In this relationship, if either n(λ) or κ(λ) are known, the 
unknown parameter may be calculated.8  
 
Mie Theory Considerations 
 Although the Mie theory is a versatile and widely used approximation, it is 
important to understand that it is not the definitive solution to all particle optics.  It may, 
however, be a powerful tool if used within its constraints and great care is taken in 
making certain assumptions.  One case is the seemingly limited use of the theory on 
particles which are strictly isotropic spheres.  It has been shown, however, that when 
working with particle sizes in the micron range, the forward scattering becomes dominant 
(Figure 3.9).  Various studies with protein aggregates, platelets, and microorganisms, 
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have demonstrated that using equivalent-volume spheres produces reliable estimations of 
the transmission spectra.9,74,75  The biconcave shape of red blood cells proves to be no 
different as the studies in this dissertation suggest that the equivalent sphere 
approximation yields dependable calculations.   
 Another consideration is the relationship between particle concentration and the 
light interaction among multiple particles.  In theory, it would be easiest to examine the 
optical behavior of a single particle, but in reality, this is not the case as the particles are 
suspended in media in numbers.  The problem posed by a concentrated particle 
suspension is presence of the multiple scattering phenomenon.  Given that the system is 
crowded enough, the scattered light will be reradiated by numerous particles, 
complicating the interpretation of the spectrum.  In the case of erythrocytes, it has been 
determined that diluting whole blood or a red cell suspension to approximately 4000 
cells/µl provides enough separation of the cells in the media that it does not give rise to 
the multiple scattering problem.  The value of ~4000 cells/µl is not an arbitrary number.  
It is a concentration that produces an optical density value nearing the upper limit (1.2) of 
the linear range of the spectrophotometer.  (See Appendix B for details of multiple 
scattering and instrumental limits in the context of our methods.) 
 
3.3 Spectroscopy of Blood and Erythrocytes 
Spectroscopy of Whole Blood  
 Since blood is one of the most important biological fluids dealt with in clinical 
settings, much is known about its properties as well as methods of its evaluation.  In 
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terms of optics, Angstrom was the first to use spectroscopic methods to study blood 
characteristics in 1855, and the spectroscopy of hemoglobin came soon after in 1862.76  
Since this time, advancements in this field of research have brought about various ways 
of depicting the optical properties of blood components.  In terms of optical contributions 
by cells, erythrocytes which compose approximately 99% of all blood cells, is the major 
contributor of spectral features.  This is further compounded by the fact that the 
hemoglobin is a strong chromophore.  It is not to say, however, that other cells such as 
leukocytes and platelets are spectrally invisible.  The sensitivity of multiwavelength UV-
visible spectroscopy allow for the detection of more subtle changes such as leukocyte-
depletion.  Changes in spectral features as a result of platelet activation can be detected as 
well, with calculations reflecting the alterations in the platelet count and size due to 
aggregation.9  Moreover, the plasma, which is approximately 55% of the total whole 
blood volume, will contribute absorbance bands in the UV range owing to its protein 
content.   
 
Spectroscopy of Erythrocytes 
 The topic of interest in this dissertation is the erythrocyte and its behavior in a 
field of light.  The spectroscopic study of red cells is facilitated by some important 
properties of red cells:  1) it contains hemoglobin, a strong chromophore, 2) it exists free 
in a suspension unlike tissue cells hence it can be diluted into the realm of single 
scattering 3)  it can be isolated with relative ease due to its density, 4) there are seemingly 
no complex internal structures (although the formation of transient structures of 
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aggregated hemoglobin cannot be completely discounted), and 5) its properties fit within 
the acceptable limits of the Mie theory.  In order to intelligently scrutinize red cells and to 
be able to make certain well-informed assumptions in relation to spectral 
characterization, several important parameters must be considered:  the hematocrit (i.e. 
concentration), hemolysis, osmolarity, aggregation, orientation, sedimentation, and 
deformation of the cells.76  Hemolysis in the red cell suspension would be evident as a 
significant hemoglobin band (417 nm) band in the red cell spectra and the investigator 
must be alert to noticing such changes.  Sensitivity to hemolysis would be valuable to the 
quality control of whole blood in blood banks.  Changes in osmolarity would modify both 
the size and the shape of the cell.  Red cells placed in hypotonic media will expand into 
an ellipsoid and cells in hypertonic media will shrink.  A suspension of red cells has been 
suggested to adopt some degree of organized orientation and a complete optical 
characterization of red cells would require the interpretation of these orientation effects 
with respect to the spectral features.77  For this reason, applying mechanical force to the 
system in an effort to orient the cells in some uniform fashion should manifest changes in 
the spectra.  Additionally, the density of the cells will cause erythrocytes to sediment to 
the bottom of the suspension over time.  The rate of sedimentation, however, is low and 
settling takes place over a course of hours.78  Finally, the flexible membrane of the red 
cells allows them to deform as they flow through blood vessels.  In a relatively static 
experimental system (suspended in a medium inside of a cuvette), no such force is 
present to deform the shape of the cell to any significant extent.  However, Brownian 
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bombardment of the membrane cause flickers in the cells that may play a role in its 
orientation and sedimentation rates.77 
 Erythrocyte modeling has been shown to fit within the framework of the Mie 
theory.  One reason for this success is that red cells do not contain any organelles hence 
they may be generally treated as homogeneous scatterers.  Steinke and Shepherd showed 
by using single wavelength scattering that the calculated scattering cross section of the 
RBC can predict experimental values of the cells.79  The merit of using the Mie theory 
has been independently confirmed, and the theory has also been applied to two-angle 
light-scattering measurements for the determinations of hemoglobin concentration and 
erythrocyte volume.80,81   
 The difference in our approach stems primarily from the analysis of multi-
wavelength spectra in the UV, visible, and near-infrared regions.  Our efforts exist on a 
grand scale as we attempt to examine particle characterization across the entire 
wavelength range of 190 – 1100 nm.  In doing so, we hope to gain the knowledge to 
recognize qualitative spectral features related to hematologic parameters as well as 
developing the ability to reliably quantify values such as cell volume, cell number, and 
hemoglobin concentration.   
 Generally in particle suspension analysis, the optical density of a particle 
suspension is directly affected by changes in the medium, the shape of the particle, or the 
chemical composition of the particle.82  The result may be a shift in maxima, an increase 
or a decrease in the overall elevation of the spectrum, or the masking or unmasking of 
absorption peaks by the scattering component.  Red cells fall into the regime of 
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macroscopic particles where scattering eclipses much of its absorptive features, rendering 
its analysis to be more complex than simply taking the sum of its parts.  An important 
contributor to the large-particle effect of erythrocytes is the hemoglobin encapsulated 
within the cells.   Its strongly chromophoric quality gives rise to whole particle scattering 
which in turn is related to its high physiological concentrations.   
 
Spectroscopy of Hemoglobin 
 In order to spectroscopically characterize red blood cells, it is important to first 
examine the extinction spectrum of hemoglobin.  Figure 3.10 shows the multiwavelength 
extinction spectra of two common hemoglobin derivatives, oxyhemoglobin and 
methemoglobin.  The spectrum of oxyhemoglobin was obtained experimentally by 
members of our group, using commercially available human hemoglobin A0 (Sigma-
Aldrich).  The spectrum of methemoglobin was mathematically acquired.69  Both spectra 
agree well with previously published data.83  The oxyhemoglobin derivative exhibits 
characteristic bands at 270, 337, 417, 547, and 575 nm.  The methemoglobin shows a 
larger peak around 400 nm that is shifted compared to that of the 417 nm oxyhemoglobin 
peak.  Moreover, the methemoglobin no longer shows that 547/575 nm doublet, 
characteristic of the oxyhemoglobin.  This work uses oxyhemoglobin as the primary 
derivative in the modeling of red cell spectra.  This assumption is accurate since red cells 
exposed to the atmosphere become almost completely oxygenated.  A small amount of 
the oxyhemoglobin may become oxidized to methemoglobin and this will be examined 
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briefly by a version of our interpretation model (for the quantification of hemoglobin) in 
Appendix G.   
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Figure 3.10:  Extinction spectra of oxyhemoglobin and methemoglobin.  Each has 
unique features that reflect the characteristics of the heme group.  
  
Hypochromism 
Although erythrocytes can be described as translucent biconcave ‘bags’ 
containing a homogenous distribution of hemoglobin, this simplicity is deceptive when 
considering its light scattering properties.  Successful characterization and modeling of 
red cell spectra begins with the acquisition of reliable optical properties for hemoglobin 
and knowledge of the constraints of our model system.  Moreover, when dealing with a 
strongly absorbing protein such as hemoglobin at high concentrations, we cannot ignore 
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the possibility of the significance of a hypochromic effect reported in similarly 
chromophoric biomolecules like chlorophyll and deoxyribonucleic acid (DNA).84,85,86,87  
Hence, observed hypochromism is defined as any decrease in the observed absorption 
coefficient relative to the solution spectrum of the same chromophore (Beer-Lambert).  
Bear in mind, that this is a specific usage of the term and is different from the decrease in 
absorbance seen with a proportional decrease in the chromophore concentration.   
Early perceptions of the hypochromic effect of biomolecules surfaced in the 
1950s and 1960s which largely dealt with the stacking behavior of polynucleotides with 
respect to optical density.86,88  Moreover, chlorophyll in chloroplasts was reported to 
cause permutations in transmission spectra.85  Molecular hypochromism was defined by 
these studies to be a decrease in absorption (and extinction) due to changes in electronic 
interactions from altered proximity between chromophores.5  The studies typically dealt 
with chromophores in polymeric structures where one absorbing center would shield an 
adjacent absorbing center such that the second molecule is seeing a local field produced 
by the neighboring molecule, not the field from the incident light.  Although more than 
one type of interaction influence the change in optical density, the predominant effect is 
thought to be the Coulombic interaction between the dipoles of the molecules.  Lawley 
(1956) showed this phenomenon with DNA when he compared two different 
arrangements of the polynucleotides (Figure 3.11).88  The band of greater amplitude 
represents DNA in its denatured state.  When the nucleotides are stacked in a more 
ordered double-helix, however, the extinction coefficient decreases by up to 35%.       
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Vekshin (1999) showed a similar effect by the empirical stacking of adenines into 
an oliginucleotide.89  The result is illustrated in Figure 3.12 where the X-axis is the 
adenine count of poly(A) and the Y-axis is the optical density.  As the oligonucleotide 
chain was increased in length, the optical density at wavelengths of 210 nm and 260 nm 
 
Figure 3.11:88  An example of molecular hypochromism exhibited by DNA in a double 
helical configuration.  When denatured into a random coil, the DNA shows a higher 
extinction band. 
 
decreased by as much as 28%.  Vekshin proposed a model that accounts for the 
hypochromic phenomenon not in terms of dipolar interactions but as a probability 
function describing the likelihood of the k-th chromophore in a stack seeing and 
absorbing the light that is not shielded by an adjacent chromophore.90  The probability of 
absorption of the first chromophore of the stack as a function of wavelength (P1(λ)) is 
defined as 
 68
P1(λ) = σ(λ)/S1 
where σ(λ) is the absorption cross-section and S1 is the effective geometric area of the 
chromophore.  The probability of light absorption by the k-th chromophore is defined as 
          Pk(λ) = [1-P1(λ)]k-1P1(λ) 
and the probability of light absorption by the whole stack is 
       P0 = P1(λ) + P2(λ) + ….. Pk(λ) 
 
Figure 3.12:6  The effect of chain length of a polyadenine oligonucleotide on optical 
density, where the x-axis is the chain length and the y-axis is the optical density.  With 
increased stacking, a molecular hypochromic effect is seen, decreasing the optical density 
by up to 28%. 
 
 
210 nm
260 nm 
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In Figure 3.13, Vekshin showed that his model was able to account for the 
molecular hypochromism of stacked poly(A) oligonucleotides.6  Curve 1 shows the 
extinction spectrum for of adenosine and curve 2 is the spectrum for penta-adenosine 
phosphate.  The stacked nature of the penta-adenosine properly shows the expected 
hypochromism.  Furthermore, the calculated prediction of the penta-adenosine (curve 3) 
fits the experimental data fairly well. 
 
Figure 3.13:6  Theoretical vs. experimental spectra of poly-adenosine stacks.  Curve 1 is 
experimental data of single adenines and curve 2 is that of penta-adenosine stacks.  The 
molecular hypochromism is evident in the stacks.  Curve 3 is a theoretical calculation of 
the penta-adenosine spectrum using Vekshin’s model. 
 
 
 In terms of hemoglobin, its high extinction coefficient raises the question of 
potential molecular hypochromism.  At low concentrations of hemoglobin on the order of 
spectral dilutions (< 15 mg/ml), the molecules are dispersed enough so that no significant 
stacking or dipolar interactions are present.  With increasing concentrations approaching 
the physiological value of ~33% (330 mg/ml), the molecules reside significantly close to 
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one another.  Nonetheless, contrary to the fixed nucleotides of a helix where the partially 
stacked bases are in Van der Waals contact, hemoglobin encapsulated in red blood cells 
presumably exist as independent proteins with their intermolecular distance estimated to 
be 62 – 75 Å36,91 (compare to hemoglobin dimensions of 64 x 55 x 50 Å).28,38  Under 
such conditions, random collisions are prevalent, however, the effect of organized 
molecular hypochromism is questionable. 
 Studies based on the Mie theory done by our group predicted a decrease in the 
absorption component of hemoglobin when encapsulated in erythrocytes, an event that 
can be accounted for by a second classification of observed hypochromism:  macroscopic 
hypochromism.  This is defined as a phenomenological decrease in the absorption due to 
the combined effects of absorption and scattering of chromophores in aggregated and 
encapsulated systems.  The effect is directly related to the size of the particle and the 
refractive index of the particle both of which describes whole particle scattering.  Such 
effects could be implicated in erythrocytes, given their size and chemical composition.  
Mie theory converges to the Beer-Lambert law under the conditions that the molecular 
size approaches zero and the particle-to-medium refractive index ratio (n/n0) approaches 
one.73,92   This means that the optical density of the system is a direct result of the 
absorption component, with the scattering component becoming negligible.  However, as 
the encapsulated hemoglobin concentration is increased, our Mie-based simulations 
suggest that a scattering-related decrease in absorption transpires.   
 Historically, spectroscopic work has been done on red blood cells with mixed 
results due to conflicting interpretations of models and/or experimental systems.  Kramer 
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et al. (1951)93 suggested that non-hemolysed blood does not follow the Beer-Lambert 
Law due to its scattering properties and “by the magnified absorption of light by 
intracellular hemoglobin due to the refraction of light between and within erythrocytes.”  
The paper attributed part of the attenuation of the transmitted light to an increase in light 
absorption.  Anderson and Sekelj (1967) observed undiluted blood in an integrating 
sphere spectrophotometer.94  By implementing a model correcting for the multiple 
scattering effects of the concentrated particulate system, Anderson and Sekelj showed 
that the absorption of light was the same in both an erythrocyte and a hemoglobin 
solution.  In contrast, our studies using the Mie theory suggested that the high refractive 
index difference between the erythrocyte and the medium resulted in the dominant 
contribution of the scattering component with very little chromophore sampling by the 
light.  The deconvolution of spectra by means of light scattering theory supports this idea.  
The question of hypochromicity bears multiple layers: 
1. In an encapsulated system such as red blood cells, do the internal chromophores 
exhibit molecular hypochromism as suggested by other studies or can it be 
explained by the scattering theory as macroscopic hypochromism (or a 
combination of the two)? 
2. In studies examining the hypochromism of red cells and related macroscopic 
particle systems, many fail to detail the instrumental configuration of their 
experiments.  That is, the angle of acceptance of the detector is not properly 
defined, hence what has been perceived as molecular hypochromism may be an 
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issue of improper interpretation of data in the context of instrumental 
configuration.   
 
Considerations of Instrumental Configuration 
 The interaction of light with particles results in absorption and scattering 
phenomena; particles scatter light in all directions and, depending on the experimental 
set-up, changes in the properties of the scattered light relative to the incident light may be 
measured as a function of the observation angle. For finite aperture detectors, the angular 
resolution of the scattered light depends on the acceptance angle (γ) of the detector. 
Therefore the detector response is proportional to a weighted average of the scattered 
intensity over the angles defined by its aperture; a limiting case being measurements with 
an integrating sphere where essentially all scattered light is measured and subtracted from 
the transmitted light to obtain estimates of the attenuation due to absorption.  The angle 
of acceptance is defined in Figure 3.14 and it is related to the radius of the detector and 
the distance of the sample to the detector, where 0o is the direction of the incident light.  
The importance of the acceptance angle stems from the inherently pronounced light 
scattering properties of macroscopic particles as they change in size and refractive index.  
Associated with such change is the angular dependence of scattering and the 
effectiveness of the data interpretation would be a direct correlation to the awareness of 
photometer design.  Latimer (1975)95 detailed the importance of considering the angle of 
acceptance of the detector, however his work has been largely ignored. 
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Optical scattering analyses of erythrocytes have typically been limited to a single 
wavelength79 or to a small number of select wavelengths,80,81,96 while multiwavelength 
representations have been reported as diffuse spectra.6,7  Diffuse transmission spectra 
(DTS) results from the acquisition of a large amount of scattered light at wide 
 
Figure 3.14:  Schematic representation of the angle of acceptance.  The size of the 
detector radius determines the amount of scattered light captured by the 
spectrophotometer. 
 
 
angles and is typically defined by the angle of acceptance of the detector.82  The 
collection of diffuse scattering plays an important role in the features of an optical density 
spectrum of a macro-particle system.  Light collected by a small acceptance angle shows 
a general increase in the OD and a larger addition of the scattering component compared 
to that obtained with a larger detector angle.97  In contrast, data for red cells reported as a 
DTS shows an overall decrease in the intensity of the spectrum.  This is because as 
scattered light is collected at more angles, the light is averaged out and is subtracted out 
of the transmission spectrum.  Since a small angle transmission spectrum (SATS) collects 
 74
less of the scattered light, the weighted average of the uncollected scattered light is not 
subtracted from the transmission spectrum.  Therefore, it is possible to infer the amount 
of light scattered at angles greater than γ and to successfully deconvolute the spectrum 
into its absorption and scattering components.   
A misconception in the use of OD data of suspensions is that the scattering 
component is a confounding constituent devoid of any significant information, and thus 
eliminated by a simplified scattering correction, such as in the case of Leach and Sheraga 
(1960).98  Spectra of particle suspensions corrected in this manner typically reveal 
absorption bands of decreased magnitudes and introduce a need for an empirical 
correction factor to provide relevant quantitative information.  By accounting for both the 
absorption and scattering components of the spectrum using the light scattering theory, 
apparent alterations in absorption can be justified.   
  
Defining the Problems 
 Although the task of spectroscopically characterizing red blood cells seems quite 
straight-forward, there are a number of confounding issues associated with fact that the 
cells are significant scatterers of light.  These issues are detailed here. 
1. It is necessary to determine the best instrumental configuration for the 
examination of our particle suspension.  Since red cells scatter light, it is 
important to know the acceptance angle of the spectrophotometer, and at what 
acceptance angle the OD spectrum contains the most complete absorption and 
scattering information.   
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2. The examination of molecular hypochromism in a hemoglobin solution is not 
possible due to the limitations of the instrument and the high extinction values 
(see figure 3.10).  The upper concentration limit for the small doublet peaks (500 
– 600 nm) using a 1 mm pathlength cuvette is ~14 mg/ml.  The upper limit for the 
larger 417 nm band is even lower at ~1.5 mg/ml (1 mm pathlength).  This is not 
close to the physiological concentrations of ~330 mg/ml. 
3. Obtaining spectra of free hemoglobin is not a good representation of its optical 
behavior when encapsulated within red cells.  Hemoglobin molecules free in 
solution are small, Rayleigh scatterers and their spectra are represented by their 
dominant absorption features.  However, when they are encapsulated, they affect 
the refractive index of the cell, contributing to the macroscopic whole particle 
scattering properties of the cell.   
4. An effective experimental model system needs to be implemented in order to 
optically characterize the red blood cell and to allow for the evaluation of 
hypochromism.  Corroborative methods for important particle parameters such as 
cell count, hemoglobin concentration, and cell size must be established to 
complement the experimental system. 
5. A dependable theoretical model relying on light scattering theory is necessary to 
evaluate the experimental data.  Mie theory, based on spherical particles of 
equivalent volume, has been successfully tested on particles of smaller refractive 
indices (platelets, microorganisms).  The theory must be tested on red blood cells 
for compatibility.   
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Experimental and Theoretical Approach 
 With the problems clearly defined, a multi-pronged approach was devised 
employing experimental methods in combination with theoretical interpretation.  This 
approach is outlined as follows: 
1. Red blood cell samples were examined in commercially available 
spectrophotometers bearing different acceptance angles to demonstrate the 
importance of optical configuration on spectral features. 
2. Red blood cells were permeabilized and resealed to obtain modified hemoglobin 
concentrations. 
3. Lipid vesicles (liposomes) were used to encapsulate varying concentrations of 
hemoglobin or other model protein.  (See Appendix C) 
4. A mathematical model based on the light scattering theory was used to simulate 
and interpret spectra of the experimental model systems. 
 
An examination of the significance of instrumental design was performed using 
three spectrophotometers with different angles of acceptance.  Purified red cells diluted to 
the same concentration under the same conditions were analyzed on all three 
spectrophotometers and compared.  Each spectrum was also compared to a spectrum of 
free hemoglobin in solution with the mass held constant.  The results obtained from this 
study allowed us to determine the optimal photometer design for red cell characterization 
and to verify the reliability of previously published studies. 
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The next proposed experimental approach was to isolate red cells and manipulate 
the hemoglobin concentration across various ranges to examine its spectral 
manifestations.  A modified protocol was established for this purpose.  The red blood 
cells were permeabilized in a hypotonic buffer solution to cause the cells to spill out 
hemoglobin in different amounts.  The partially drained cells were then forced to reseal 
by restoring the tonicity of the solution.  The result was red cells containing modified 
amounts of hemoglobin.   
It may appear that the characterization of unmodified erythrocytes alone is 
enough to answer most questions, but it will not present the complete picture.  If our 
knowledge is limited to normal physiological parameters, applications of this analysis 
cannot be extended into abnormal values.  It is also in the interest of pure science to 
broaden the limits of the study as wide as possible.  Hence the target of the red cell 
modifications was to achieve encapsulated hemoglobin concentrations in the medium 
range (MCHC ~ 15-20% w/v) and in the low range (MCHC ~ 5-10% w/v) to characterize 
a trend, if any, in the absorption and scattering components of the optical density spectra.   
 A theoretical model based on the Mie theory was used to analyze the spectra 
acquired from the modified red cells.  Using the particle parameters obtained from a 
hematology analyzer (see Chapter 4), the model was used to simulate features and trends 
seen in the experimental data.  Moreover, the Mie theory was extended to interpret the 
spectral data to elucidate values for particle parameters such as particle count, particle 
size, and hemoglobin concentration.   
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 Finally, the possibility of using a liposome model to encapsulate hemoglobin and 
model proteins was explored (Appendix C).  Results showed, however, that the 
liposomes were hard to characterize optically due to their multi-lamellar nature and small 
size (10-9 m diameter).  Although extended work on the liposome model would have 
resolved such issues, the modified red cell approach in combination with the theoretical 
model offered conclusive answers to the problems defined in the previous section.   
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Chapter 4: Spectrophotometry of Purified and Modified Red Blood Cells 
   
4.1 Hypotonic Modification of Erythrocytes 
 Hypotonic modification of red cells has been used for various purposes including 
loading the cells with isotope-labeled hemoglobin, hemoglobin S and C, dextran, ferritin 
and enzymes.99,100,101,102,103  The biological tool has demonstrated its usefulness in 
different ways, ranging from model systems of membrane behavior to delivery devices 
for enzyme therapy.  The manipulable characteristics of the red cell membrane proved to 
be advantageous in modifying the encapsulated hemoglobin concentrations thus we have 
developed a protocol exclusively for the purpose of our investigation.   
 The erythrocyte membrane under native conditions is normally not permeable to 
large proteins such as hemoglobin.  Upon addition of a hypotonic buffer, however, the 
change in the osmotic pressure on the outside environment will cause water to enter 
through the semi-permeable membrane and instigate cell swelling.  The osmotic pressure 
(π) can be defined by the equation π=MRT where M is the molarity of the solution, R is 
the ideal gas constant (0.0821 L-atm/mole-K), and T is temperature in Kelvin.63  Thus in 
a hypotonic medium, the internal osmotic pressure of the cell will become greater than 
that of the medium (πint > πext), initiating the flow of water into the cell (Figure 4.1).  
When the internal pressure is great enough, the membrane produces holes of roughly 200 
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- 500 Å allowing the passage of large molecules.101  Seeman (1967) reported that the 
holes were transient and exist only for 15 – 20 seconds following the hypotonic shock.104  
During this time, a chemical gradient generates the flow of material in and out of the cell.  
Tonicity is then restored to isotonicity (0.9% ionic strength) to assist in the resealing of 
the cell.100,101,113 
Hb
Hb
Introduction of hypotonic buffer
Critical step! Incubation, restoration of tonicity
πint > πext
 
Figure 4.1:  Illustrated representation of the hypotonic permeabilization of red blood 
cells.  The final hemoglobin concentration in the restored cells is controlled by the time 
of incubation after the cells are permeabilized. 
 
 According to a study by Bodemann and Passow (1971), the hypotonic shock 
procedure produces three types of cells:  type I are cells that reseal relatively quickly 
following hemolysis, type II cells reseal after restoration of the media to its original ionic 
strength, and type III are cells that remain lysed and never reseal.113  Temperature 
conditions during the experiment affect cell resealing as well.  At 0 oC, there are virtually 
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no type I cells but mostly type II whereas experiments done at 37 oC show that the 
proportion shifts in favor of type I cells.  Furthermore, the permeabilization step 
performed at 0 oC and 25 oC show the presence of approximately 38% type III cells, but 
cells modified at 37 oC show that 75% of the cells are type III.   
The purpose of our red cell modification was not to load the cells with foreign 
molecules, but to reduce the internal hemoglobin concentration for spectral interpretation 
(i.e., hemoglobin out, H2O in).  Thus a modified protocol was established.  The method 
had three distinct steps:  1) hypotonic shock, 2) incubation, and 3) restoration of tonicity 
for resealing (Figure 4.1).  It was found that the resulting hemoglobin concentration of 
the restored cells could be controlled by managing the volume of hypotonic buffer, and 
the incubation time.  For a desired MCHC in the low range (~ 0.05 – 0.15 mass fraction), 
a relatively large volume of buffer was used for permeabilization and the sample was 
incubated for 30 minutes on ice prior to the resealing step.  In this case, the hemoglobin 
concentration gradient is large and the low temperature maintains the membrane holes 
while the gradient is allowed to equilibrate.  If a higher MCHC was intended, smaller 
volumes of hypotonic buffer and shorter incubation times were used (such as a 1:1 
volume ratio of packed red cell to hypotonic buffer). (See Materials & Methods section 
for details.)  The ability to obtain encapsulated hemoglobin concentrations from 
physiological values (~ 0.33 mass fraction) down to very low mass fractions of ~ 0.05 
provides a valuable opportunity for the fundamental investigation of hypochromism.   
 
 
 
 
 82
4.2  Materials and Methods 
The UV-Visible Spectrophotometer 
 The spectral measurements represented in this dissertation were performed 
predominantly on a Hewlett Packard/Agilent 8453 diode array spectrophotometer.  The 
unit houses a single levered cuvette slot (Figures 4.2 and 4.3) and generates optical 
density values across a wavelength range from 190 nm to 1100 nm.  The 
spectrophotometer is interfaced to a personal computer loaded with the Agilent 
Chemstation software which is capable of customizable spectral processing.   
 
 
Figure 4.2:105  The front view of a Hewlett Packard/Agilent 8453 Spectrophotometer 
 
Figure 4.4 illustrates the optical arrangement of the spectrophotometer.  The radiation 
emissions come from two sources:  a deuterium lamp and a tungsten lamp.  The 
deuterium lamp emits light radiation over a wavelength range of 190 nm to 800 nm and 
the tungsten lamp contributes radiation in the higher wavelengths from 370 nm to 1100 
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nm.  The wavelength range of the deuterium lamp corresponds to the ultraviolet and 
visible regions whereas that of the tungsten represents the visible and the near-infrared 
regions.   
 
 
 
Figure 4.3:105 Cuvette slot of an HP/Agilent 8452 spectrophotometer with a levered 
locking mechanism. 
 
  As the source radiation is emitted, the source lens collimates the light 
aimed to pass through the sample.  The shutter opens to allow the light to propagate 
towards the sample and close as soon as the measurement is finished.  Once the incident 
light passes through the sample, the transmitted light is passed through a spectrograph 
source lens which refocuses the light towards the slit.  The slit is a small aperture which 
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limits the size of the incoming beam and prepares it for the grating, which in turn 
separates the light into its full array of wavelengths.  The diode array detects the full 
spectrum of wavelengths and transmits the information to the interfaced computer where 
it can then be manipulated for analysis.   
 
 
Figure 4.4:105  The optical machinery of the HP/Agilent 8453 spectrophotometer. 
 
Types of Spectrophotometers Used 
 The Agilent 8453 spectrophotometer with a 2o angle of acceptance was the 
primary instrument used for data acquisition and analysis.  However, an important aspect 
of our investigation related to apparent hypochromism was suspected to be a result of 
instrumental configuration.  We therefore employed two alternate spectrophotometers 
with varying setups.  Diffuse transmission spectra were obtained using the Perkin-Elmer 
Lambda 900 (Perkin-Elmer, CT) spectrophotometer.  The sample cuvette was placed in 
front of an integrating sphere module and the diffuse spectra was acquired by the light 
being transmitted across the sphere (acceptance angle > 2o).    The Perkin-Elmer Lamda 
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18 fitted with an integrating sphere module (RSA-PE-18, Labsphere, NH) was used to 
collect essentially all of the light scattered by the suspension.   
 
Care and Preparation of the Cuvette 
 The cuvettes used in this project are quartz cuvettes (Starna Cells Inc, CA) which 
allows for sample reading in the ultraviolet, visible, and near-infrared wavelength ranges.  
Cuvette capacities are typically 3 ml and 1 ml, both with a 1 cm pathlength.  The cuvettes 
are handled and stored with care, cleaning as often as necessary to prevent build-up of 
protein deposits on the walls.  An effective cleaning method is sonication in dilute soap 
water for approximately 30 minutes followed by a methanol wash to eliminate any water-
insoluble contaminants.  To ensure that this method does not lead to surfactant build-up, 
an occasional and brief (1 minute) treatment with chromic acid is recommended.  In 
between experiments, the cuvettes are routinely filled and stored with deionized water to 
prevent any residual proteins and other contaminants from drying and adhering strongly 
to the walls.  Such a preventative measure facilitates the cleaning process prior to each 
experiment.   
 
Preparation for Spectrophotometry 
 Prior to experiments, the spectrophotometer was switched on and allowed to 
warm up for approximately 20-30 minutes, which is a conservative time frame compared 
to the manual’s suggestion of 15 minutes.  This allowed the lamps to reach their full 
intensity and provide reliable spectra.  Once the lamps were ready, a blank was taken 
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without a cuvette inserted into the compartment to provide the spectrophotometer with a 
point of reference.  A good blank should show a relatively uniform baseline throughout 
the spectrum (Figure 4.5). 
 
 
Figure 4.5:105  A representative blank spectrum used to correct for ambient conditions 
prior to sample measurement, where the X-axis is the wavelength in nanometers, and the 
Y-axis represents optical density units. 
 
Spectrum of Deionized Water 
 Prior to taking the first sample spectrum of the day, a clean cuvette was rinsed 
repeatedly with deionized water and then was filled to approximately two-thirds of its 
capacity with the deionized water (the level must be high enough for the incident beam to 
go through the sample).   
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The spectrophotometer was configured to an integration time of 15 seconds.  
Since the HP 8453 spectrophotometer takes ten complete multiwavelength scans over one 
second, a 15 second integration time produces a spectrum which is an average of 150 
consecutive scans.  The output file provides the mean and standard deviation of the total 
number of scans per wavelength.   
 The deionized water was scanned in the spectrophotometer and the resulting 
spectrum served two purposes.  The first was to guarantee the proper functionality of the 
instrument by ascertaining the consistency of the background water spectrum from 
experiment to experiment.  The second purpose was to evaluate the cleanliness of the 
cuvette.  Figure 4.6 shows a representative spectrum of deionized water in a clean 
cuvette.  The optical density value at 190 nm should typically be below 0.25 AU.  The 
peak located at approximately 980 nm is characteristic of water and is seen in spectra 
taken with a 1 cm pathlength cuvette.  A 1 mm pathlength cuvette is not sufficient to 
show a prominent peak.  Evidence of impurities would usually show in the absorption 
range roughly between 200 and 500 nm.  This is not to say that absorptions do not occur 
past 500 nm, however, Soret bands of chromophoric proteins are more commonly in the 
UV and low visible wavelength range, and slight contamination on the walls of the 
cuvette would show up as small bumps or elevations of the baseline in that region. 
 
Background Correction 
 Once the cuvette was verified to be clean, the spectrum for the solvent 
background was established so that the background correction could be implemented to 
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the spectral analysis.  The cuvette was washed a few times with the solvent which is most 
commonly isotonic (0.9%, pH 7.0-7.2) blood bank phosphate buffered saline (PBS) 
obtained from Nerl Diagnostics, RI.  The PBS was composed of 0.150 M sodium 
chloride, 0.006 M sodium diphosphate, and 0.002 M potassium phosphate.  The PBS was 
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Figure 4.6:  Representative spectrum of deionized water.  This is an important step taken 
prior to any experimentation to ensure the cleanliness of the cuvette.  Any contamination 
will show up as slight peaks, typically in the UV and low visible wavelengths. 
 
scanned for 15 seconds in the spectrophotometer and obtained a spectrum represented by 
Figure 4.7.  The water peak at around 980 nm was still evident.  The ionic interactions of 
the sodium chloride (NaCl) produced an intense, saturated peak below 210 nm.  The 
saturation occurred when the absorption intensity exceeded the linear range of the 
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instrument (upper limit: 1.2 OD), hence this region lacks reliable information about the 
system (see Appendix B for explanation of instrumental linearity). 
 The saline spectrum was saved as an auxiliary file in the Hewlett Packard 
Chemstation software.  The software was customized so that this background (auxiliary) 
spectrum is automatically subtracted from each scanned sample.  The auxiliary spectrum 
was updated three or four times during the experiment to account for any unforeseen 
changes in the instrument (i.e. lamp intensity), the cuvette, or ambient lighting in the 
room.  The most common sign for the spectrum to be updated was when parts of the  
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Figure 4.7:  Representative spectrum of isotonic (0.9%) PBS (pH 7.0-7.2).  Features 
include the water peak around 980 nm and a saturated peak below 210 nm. 
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baseline of the processed spectrum dipped below zero.  Visual examination of the solvent 
in the cuvette was also conducted consistently to ensure that any scatterers such as dust 
particles were not present to elevate the baseline of the auxiliary spectrum.   
 
Hematology Analyzer 
 The major method of experimental corroboration was performed with the 
hematology analyzer model 9110+ (Serono-Baker, PA).  The instrument is primarily a 
cell counter, giving cell number and cell volumes by means of electrical impedence.  
Reagent flows through an aperture between electrodes that conduct a constant electrical 
current.  The homogeneity of the reagent (free of contaminations) keeps the current 
consistent and establishes a baseline.  As biological cells are introduced into the system 
and flow through the electrical field, they act as partial insulators and temporarily 
increase the electrical potential.  The magnitude of the circuit resistance is directly 
proportional to the cell volume and is compared against a calibration to give the mean 
cell volume.  The number of cells passing through the aperture per unit sample volume is 
also quantified to yield the cell counts.  A discriminating threshold system for size ranges 
is used to categorize the results into red cells, white cells, and platelets, and eliminate any 
possible detection of debris.106   
 A modified Drabkin’s solution is used for quantification of hemoglobin.106  The 
red cells are lysed and the hemoglobin is converted to cyanomethemoglobin by the 
solution.  An optical density reading is taken at 540 nm and compared against a 
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calibration, where the absorbance value is directly proportional to the concentration of 
hemoglobin in the blood sample.   
 The readout of the Serono-Baker provides the following information (Figure 4.8): 
 
Figure 4.8:  A sample readout obtained from the Serono-Baker hematology analyzer.   
 
where WBC is white blood cell count, RBC is red blood cell count, HGB is hemoglobin 
concentration in solution once the cell is lysed, HCT is hematocrit, MCV is mean 
corpuscular volume, MCH is mean corpuscular hemoglobin, MCHC is mean corpuscular 
hemoglobin concentration, RDW is red cell distribution width, PLT is platelet count, and 
MPV is mean platelet volume.   
Although the instrument is typically used to analyze physiological values in 
clinical settings, it can reliably detect values beyond normal ranges.  The linear ranges of 
the analyzer for some important parameters are defined in Table 4.1.  The error of the 
instrument is defined per parameter in the brochure of the Para 12 Multi-parameter 
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Assayed Hematology Control (Streck Laboratories, La Vista, NE) and are shown in Table 
4.2 in the context of normal physiological values.  In Table 4.3, a six- replicate analysis 
of the same whole blood sample was obtained from the Serono-Baker system.   
 
     Linearity Range 
RBC  0.45 – 7.26 mill/µl 
HGB     0.1 – 30.0 g/dl 
PLT  20 – 1071 thsn/µl 
 
Table 4.1:  Linearity ranges for some important parameters of the Serono- 
Baker hematology analyzer. 
 
 
 
      Mean + error 
RBC  4.17 + 0.020 mill/µl 
MCV  85.6 + 4.0 fl 
MCHC 33.9 + 2.3 % (w/v) 
HGB  12.1 + 0.4 g/dl 
PLT  237 + 30 thsn/µl 
 
Table 4.2:  Error of the parameters of Serono-Baker hematology analyzer outputs as 
defined by the Para 12 Multi-parameter Assayed Hematology Control.  The control 
represents normal physiological values. 
 
 
      Mean + error 
RBC  4.99 + 0.077 mill/µl 
MCV  91.9 + 0.4 fl 
MCHC 32.3 + 0.4 % (w/v) 
HGB  14.8 + 0.1 g/dl 
PLT  216 + 3 thsn/µl 
 
Table 4.3:  Error of the parameters of Serono-Baker hematology analyzer outputs 
calculated from 6 replicates of the same sample.   
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The manual analysis typically showed smaller error compared to those reported by the 
control manufacturers, with the exception of the RBC count.  It should be noted, 
however, that six replicates of one patient sample does not necessarily represent larger 
test batches.   
 
 
   
Drabkin’s Hemoglobin Determination Assay 
 A manual assay was employed throughout the experimentation for two reasons.  
The first was to supplement and verify the hemoglobin concentrations obtained by the 
Serono-Baker hematology analyzer.  The second was to acquire hemoglobin 
concentrations for steps in which use of the hematology analyzer was not feasible.  For 
example, the hematology analyzer only accepted samples in the form of a particle 
suspension.  Therefore, free hemoglobin solutions not encapsulated in cells could only be 
analyzed using the manual Drabkin’s assay.   
 The kit used for the manual Drabkin’s hemoglobin assay (HG980) was obtained 
from Randox Laboratories Ltd, UK.  The method used a colorimetric assay that was 
standardized by the International Committee for Standardization in Haematology.46,47  
The principle of this assay is based on the fact that all derivatives of hemoglobin with the 
exception of sulfhemoglobin are capable of being converted to a stable form of 
cyanomethemoglobin.  Since in most cases, the sulfhemoglobin content is negligible, the 
method is effective in quantifying the total hemoglobin concentration, typically in percent 
(%), or grams of hemoglobin per deciliter of solution (g/dL).   
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 The kit included concentrated Drabkin’s reagent (52 mmol/L potassium 
phosphate, 30.4 mmol/L potassium ferricyanide, and 38.4 mmol/L potassium cyanide), 
Brij-35 solution (detergent, 25%), and methemoglobin standard (18 g/dL).  The standard 
was used to generate a calibration curve to which the unknown data can be compared for 
quantification.  The working Drabkin’s solution was mixed by adding the contents of one 
20 ml bottle of concentrated Drabkin’s reagent to 980 ml of deionized water and 0.5 ml 
of Brij-35 solution.   
For the calibration curve, four tubes were prepared and the standard solution was 
mixed with Drabkin’s solution according to the specifications indicated in the table below 
(Table 4.4): 
 
   Standard Drabkin's Blood 
  Tube Solution Solution Hemoglobin 
  NO. (ml) (ml)  (g/dl) 
 
  1 0.0 6.0  0.0 
 
  2 2.0 4.0  6.0 
 
  3 4.0 2.0  12.0 
 
  4 6.0 0.0  18.0 
 
Table 4.4:  Recipes for the mixing proportions of each tube to obtain the concentrations 
in the Blood Hemoglobin column.  The absorbance measurements obtained from each 
tube will be used to generate the standard curve. 
 
Each of the tubes was mixed well by inversion and was allowed to stand at room 
temperature for approximately 15 minutes to ensure total conversion of the 
methemoglobin to cyanomethemoglobin.  The samples were then scanned in the 
spectrophotometer, using the Drabkin’s solution as the auxiliary spectrum for background 
correction.  The optical density values at a wavelength of 540 nm were collected and 
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these values were plotted as a function of concentration.  The resulting extrapolated line 
was expected to pass through the origin.  The equation of the line served to evaluate the 
concentrations of unknown solutions by obtaining the optical density value at 540 nm. 
 The unknown samples being assayed could either be free hemoglobin or 
hemoglobin encapsulated in red cells.  The latter is feasible because of the presence of the 
detergent (Brij-35) in the reagent.  The amphiphilic detergent molecules will disrupt the 
membrane, forming detergent-lipid-protein micelles and bursting the cells.107  The cells 
spill their hemoglobin content in solution where it will be first oxidized to 
methemoglobin, then converted to cyanomethemoglobin.  For the assay, suggested 
volume ratios for Drabkin’s to sample are 5.00 ml : 0.02 ml, or 2.50 ml : 0.01ml.  The 
former ratio was used because larger quantities will render small errors negligible.  Once 
mixed, the sample was allowed to stand in room temperature for approximately 20 
minutes and then a spectrum was obtained and background-corrected with the Drabkin’s 
reagent.  The OD value at 540 nm was converted to a concentration using the equation 
for the standard curve. 
 It was important to note that the concentration obtained from a suspension of red 
cells using this assay did not directly reflect the mean corpuscular hemoglobin 
concentration.  The acquired value represented the hemoglobin concentration in the 
original sample if the cells were completely lysed and the hemoglobin was diluted in the 
media.  This value was the same as the HGB parameter obtained by the hematology 
analyzer.  Calculation of the MCHC required the relationship  
MCHC = (HGB x 100)/HCT (L/L volume fraction) 
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where HGB is g/dl and MCHC will be reported as g/ml.  The hematocrit (HCT) was 
acquired by the hematology analyzer, hence may introduce instrumental bias into the 
calculated MCHC.    
 
Calibration of Conductivity Meter for Ionic Strength Measurements 
 For the purpose of determining the ionic strength of prepared saline solutions, 
Conductivity Monitor Model #1670440 (BioRad, CA) was used to prepare a calibration 
curve using carefully prepared dilutions of stock 0.9% (determined by the company for 
the particular lot used) isotonic phosphate buffered saline at room temperature.  The stock  
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Figure 4.9:  A stardard curve of conductivity vs. PBS concentration (%).  The dilutions 
were carefully prepared from a stock 0.9% PBS and each sample was measured with the 
conductivity meter.  They obtained values were converted to micromho/cm by 
multiplying by a factor of 35.46. 
 97
PBS was diluted accordingly at 0.1% intervals from 0.9% to 0.1% and each sample was 
measured for conductivity.  For each measurement, the value obtained by the meter was 
multiplied by a factor of 35.46 to get conductivity units of micromho/cm.  The unit mho 
represents inverse ohms which is a unit of electrical resistance.  Figure 4.9 illustrates the 
standard curve of conductivity as a function of PBS concentration.  The equation of the 
line y = 17761x + 550.29 was used to calculate the concentration of an unknown saline 
sample, where y is the conductivity value in micromho/cm and x is the % PBS.  The error 
limits of the isotonic saline were reported to be approximately 0.88 + 0.02 and each batch 
was tested by Nerl on red cells to ensure their viability (personal communication with a 
Nerl technical director).  Hence using the isotonic value of 0.9% for the stock solution 
kept us within reasonable limits of the calibration curve.   
 
Sample Preparation for Resealing Experiments 
 Cells were obtained from the Florida Blood Services in two forms.  The first was 
a 5 ml whole blood sample stored in EDTA tubes and kept for screening purposes.  The 
cells were refrigerated at -4o C.  Typical samples used for the spectroscopic experiments 
were no older than two days unless otherwise specified.  The age of the cells have been 
shown to have significant effect on morphology (i.e. crenation) as demonstrated by 
another member of this project (unpublished data).108  The second type of sample was 
packed cells suspended in AdsolTM (Fenwal Division, Baxter Healthcare Corp, IL).  
AdsolTM is used as a stabilizer for blood cell units and can extend the storage period for 
red blood cells.  As a common blood banking practice, a large number of transfusable 
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units were packed and the plasma was replaced by AdsolTM for prolonged viability of the 
cells for up to 42 days.  The age of the packed cells was also no more than two days old 
unless otherwise noted.  The packed cells typically came in transfusable volumes of one 
pint and were used for the preparation of isolated erythrocytes via leukocyte-depletion 
and washing.   
Initial exploratory studies were done using the 5 ml whole blood samples.  The 
whole blood was analyzed for cell counts and hemoglobin content on the Serono-Baker 
hematology analyzer.  This allowed for the verification of the parameters to be within the 
normal range of human physiology.  The obtained red blood cell count is also helpful in 
obtaining the proper dilution of the whole blood sample for spectral purposes.  That is, it 
has been previously determined that diluting the erythrocyte count to ~4000 
(cells/micron) will give an optical density of approximately one.109  As noted previously, 
the upper linear limit of the instrument is an optical density value of 1.2. (see Appendix 
B)  
The dilution calculation is performed as follows, using a red cell count from data 
obtained on March 1, 1999: 
RBC count obtained from Serono-Baker:  5,130,000 cells/mm3 
where cubic millimeters is equivalent to the volume unit of microliters (µl).  Due to the 
large number of cells, it is not accurate to dilute down to ~4000 cells/µl in one dilution.  
The routine protocol calls for a series of two dilutions, with the first being a 1:50 dilution, 
or 0.050 ml of whole blood suspension (mixed well by inversion) in 2.45 ml of isotonic 
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0.9% phosphate buffered saline.  Further calculation is done for the second dilution, 
which is contingent upon the concentration from the first dilution: 
First Dilution: 
M1V1=M2V2 
(5.13 x 106 cells/µl)(0.050 ml) = M2(2.50 ml) 
M2 = 1.03 x 105   
Second Dilution: 
(1.03 x 105)V1 = (4000 cells/µl)(3.00 ml) 
V1 = 0.117 ml of the 1:50 whole blood dilution (total dilution factor = 1:1250) 
 
Hence, 0.117 ml of the 1:50 dilution was pipetted into 2.883 ml of isotonic PBS for a 
final volume of three milliliters.  The 3 ml volume was the capacity used in 3.5 ml 
cuvettes so that the suspension may be mixed directly into the vessel.   
 The whole blood suspension was then transferred into a 15 ml conical tube with a 
cap for washing.  The tube was filled to the top with isotonic PBS, capped, and carefully 
inverted several times to homogenize the suspension of cells.  The tubes were placed 
evenly in a table top centrifuge (Allegra 6, Beckman Coulter, Inc.) with a swinging 
bucket rotor (GH-3.8A) and spun for approximately five minutes at 3500 RPMs (1500 x 
g).  The spin packed the cells at the bottom of the tube and the supernatant left above the 
packed cells was carefully extracted with a transfer pipet.  The cells were resuspended in 
PBS and washed for a total of three times at which point the cells were relatively free of 
platelets and plasma protein, and the leukocytes were dramatically reduced in number.  
 100
After the third wash, the packed cells were suspended to a rough 1:1 volume ratio with 
PBS and examined in the Serono-Baker for platelet and leukocyte reduction, and to verify 
that the red cell volume and corpuscular hemoglobin have been maintained (i.e. that the 
erythrocytes had not been generally disrupted).  The RBC counts are also used to 
determine the proper dilution (previously described) for a spectrograph.  A spectrum of 
the washed cells will provide a qualitative assessment of the plasma reduction as well as 
any unforeseen changes that may have ensued following the preparations, such as 
morphological alterations or significant lysing of the red cells.   
The AdsolTM units were obtained as whole donor units held in 450 ml (~ 1 pint) 
collection pouches.  The AdsolTM contained 2000 mg/dl of dextrose, 750 mg/dl of 
mannitol, 27 of mg/dl adenine, and 900 mg/dl of sodium chloride.110  A spectral 
evaluation of AdsolTM was performed and is presented in the results section.  The 
isolation of red cells from these donor units was more elegant.  The bag of red cells was 
subjected to a leukocyte reduction by physically linking the bag to a leuko-reducing filter 
(Sepacell Pre-Storage R-500 II Leukocyte Reduction Set for Red Cells, Baxter 
Healthcare Corp., Fenwal Division, IL).  The leukocyte reduction efficiency was reported 
to give residual WBC counts of < 1.1 x 105 cells per unit with a 91% RBC recovery.111  
The common clinical use for these filters is to reduce leukocytes for transfusion purposes.  
The advantages of leukocyte reduction are 1) to prevent nonhemolytic febrile reactions as 
a result of antibodies to leukocytes in a recipient previously exposed to transfusions or 
pregnancy and 2) to minimize transmission of viral disease such as cytomegalovirus.14,112  
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The filtration was performed in a cold room (4o C), using gravity to pass the 
sample through the filter and into a collection bag.  The filtered blood cells were then 
placed in an automated cell washer where they were packed by centrifugation and the 
AdsolTM was replaced with isotonic saline.  The cells were used within 24 hours after 
preparation.  Samples from each step were kept so that it was possible to 
spectrophotometrically monitor the changes.   
 
Spectrophotometry of Leuko-Reduced Red Cells 
Counts were performed on the Serono-Baker hematology analyzer to obtain RBC 
counts, hemoglobin concentration, and also to monitor the effectiveness of the leuko-
reduction.  The RBC cell counts were used to make the necessary dilutions to acquire the 
proper cell concentrations for spectrophotometry as previously described.   
The spectra were collected from each step of the red cell isolation process to show 
the sensitivity of UV-visible spectroscopy to detect the changes in the system.  After the 
spectra were taken, each sample was retrieved from the cuvette and spun down for 
approximately 8 minutes at 1500 x g.  This pelleted the suspended cells in the sample.  
The resulting supernatants were scanned in the spectrophotometer to detect any free 
hemoglobin in solution which may have resulted from cell lysis.  The Drabkin’s assay 
was performed on the post-leuko-reduced, post-washed (PLR/PW) sample to verify the 
values obtained by the Serono-Baker for further quantifications and calculations. 
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Calculations for Resealing Experiments 
 The following is an example of the calculations performed in preparation for a 
typical resealing experiment.  Numbers differed from experiment to experiment 
depending on the desired corpuscular hemoglobin concentration contained within the 
resealed cells.   
 Two types of buffer were needed for the permeabilization experiments (low salt 
and high salt phosphate buffers).  The low salt (hypotonic) phosphate buffer (7mM, pH 
7.2) was prepared by combining 1.44 g Na2HPO4 and 0.24 g KH2PO4.  Isotonic (0.9%) 
phosphate buffered saline (PBS) (pH 7.0-7.2) (Nerl Diagnostics, RI) was obtained from 
Florida Blood Services.  When a higher ionic strength PBS was necessary (eg. 2.0% 
PBS), NaCl was added to the isotonic PBS and the tonicity was determined by 
conductivity.   
 The cells to be permeabilized were packed by centrifugation and mixed in a 1:1 
volume ratio with the hypotonic phosphate buffer.  Exact quantities were 1 ml of packed 
cells in 1 ml of hypotonic buffer.  The resealing process required the determination of 
concentrated PBS to bring the permeabilized system back to isotonicity.  The 
concentration of this restoration buffer was calculated by the following process: 
The cells were assumed to contain the salt concentration equivalent of 0.9%, or 
0.009 g/ml.  Hence,  
                     1 ml packed cells  x 0.009 g/ml = 0.009 g equivalent 
For the 7 mM PB, approximately 1.7 g of salt was dissolved into one liter of water, hence 
the w/v concentration was 0.0017 g/ml.   
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           1 ml PB x 0.0017 g/ml = 0.0017 g salt 
So 1 ml of PB contributed 0.0017 g salt to the mixture.  Summing up the two values gave 
a total of 0.0107 g salts in the 2 ml mixture.  
 Since the reaction tube held up to approximately 6 ml, it was arbitrarily 
determined that the total reaction volume would be 4 ml (although any other volume up 
to 6 ml would have been viable alternatives).  Thus the final volume of 4 ml needed to be 
restored to 0.9%, or  
  0.009 g/ml x 4 ml = 0.036 g salt needed in final mixture. 
The difference between the final weight needed (0.036 g) and the current weight 
contained in the original 2 ml mixture (0.0107 g) was 0.0253 g.  That is, 2 ml of solution 
containing 0.0253 g of salt was needed to restore the mixture back to isotonicity.  
    (0.0253g/2ml)*100 = 1.3% PBS 
So 2 ml of 1.3% PBS was needed to bring the reaction mixture to a 4 ml volume of 
isotonic condition. 
 The 1.3% PBS was prepared by adding NaCl to the isotonic blood bank saline and 
checking the tonicity with a calibrated conductivity meter.  Typically, a stock solution of 
approximately 2.0% was made and diluted to 20 ml of the desired PBS concentration as 
demonstrated below: 
    M1V1 = M2V2 
      (2.0%)V1 = (1.3%)(20 ml) 
       V1 = 13 ml of 2.0% PBS 
Add 7 ml of deionized water for final volume of 20 ml 
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Red Cell Resealing Experiment 
 The procedures for hypotonic modification of red cells have been taken and 
modified from a number of published methods.99,100,101,102,103,113,114  The goal was to be 
able to vary the hemoglobin concentration in the resealed cells and successfully 
reproduce the data in high, medium and low concentration ranges for further analysis.  As 
previously mentioned, the cells to be modified were prepared either by washing a 5 ml 
sample of whole blood by centrifugation, or a large adsol-red cell unit was leuko-reduced 
and subjected to an automated wash.  The Drabkin’s assay was administered to the 
prepared red cell suspension for hemoglobin quantification, and counts were obtained 
from the Serono-Baker hematology analyzer.   
 The cells were permeabilized under different conditions depending on the desired 
outcome.  For low concentrations of final MCHC, relatively large amounts of hypotonic 
buffer (7 mM phosphate buffer) were used in relation to the packed cell volume.  For 
example, the ratio of packed cell volume to hypotonic buffer volume might be 1:5.  The 
suspension was mixed carefully by inversion and incubated on ice for approximately 30 
minutes.  At the conclusion of the incubation, the appropriate amount of hypertonic 
phosphate buffered saline would be added to restore the tonicity of the suspension to 
0.9%.  The mixture was then incubated for 45 minutes at 37o C to ensure proper resealing 
for a majority of the cells.  The result was resealed red cells containing low amounts of 
hemoglobin. 
 For medium to large concentrations of hemoglobin in the resealed cells, the 
proportion of hypotonic buffer was varied.  In one representative experiment, the packed 
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cell to hypotonic buffer volume ratio was set to 1:1.  The incubation conditions were also 
modified to 1 minute at room temperature.  The suspension was immediately restored to 
isotonicity and incubated at 37o C for 45 minutes.  The resealed cells contained higher 
amounts of hemoglobin.   
 Once the cell restoration was complete, the suspension was spun down by 
centrifugation to sediment the cells and isolate the supernatant.  The supernatant was 
evaluated for hemoglobin concentration using the Drabkin’s assay so that all of the 
hemoglobin in the sample suspension can be accounted for.  The rest of the supernatant 
was carefully extracted using a transfer pipet and isotonic PBS was added for washing.  
The packed cells were carefully resuspended via multiple vessel inversions and packed 
again by centrifugation.  The washes were performed three times, or until the supernatant 
exhibited a minimal or no noticeable red tint of hemoglobin.  After the final wash, the 
packed cells were resuspended with approximately an equal volume of PBS.  The mixture 
was analyzed in the Serono-Baker and with the Drabkin’s assay.  Using the obtained 
counts, the spectral dilution of approximately 4000 cells/µl was determined and spectra 
were taken of the samples.  Each sample being prepared in the cuvette was carefully 
inverted three times for consistency and the cuvette was placed in the holder in the same 
orientation for each scan.  In between samples, the cuvette was carefully rinsed several 
times with deionized water via squirt bottle, and then with saline (since saline is the 
sample medium).  The saline spectrum for the background correction was renewed a few 
times during each experiment to ensure that any deviations in the light source or slight 
contaminations on the cuvette walls were accounted for.  Such errors were minor, 
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however, and should not affect the spectra significantly, especially at large optical 
densities.   
 The samples prepared for spectra were transferred to centrifuge tubes and 
sedimented for the collection of the supernatants.  The spectra of the supernatants were 
taken to detect any free hemoglobin which may have been present to affect the overall 
spectra of the samples. 
 
4.3 Results and Discussion 
Effects of Instrumental Setup on the Spectra of Erythrocytes and Hemoglobin 
As an important step to achieving a meaningful interpretation of the erythrocyte 
suspension, it was necessary to examine the effects of instrumental arrangements that 
captured different amounts of scattered light.  Three instrumental constructs were 
examined: 1) the Agilent 8453 diode array spectrophotometer captured the transmitted 
light at a small (2o) acceptance angle (small angle transmission spectra), 2) the Perkin-
Elmer Lambda 900 spectrophotometer was arranged to acquire data at larger (> 2o) 
angles (referred to as diffuse transmission spectra), and 3) the Perkin-Elmer Lambda 18 
spectrophotometer was fitted with an integrating sphere module to collect light scattered 
at all angles by the sample.  Figure 4.10 shows a solid curve representing a spectrum of 
purified, diluted red cells (4000 cells/µl) containing a physiological hemoglobin 
concentration (33% w/v) taken with a small angle Agilent spectrophotometer.  The 
dashed curve shows the spectrum of a free hemoglobin solution obtained by lysing the 
same concentration of red cells in a hypotonic buffer (7mM phosphate buffer), thus the 
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total mass of the hemoglobin was constant between the two samples.  All the spectra 
presented in this section were obtained in replicates of three with good reproducibility.  
The spectrum of the encapsulated hemoglobin exhibits a significantly greater OD 
throughout the entire wavelength range compared to the spectrum of the hemoglobin 
solution, however it lacks the prominent absorption peaks that define free hemoglobin 
(characteristic hemoglobin peaks at 270, 337, 417, 547, and 575 nm).   
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Figure 4.10:  Representative comparison spectra of purified red cells and hemoglobin in 
solution acquired from an Agilent 8453 spectrophotometer with an acceptance angle of 
2o.  The RBCs were purified by washing whole blood by centrifugation and passing the 
suspension through a leuko-reduction filter.  The RBC concentration is approximately 
4000 cells/µl.  The spectrum of the hemoglobin solution represents a concentration of 
~0.12 mg/ml.   
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Figure 4.11 illustrates spectra of the same samples prepared in the same manner 
as Figure 4.10 but captured as a diffuse transmission spectrum (DTS) on a Perkin-Elmer 
Lambda 900 spectrophotometer with a larger acceptance angle.  Two features are 
immediately apparent compared to the spectra in the previous figure.  First is the 
presence of hemoglobin peaks in the DTS, whereas these peaks in the small angle 
transmission spectrum (SATS) were masked.  Second, the DTS of the suspension showed 
an overall lower spectral intensity across the entire wavelength range compared to the red 
cell spectrum taken with the smaller, 2o acceptance angle (Figure 4.10), although it was  
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Figure 4.11:  Representative comparison spectra of purified red cells and hemoglobin in 
solution acquired from a Perkin-Elmer Lambda 900 spectrophotometer with an 
acceptance angle >2o.  The RBC concentration is approximately 4000 cells/µl and the 
concentration for the hemoglobin in solution is ~0.12 mg/ml.   
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still elevated compared to the free hemoglobin spectrum.  The lowered OD for the DTS 
was attributed to the loss of scattering information as the wider angle collected scattered 
light from more particles.   
Figure 4.12 represents spectra acquired by an integrating sphere.  In this 
arrangement, all of the scattered light was collected, hence the resulting transmission 
spectrum reflected solely the absorption component (hence it can be referred to as an 
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Figure 4.12:  Representative comparison spectra of purified red cells and hemoglobin in 
solution acquired from a Perkin-Elmer Lambda 18 spectrophotometer fitted with an 
integrating sphere.  The RBC concentration is approximately 4000 cells/µl and the 
concentration for the hemoglobin in solution is ~0.12 mg/ml.   
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absorption spectrum).  The baseline of the absorption spectrum per particle of the red 
cells overlapped that of the spectrum of the hemoglobin solution, contrary to the elevated 
nature of the diffuse transmission spectrum in Figure 4.11.  The hemoglobin peaks of the 
red cell absorption spectrum were more pronounced in comparison to the peaks of the 
DTS, however, the peaks at 270, 337 and 417 nm were less intense than the peaks of the 
hemoglobin solution.  The doublet at 547 and 575 nm showed good overlap between the 
whole and lysed red cell spectra.   
Examination of the red cell spectra in Figures 4.10 and 4.12 revealed clear 
differences in the presence and absence of the scattering component, respectively.  The 
integrating sphere data demonstrated similarities to the hemoglobin solution absorption 
albeit the sphere showed decreases in select peaks at the lower wavelengths.  With a 
small acceptance angle, the scattering component masked the hemoglobin absorption 
peaks and caused an overall elevation in the optical density spectrum.  It can be inferred 
that the small amount of light scattered at wide angles not captured by the detector 
provides the differences in features and information content of the three instrumental 
configurations presented here.  Moreover, for a DTS, the instrument collects more 
scattered light than a small angle detector, lowering the overall optical density and 
elucidating the characteristic hemoglobin peaks.  By capturing more scattered light, the 
DTS reflects less scattering information in the OD data.  To summarize, a configuration 
that collects a large amount of scattered light loses scattering information in the 
transmission spectrum because the intensities of the scattered light are averaged over the 
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angles accepted by the detector.  In contrast, small acceptance angle transmission spectra 
contain a better balance of absorption and scattering information. 
It is interesting to note that the spectra of the hemoglobin solution does not 
change across the three varying instrumental constructs, verifying that the differences in 
the red cell spectra are strictly related to scattering from large particles.  Using the free 
hemoglobin spectrum as a reference, it is clear that the intensity of the SATS at 417 nm is 
higher than the hemoglobin Soret band whereas the DTS and integrating sphere data 
show smaller peaks.  The reduction of select hemoglobin peaks (270, 337 and 417 nm) 
particularly with the DTS, had been previously attributed to a molecular hypochromic 
effect. 6,84,115  Our studies have clearly shown, however, that this apparent hypochromism 
is a matter of instrumental perspective.  A smaller acceptance angle captured forward 
scattered light from the macroparticles without diluting the information content by 
capturing too much scattered light from wider angles.  It was also obvious, that with a 
smaller acceptance angle, the spectrum of the encapsulated system showed no 
“hypochromism” compared to the free hemoglobin solution since this type of spectrum 
contains both absorbance (Qabs) and scattering (Qsca) information.  When the scattering 
component is eliminated from the spectrum (Figure 4.12), the attenuation of the 
absorption component (compared to the absorption spectrum of free hemoglobin) 
describes macroscopic hypochromism.  Recall that Qabs and Qsca are additive constituents 
of Qext.8  Therefore, as the relative contribution of the scattering component increases, a 
concomitant decrease in the absorption component will be observed. 
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Comparing the three instruments, the small angle Agilent spectrophotometer 
yielded spectra that contained the most complete information about the scattering and 
absorption components of the red cell suspension.  For this reason, Agilent instrument 
was used exclusively for the qualitative and quantitative characterization of red cells in 
their native and modified forms.   
 
 
Spectral Evaluation of AdsolTM 
 Since a significant number of blood units used in the experiments were stored in 
AdsolTM for prolonged transfusion viability, it was necessary to evaluate the spectral 
implications of the effect of AdsolTM.  Two spectra were taken:  AdsolTM in its undiluted 
state, and “Adsol” diluted in the same manner as whole blood.  The latter was prepared 
by first diluting the AdsolTM to 1:50 with isotonic PBS (0.050 ml AdsolTM, 2.45 ml PBS), 
and then following with a second dilution of proportions which are similar to that of 
whole blood being diluted to 4000 cells/µl (0.200 ml 1:50 Adsol, 2.800 ml PBS).  Figure 
4.13 illustrates the outcome.  Concentrated AdsolTM clearly showed prominent absorption 
at the wavelengths below 300 nm, a possible problem if the whole blood was spectrally 
processed without dilution.  The peak can most likely be attributed to adenine.  However, 
since the blood cells need to be diluted to give reliable data, such a dilution was 
simulated with the AdsolTM alone.  The result was a spectrum that was essentially devoid 
of any features.  The small peak close to 200 nm is a typical artifact of subtracting a large 
background peak from an even larger sample peak.  Since both of these peaks are well 
beyond the linear range of the instrument, they are usually saturated (as seen in the 
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concentrated AdsolTM peak) and contain little information.  Hence the difference between 
such peaks produced a peak containing unreliable information.  The water peak at 
approximately 980 nm in the concentrated AdsolTM spectrum is present because no 
background correction was employed.  A correction with  
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Figure 4.13:  Optical density spectra of Adsol.  The solid-line spectrum represents 
undiluted Adsol directly from the bag.  The dashed-line spectrum represents Adsol when 
diluted in the same manner as a red cell suspension would for spectral purposes.   
 
 
water would produce essentially the same spectrum without the 980 peak.  The diluted 
spectrum was background corrected with PBS (since the dilution was prepared with 
PBS), thus the absence of the 980 peak.    
The issue with Adsol was whether its absorption bands were prominent enough to 
interfere with the spectrum of red cells prior to washing and leuko-reduction.  At high 
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concentrations, it did in fact show high absorption in the lower wavelengths (190-400 
nm).  However, when it was diluted in the same manner as the red cell suspension, the 
Adsol was optically transparent at wavelengths greater than ~220 nm, eliminating the 
need to correct for its effects in the background (under red cell measurement conditions). 
 
Washed and Leuko-Reduced Cells 
 Before the cells were modified, they were prepared from either whole blood or 
Adsol-suspended blood.  The whole blood samples were prepared with manual washings 
by centrifugation to rid the suspension of plasma, platelets, and some white cells.  A 
combination of spectra and Serono-Baker counts show the degree of success of this 
method.  Figure 4.14 is a representative normalized sample spectra showing both whole 
blood and washed cells.  Normalization eliminates any concentration effects of the 
samples and provides a better visual comparison of the spectral changes caused by other 
parameters such as the removal of certain blood components, or changes in cell size.  
Whole blood showed an elevated optical density throughout the entire wavelength range 
encompassing the optical effects of each major component in this complex mixture.  The 
most striking difference between the washed and unwashed samples is the large peak at 
202 nm and the small but relatively broad peak at 280 – 290 nm, an effect accounted for 
by the removal of the plasma components. 
When spun down and the red cells were sufficiently packed, the remaining 
supernatant was a clear liquid with a slight yellow tint.  Shifting viewing angles of the 
supernate against the light revealed a shimmer due to the suspended platelets which were 
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less dense than the red and white cells.  Directly above the bottom layer of red cells was a 
white layer commonly referred to as the buffy coat that consisted mostly of leukocytes.  
The clear plasma containing platelets were easily extracted and removed using a transfer 
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Figure 4.14:  Normalized (by area under curve) optical density spectra of whole blood 
and washed cells.  The cells were washed manually three times by centrifugation to 
reduce the amount of white cells, platelets, and plasma proteins.   
 
pipet.  However, removal of the layer of white cells proved to be trickier and the effective 
elimination of the leukocytes meant taking with it some red cells from the bottom layer.  
After three washes, the packed red cells were resuspended in PBS at an approximate 
volume ratio of 1:1.   
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Table 4.5 shows the values obtained by the Serono-Baker hematology analyzer to 
corroborate with the changes in the spectra.  Consistent with the objective of the washes, 
there was a significant reduction seen in the white blood cell (WBC) and platelet (PLT) 
numbers, albeit the removal was not complete.  Due to the estimated volume of the  
resuspension of the packed cells (approximate 1:1 volume ratio), the result of the red cell 
 
     Whole blood  Washed cells  
 WBC(thsn/cu mm)         6.4          1.6 
 RBC (mill/cu mm)        4.29         3.81 
  HGB (grams/dl)        13.5         12.3 
 HCT (%)         43.7         38.3 
 MCV (cu microns)       101.9        100.6 
 MCH (pg)          31.5         32.3 
 MCHC (%)         30.9         32.1 
 PLT(thsn/cu mm)        276          38 
 MPV (cu microns)         10.1         10.8 
 
Table 4.5:  Values obtained by the Serono-Baker hematology analyzer of whole blood 
and washed cells. 
 
counts (RBC) varied but always on the order of 106/mm3 (106/µl).  In this case, the cell 
count decreased slightly with a corresponding decrease in the hematocrit value (HCT).  
Reduced RBC also meant a decrease in the overall hemoglobin count (HGB) as 
manifested in the results.  The mean corpuscular volume (MCV) values showed, 
however, that the washings did not disturb the size of the red cells although it is not 
possible to determine how the morphology may have been affected.  The hemoglobin 
concentration within the red cells (MCH, MCHC) were also undisturbed, as well as the 
platelet volume.   
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 The Adsol-suspended cells were prepared by automated washing and leuko-
reduction via filtration.  Figure 4.15 shows the different stages of red blood cell 
purification with the washing step done first.  The wash eliminated the plasma and the 
most significant spectral difference is the peak at approximately 200-230 nm.  With the 
removal of the leukocytes, however, a change in the overall spectral profile is evident.  In 
corroboration with the spectral data, hematology analyzer counts showed values that 
correspond with each step (Table 4.6).   
For corroborative purposes, it was important to evaluate every aspect of the  
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Figure 4.15:  Stages in the purification of red cells.  The samples were first washed with 
isotonic phosphate buffered saline and then passed through a leukocyte filter. 
    
 118
    Pre-wash/LR   Post-wash    Post-wash/LR  
 WBC(thsn/cu mm)        10.6         3.3       ***** 
 RBC (mill/cu mm)        5.53        6.54        6.47 
  HGB (grams/dl)        18.4        21.3        21.0 
 HCT (%)         55.3        64.0        63.3 
 MCV (cu microns)       100.0        97.9        97.8 
 MCH (pg)          33.3        32.6        32.5  
 MCHC (%)         33.3        33.3        33.2 
 PLT(thsn/cu mm)         72          0           0  
 MPV (cu microns)         14.4         ---         --- 
 
Table 4.6:  Values obtained from the hematology analyzer for the different stages of red 
cell purification.   
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Figure 4.16:  Comparison of red cell suspension and supernatant (I).  The blue spectrum 
represents a red cell suspension post wash/LR.  The pink spectrum of lesser magnitude is 
the supernatant after the cells were spun down by centrifugation.   
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system.  Hence it was necessary to determine whether the hemoglobin was all 
encapsulated or if some were free in solution.  In Figure 4.16, the solid line spectrum 
represents the raw data of the suspended red cells after the washing and leuko-reduction.  
The sample was then poured out of the cuvette and into a centrifuge tube.  The sample 
was centrifuged for approximately 8 minutes at 1500 x g to pellet the cells.  The pink 
dashed-line spectrum that looks more like a spectrum of hemoglobin reflects the 
supernatant obtained post-centrifugation.  The amount of free hemoglobin seen in the 
supernatant depends on the quality of the washes.  Typically, three washes were 
sufficient for elimination of a majority of the free hemoglobin.  Visual inspection of the  
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 Figure 4.17:  Comparison of red cell suspension and supernatant (II).  The blue 
spectrum represents a red cell suspension post wash/LR.  The pink spectrum of lesser 
magnitude is the supernatant after the cells were spun down by centrifugation.   
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supernatant should yield a colorless medium.  Washing excessively, however, was not 
necessarily advantageous since repeated shear between cells may cause some to lyse, 
increasing the free hemoglobin in solution.  Figure 4.17 shows a different trial with a 
more thorough wash.  The supernatant spectrum reflected a minute amount of 
hemoglobin compared to that seen in Figure 4.16.  Typical washes more often yielded 
results similar to that of Figure 4.16.  Estimated quantification of free hemoglobin 
Figures 4.16 and 4.17 using the extinction coefficient at 417 nm (7786 cm2/g) are 0.032 
mg/ml and 0.0013 mg/ml respectively.  However, the presence of any amount of free 
hemoglobin should not be a concern as long as a reliable spectrum is obtained for 
quantification.   
 
Spectrum of Resealed Red Cells 
 The desired outcome of the resealing experiments was to obtain, at the very least, 
mean corpuscular hemoglobin concentrations in the medium (~ 0.15 – 0.20 mass frac) 
and low range (~ 0.05 – 0.10 mass frac), since physiological concentrations were 
established in the previous section.  Figure 4.18 represents a resealed cell suspension with 
an MCHC of 0.084 (mass fraction), or 8.4% w/v.  A striking change in the feature 
compared to the spectrum of physiological MCHC (Figures 4.16, 4.17) is the decrease in 
overall scattering, revealing more of the prominent hemoglobin peak at 417 nm along 
with the slight emergence of the doublet between 500 and 600 nm.  The supernatant 
spectrum shows a relatively small amount of hemoglobin.   
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Figure 4.18:  Optical density spectra of a resealed red cell suspension (MCHC: 0.084) 
and the supernatant.  There is less scattering and a more pronounced hemoglobin peak in 
the cell spectrum compared to that of the high MCHC (Figure 4.12).  There is a small 
amount of free hemoglobin in the supernatant as indicated by the supernate spectrum. 
 
 Figure 4.19 illustrates resealed red cells with MCHCs in the medium range 
(0.218, 0.186 mass fractions).  There is a more prominent scattering seen throughout 
these spectra compared to that of the lower MCHC (Figure 4.18), resulting in an 
increased masking of the hemoglobin peaks.  However, the overall scattering is less than 
the physiological spectrum (Figure 4.17) and the hemoglobin absorption features are not 
completely hidden.  Between the mass fractions of 0.218 and 0.186, clear differences are 
seen to fit the scattering trend.  The supernatant spectra again show little free hemoglobin 
contamination. 
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Figure 4.19: Optical density spectra of a resealed red cell suspension (MCHC: 0.218, 
0.186) and the supernatant.  The degree of masking of the 417 nm hemoglobin peak by 
scattering is somewhere between those of the high and low MCHC ranges (Figures 4.12, 
4.13).  The supernatants show small amounts of hemoglobin. 
 
 
 Figure 4.20 shows a more complete compilation of the spectra of resealed red cell 
data spanning a broad range of mean corpuscular hemoglobin concentrations.  Every 
sample spectrum represents a cell suspension diluted to approximately 4000 cells/µl.  
Hence, the intensities of the optical densities roughly correspond to a constant cell count.  
As the encapsulated hemoglobin concentration decreases, the scattering effect decreases, 
effectively reducing the amplitude of the overall spectrum.  As previously emphasized, 
the reduction of scattering unmasks more of the features of hemoglobin.  The less the 
encapsulated hemoglobin, the more the spectrum looks like free hemoglobin in solution.  
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These changes in the features are magnified when the spectra are normalized by dividing 
through by the calculated area under the curve (Figure 4.21).  This type or normalization 
eliminates concentration effects and amplifies effects caused by only the properties of the 
particle.75  Here, it is abundantly evident that with decreasing MCHC, the 417:383 nm 
peak-to-trough ratio increases.  Though this is not necessarily a linear effect, the trend is 
intuitive and is readily recognized. 
 
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
200 300 400 500 600 700 800 900 1000 1100
Wavelength (nm)
O
D
0.336
0.228
0.150
0.084
0.048
MCHC (mass fraction)
 
Figure 4.20:  A compilation of raw spectral data of resealed cells with different 
encapsulated hemoglobin concentrations. 
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Figure 4.21:  Compilation spectra normalized using the area under the curve method.  
This normalization eliminates concentration effects to amplify the effects due to the 
optical properties of the particle.   
 
 
 
Reproducibility of the Resealed Cells 
 The hypotonic modification of the red cells was shown to be reproducible by 
performing the experiment in five parallel reaction vessels under the same conditions, 
using red cells taken from the same stock sample.  Figure 4.22 show the spectra for the 
five samples, normalized to eliminate any concentration differences as a result of 
pipetting errors.  Table 4.7 lists the values obtained from the hematology analyzer for the 
HGB, MCHC, and MCV.  The spectra of the five replicates show strong similarities in 
the features across the entire wavelength range.  The reported values in the table further 
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support the reproducibility of the experimental method.  The small differences among the 
replicates can be attributed to experimental error (such as pipetting errors) and the error 
of the hematology analyzer.  A comparison of experiments done under the same 
conditions but with different samples (not pictured) did not always yield high 
reproducibility because in this case, new variables are being introduced by varying the 
blood sample (i.e., patient genetics, how often patient donates blood, etc).   
0.0E+00
2.0E-04
4.0E-04
6.0E-04
8.0E-04
1.0E-03
1.2E-03
1.4E-03
1.6E-03
1.8E-03
190 290 390 490 590 690 790 890 990 1090
Wavelength (nm)
N
or
m
al
iz
ed
 O
D
Replicate 1
Replicate 2
Replicate 3
Replicate 4
Replicate 5
Jun303
 
Figure 4.22:  Normalized resealed cell spectra of five replicates.  The modified cells are 
in the range of 23% MCHC.  The spectra generally reflect good reproducibility with the 
spectra sharing common features across the entire wavelength range. 
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   HGB (g/dl) MCHC (mass frac) MCV (fl) 
Replicate 1       7.4   23.8      86.2 
Replicate 2       6.3   22.8      89.1 
Replicate 3       7.2   23.9      86.8 
Replicate 4       6.8   22.0      88.0 
Replicate 5       6.1   22.8      87.8 
 
Table 4.7:  Values obtained for five experimental replicates of resealed cells for the 
parameters HGB, MCHC, and MCV.  The values show good agreement indicating high 
reproducibility of the hypotonic modification experiments. 
 
 
Microscopy 
 
 With each experiment, visual corroboration of the red cells was established by 
observing smears of the samples under the microscope.  On a few occasions, we gained 
access to a camera-mounted phase contrast microscope (Nikon Diaphot, Department of 
Biology, University of South Florida) to document photographs of the cells.  Both 
microscopes used were equipped with a 10x ocular lens with objective lenses of 10x, 40x, 
and 100x (oil immersion) where the total magnification was the product of the ocular and 
the objective magnifications.  Typically, 400x and 1000x magnifications were used to 
assess the morphologies of the cells.   
 A quick microscopic inspection of the whole and washed cells was useful in 
evaluating the quality of the cells.  Although the scope of the field of vision is small, 
examining a large number of random areas of the blood smear on the microscope slide 
gave an idea of whether or not there were any obvious morphological abnormalities in a 
particular sample.  A high quality red cell suspension should look like Figure 4.23 where 
a majority of the erythrocytes assume a biconcave shape with the dimple clearly visible in 
the center of the donut shape.  The hash marks at the bottom of the photograph give a  
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Figure 4.23:  A phase contrast microscopy picture of erythrocytes in their native state 
magnified 400x.  The sample was prepared by smearing a small drop of the cell 
suspension on a glass microscope slide.  The hash marks at the bottom represent 10 µm 
per interval.  The cells show their characteristic biconcave shape with a noticeable dimple 
in the center. 
 
good estimation of the overall sizes of the cells, where one interval represents 10 µm.  An 
alternate sample suspended in PBS at room temperature for a few hours is illustrated in 
Figure 4.24.  This photograph shows crenation in which the cells have adopted a 
spherical conformation with spiculated protrusions.    If this phenomenon is seen in 
whole blood samples, it could be a result of aging, contaminated medium, or improper 
storage (temperature).  It has been demonstrated that over time, stored red cells will lose 
their membrane integrity and begin to crenate.  Red cells suspended in isotonic PBS will 
adopt the speculated morphology sooner than its whole blood counterpart (matter of 
hours for a dilute suspension).  The non-crenated cells in the picture show a flatter  
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Figure 4.24:  A phase contrast microscope image of non-viable red cells.  Some of the 
cells show a crenated conformation in which they take on a spherical shape with 
protruding spicules.  Other cells show a less defined dimple.  Each interval at the bottom 
of the picture represents 10 µm. 
 
discoid shape with a less apparent center dimple.  In this case, the cells may have 
acquired excess water to become more elliptical, or indicate imminent crenation.   
 Likewise with the washed and leuko-reduced cells, observing the cells was a 
quick and easy assessment of quality.  Since the washes were performed with isotonic 
PBS, if the ionic strength buffer was inaccurate, it would have affected the cells in ways 
such as crenation and swelling.  Moreover, both washing and leuko-depleting filtration 
posed the possibility of disrupting the native membrane shape due to shear force.   
 Figure 4.25 shows an oil immersion (1000x magnification) picture of resealed red 
cells representing an estimated mean corpuscular hemoglobin concentration of 21.4% 
(compared to a physiological concentration of 33%).  In the act of permeabilizing and 
resealing, the cells have lost their biconcave conformation and seemed to have adopted  
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Figure 4.25:  A phase contrast microscope image (1000x, oil immersion) of 
hypotonically resealed red cells containing 21.4% (w/v) hemoglobin.  The variation in 
sizes has increased and the morphology has changed significantly to distorted shapes 
(crenated and elliptical cells).  Each interval of hash marks represents 10 µm. 
 
more distorted shapes (crenated or elliptical).  The approximate diameters of the cells 
look to be slightly larger than their unmodified counterparts with a slightly broader 
distribution of sizes.  Figure 4.26 is an oil immersion picture of a sample with a reported 
MCHC of 5.6%.  Due to the low hemoglobin concentration, the contrast of the cells with 
respect to the background medium is greatly reduced (n/n0 is approaching 1).  The sizes 
seem a bit more uniform at approximately 5 µm compared to the cells containing 21.4% 
(Figure 4.25).  This may be due to the fact that with the low MCHC samples, the samples 
are equilibrated for 30 minutes on ice after being subjected to hypotonic shock.  In 
contrast, the medium range MCHC samples are exposed to the shock for approximately a 
minute before being restored.  Thus these latter samples do not have time to equilibrate  
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Figure 4.26:  A phase contrast microscope image (1000x, oil immersion) of 
hypotonically resealed red cells containing 5.6% (w/v) hemoglobin.  The reduction in the 
corpuscular hemoglobin concentrations has significantly reduced the contrast between the 
cell and the background medium.  The cell diameters seem to be typically in the 5 µm 
range.  The shapes seem to be spherical, however, it is impossible to assess accurately the 
3-dimensional shape.  Each interval of hash marks represents 10 µm. 
 
and depending on the age of the cells present, it is possible to get more of a mixed 
population of resealed cells.   
The sizes of the resealed cell samples were difficult to visually estimate.  The 
diameters of the cells seemed to typically be 5 – 10 µm in all the samples evaluated (3 
samples documented per low, medium and high MCHC ranges).  The shapes were mostly 
perceived to be elliptical or crenated (more spherical).  However, since light microscopy 
did not provide a good estimate of the three dimensional morphology, it is not a good 
method to corroborate the sizes (volumes) of the cells to the values obtained by the 
hematology analyzer.   
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Comments on the Acquired Experimental Data 
The first significant assertion made in this dissertation is that perceived 
hypochromism can often be accounted for by understanding the manner in which the 
spectrophotometer collects the light.  There are clear differences in the spectral features 
of the same sample taken with a small angle detector and an integrating sphere.  Studies 
that have reported spectra of macroscopic particles with high refractive indices have 
presented diffuse scattering data and have maintained that any OD decreases of the 
encapsulated system compared to that of the free chromophore in solution are a result of 
molecular hypochromicity.6,7  We have shown here that this is not the case, but instead 
the OD decrease can be attributed to a scattering-related effect.  In this effect, the 
increase in the scattering component resulted in the attenuation of the absorption 
component and was defined above as macroscopic hypochromism.  Moreover, it was 
determined that a small angle spectrophotometer contained the most complete scattering 
information useful in the qualitative and quantitative analysis of particle suspensions.  
Thus to summarize, observed hypochromicity has been redefined on two levels: 
• Macroscopic hypochromicity which is due to changes in scattered light and as 
consequence is proportional to the size and refractive index of the scattering 
elements.  
• Microscopic or molecular hypochromicity which is due to the electronic 
interactions resulting from close proximity of chromophoric groups and therefore 
a function of the chromophore concentration within the particle. 
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Preliminary assessment of the red cell purification and resealed red cell data 
indicates the proficiency of a small angle spectrophotometer to detect changes in the 
composition of the suspension (purification of erythrocytes) and changes in encapsulated 
hemoglobin concentrations.  For the purification of red cells, the removal of the plasma 
components and white blood cells reflected small changes in the spectrum.  The post-
washed/post-LR spectrum (Figure 4.15) showed the largest difference in the spectral 
features that could be a result of the leukocyte removal, or a change in morphology of the 
cells after being suspended in PBS (or a combination of the two).   
Resealed cells in the high, medium, and low MCHC ranges all showed clear 
differences in the spectral features.  High hemoglobin concentration increased the 
contrast of the cells with respect to the medium by increasing its complex refractive 
index.  The resulting increase in scattered light was represented by an elevation of optical 
density across the entire wavelength range.   
Light microscopy proved to be a useful tool in evaluating the quality of the cells 
prior to and after the resealing experiments.  Each experiment was visually monitored at 
select steps to ensure consistency the results.  It was also possible to make rough 
estimates of the sizes of the cells.  However, such approximations were too vague to 
make accurate quantifications of the cell volumes.   
The data acquired by red cell purification and hypotonic modification amounted 
to over 50 samples.  The data was assessed in terms of important parameters such as the 
mean corpuscular volume (MCV) and the mean corpuscular hemoglobin concentration 
(MCHC) to identify spectral trends and features.  This analysis was necessary in our 
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efforts to corroborate the experimental data with spectra modeled mathematically based 
on the Mie theory.   
As previously mentioned, a sample spectrum is represented by a set of 
parameters, each unique to the particular sample being examined.  It is important to pay 
particular attention to the experimental conditions and corroborative outcomes to 
accurately explain the different features being manifested in the spectra.  It should be 
noted that changes in key parameters of the particulate systems (i.e. MCHC, MCV, etc.) 
are not reflected spectrally in a linear fashion and therefore are often not intuitive.  This 
complexity stems from the fact that the spectral changes arise from a combination of the 
absorption and scattering effects and it is this synergy that we are striving to understand 
by using a combination of wet chemistry and mathematical modeling.   
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Chapter 5:  Implementation and Validation of the Mie Theory 
 
 As described in Chapter 3, the model for the mathematical construction of spectra 
is based on Mie theory, which represents the spectra as the combined effect of the 
absorption and the scattering components of the cell suspension.  An effective 
implementation of modeling has proven to be a valuable tool in providing guidance in 
experimental direction.  Where there are instrumental limitations in obtaining empirical 
data, theoretical modeling sees no such restrictions.  Through modeling, it is possible to 
quickly generate a series of spectra allowing for the exploration of trends and 
manipulations of variables.  Using modeled spectra as a guide may help raise a red flag 
when an unexpected feature is seen experimentally.  Ultimately, these simulations help 
the scientist make an educated decision about the direction of their experimentation and 
also be used for verification post data-collection.   
 
5.1 Sensitivity Analysis of Mie Theory:  A test of the model 
Given enough knowledge of the parameters of a cell suspension, it was possible to 
calculate a mathematical representation of the spectrum where the qualitative features 
were similar to those of the experimental spectrum.  The current working implementation 
of the model was used to simulate the combined effect of cellular and plasma components 
of whole blood.69  The flexibility of this model allowed for the exploration of isolated 
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effects of single blood components, and hence the program was used for the 
interpretation of red blood cells.   
Since the model is based on Mie theory, the cells are represented by spheres of 
equivalent volume.  Though this may be initially be construed as a restriction, the model 
was demonstrated to give good estimations of experimental values, and effectively 
predicted trends with changing parameters.   
 
 
dDDfmQDN extp )())(,(4
2
0
λαπτ ∫∞=  
)(
)()()(
0 λ
λκλλ
n
inm +=
 
 
Figure 5.1:  Diagram of the model used to calculate spectra and its inputs.  The model is 
based on the turbidity (τ) equation and the optical properties of the suspended cells 
(m(λ)).   
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Figure 5.1 shows a block diagram of the inputs of the model.  Each of the parameters 
serves an important purpose in describing the joint property distribution and it is their 
cohesion that gives rise to the qualitative and quantitative features of the calculated 
spectrum.  The diameter, as mentioned above, is that of a sphere of equivalent volume 
(often referred to as the equivalent sphere).  The cell volume fraction is a variable 
representing the hematocrit (HCT) value.  The model is capable of predicting the effects 
of multiple chromophores within the cells.  Hence the number of protein components 
must be specified.  In the case of red cells, hemoglobin is the sole protein component, 
although there is the capability of including multiple derivatives of the protein 
(deoxyhemoglobin, methemoglobin, etc).  The mass fraction or the concentration of the 
protein is a particularly important parameter due to the strong absorptivity of 
hemoglobin.  The complex refractive index (m(λ)) of hemoglobin is defined by an optical 
properties file representing the absorption coefficient (κ) and refractive index (n) as well 
as the refractive index of the medium, water.  Figure 5.2 depicts the components of the 
optical properties file of oxygenated hemoglobin.  The shape of the absorption 
component of hemoglobin resembles that of a typical hemoglobin absorption spectrum 
and was derived from experimental optical density spectra of hemoglobin in solution.  
The real part of the complex refractive index of hemoglobin (n(λ))69 was then generated 
from κ(λ) using the Kramers-Kronig transform mentioned previously in Chaper 3.  The 
refractive index of the medium (water) was obtained from values reported by 
Thormaehlen et al. (1985).116 
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Figure 5.2:  Plot of the contents of an optical properties file for oxyhemoglobin over the 
wavelength range of 190-1100 nm.  Plots include the absorption coefficient and refractive 
index of hemoglobin and the refractive index of water. 
 
 Although the model is strictly used in this case for the modeling of red blood 
cells, its flexibility of usage extends beyond the scope of this study.  The Mie theory was 
adapted to build a complete spectrum of whole blood or spectra of their individual 
components, given that reliable optical properties existed for each component.  Aside 
from the erythrocytes, the major components of interest included leukocytes, platelets, 
and plasma proteins.  Spectral features of platelets were successfully calculated to look 
like those obtained experimentally.9  Conversely, information such as particle size 
distribution (PSD) and platelet activation states were extracted from the features of the 
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experimental spectra.9,117  Narayanan (1999) was able to accurately model the spectrum 
of albumin, the major plasma protein.118 
 
Simulation of Erythrocytes 
 The initial stage in the modeling required the program (Bldgen08) to demonstrate 
its ability to calculate a spectrum of a red cell suspension at physiological parameters.  
The inputs of the simulation were as follows: 
Wavelength range for analysis:  190 1100 
Spectral resolution in nm:  1 
Blood concentration (g/ml) in cuvette:  1e-3 
Cell pathlength in cm:  1 
Erythrocyte volume fraction:  0.45 
Erythrocyte average diameter (cm):  5.56e-4 
Erythrocyte density (g/ml):  1 
Number protein components:  1 
Mass fraction for component #1:  0.33 
Property filename for component #1:  ophbo2.01 
Leukocyte volume fraction:  0 
Platelet volume fraction:  0 
Plasma volume fraction:  0 
 
 This analysis was done for the entire spectral wavelength range of 190-1100 nm 
at 1 nm intervals (911 total points).  The blood concentration in the cuvette (1e-3 g/ml) is 
an arbitrary number which is typically held constant.  Since this is a weight-based 
concentration, one must be conscious of the fact that holding this number constant and 
varying the size of the cell would change the number-based concentration.  Physiological 
values were maintained for the erythrocyte volume fraction (hematocrit), the mass 
fraction of hemoglobin, and the diameter of the equivalent sphere (calculated from a 
volume of 90 fl).  Figure 5.3 represents the generated spectrum.  The overall shape of the 
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spectrum closely resembles that of the experimental data of red cells (see Figures 4.8, 
4.10).  The 190-600 nm range includes all of the absorption peaks; hence the spectrum is 
rich with features resulting from the absorptive effects of hemoglobin.  The 600-1100 nm 
range is largely considered the “scattering range” due the lack of any strong absorbance 
peaks.  However, it would be a misconception to assume that features in the 190-600 nm 
range are devoid of any scattering effects.  In fact the scattering is typically more 
prominent from 190 to 600 nm than in the “scattering range”.  The model typically does a 
good job fitting the scattering portion above 600 nm.  However, as both the absorption 
and scattering effects both become important below 600 nm, the model may not  
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Figure 5.3:  Simulated spectrum of red blood cells under physiological conditions.  The 
simulation was calculated by the model based on the Mie theory. 
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necessarily provide a perfect reproduction of the features of the experimental spectrum.  
This may be due to the spherical approximation of Mie theory.  The spherical assumption 
eliminates potentially important particle suspension characteristics such as particle shape 
and orientation which may be necessary for improved fits.   
 
Effect of Size on Erythrocyte Spectra 
 One of the important parameters of the spectral characterization or erythrocytes is 
size.  Physiologically, the reported volume limits of red cells range between 80 – 100 fl 
(see Chapter 2).  The simulations serve as a sensitivity analysis for the qualitative 
features of the red cell spectra in relation to size.  Since the model takes the size input as 
the diameter of a sphere of equivalent volume, the volume values were converted using 
the equation of a sphere and are reported in Table 5.1. 
 
   Volume (fl)  Diameter (cm) 
80 5.35e-4 
85 5.46e-4 
90 5.56e-4 
95 5.66e-4 
100 5.76e-4  
 
Table 5.1:  Physiological volume range of red cells in 5 fl increments and their 
equivalent sphere diameters. 
 
 
The simulations held the following parameters constant: 
Wavelength range for analysis:  190 1100 
Spectral resolution in nm:  1 
Blood concentration (g/ml) in cuvette:  1e-3 
Cell pathlength in cm:  1 
Erythrocyte volume fraction:  0.45 
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Erythrocyte density (g/ml):  1 
Number protein components:  1 
Property filename for component #1:  ophbo2.01 
Leukocyte volume fraction:  0 
Platelet volume fraction:  0 
Plasma volume fraction:  0 
 
 
 
Figure 5.4:  Illustration of cell suspension where the size is increased by the hematocrit 
and weight-based cell concentration remains constant.  Under these conditions, the cell 
number changes, hence the need for further corrections for a comparison on a per cell 
basis. 
 
 
The five sizes from Table 5.1 were repeated with hemoglobin mass fractions of 0.33, 
0.20, and 0.05 (high, medium and low MCHC values respectively).  Figure 5.4 illustrates 
physical implications of the system in terms of varying cell size.  The simulation was 
initially done by keeping the hematocrit and the weight-based cell concentration (g/ml) 
constant while varying only the mean corpuscular volume.  The problem however, is that 
this changed the number of cells in the system.  Thus the concentration effects must be 
eliminated to isolate the comparison to changes in volume.  One solution was to adjust 
the hematocrit and weight-based cell concentration values accordingly so that the cell 
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number was kept constant.  The second solution was to correct the discrepancy by 
normalizing each of the spectra by the area under the curve.  The latter method was 
employed.   
 Figure 5.5 shows the effect of size on cells with a low mean corpuscular 
hemoglobin concentration of 0.05.  Slight differences in intensities are seen in the two 
prominent peaks at 225 nm and 417 nm.  The peak at 417 nm and the doublet between 
500 – 600 nm represent the characteristic peaks of hemoglobin.  Observing the peaks, one 
can notice that the smaller sizes have higher optical densities.  This trend is 
counterintuitive when considering the absorption component alone.  The larger the 
particle, the more hemoglobin in the pathlength of the light hence it would seem that the 
larger cell should adopt the higher absorption peak.  But in reality, the opposite is true 
and this is consistent with the theory and the observations of Garcia-Rubio (1987) on the 
effect of particle size on the absorption spectra.92   
 Across the entire wavelength range (at low MCHC), there is a minimal change of 
features as size increases.  This is a direct result of the low hemoglobin concentration 
within the cells.  A low MCHC implies a low contrast between the refractive indices of 
the cell and the medium and under such conditions, the scattering component is relatively 
small compared to cells containing hemoglobin at a physiological level.   
 Figure 5.6 illustrates the effect of size on cells at a medium hemoglobin 
concentration (mass fraction of 0.20).    The hemoglobin bands are present but to a lesser 
degree, as scattering across the entire wavelength range is more prominent.  The 
difference in the spectra due to the increase in cell size is more noticeable as well.  As 
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seen with the previous simulation, the intensity in the absorption region (190 ~ 500 nm) 
decreases with an increase in size.  The larger refractive index ratio of cell/medium (n/n0) 
accounts for a more significant contribution of the scattering component which explains 
the more pronounced spectral differences between the cell sizes.  Furthermore, the 
medium MCHC is beginning to show signs of the flattening of the spectra, a phenomenon 
previously seen with size increases due to swelling or aggregation.118  This flattening is 
typically marked by the reduction of the optical density in the absorption region with the 
increase in size and also the decrease in the slope of the scattering region (600 – 1100 
nm).  The spectra shows an isosbestic point at approximately 480 nm and the trend of 
intensity vs. size inverts as this point is crossed coming from either direction.   
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Figure 5.5:  Simulated spectra of varying MCV at constant MCHC (0.05 mass fraction). 
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Figure 5.6:  Simulated spectra of varying MCV at constant MCHC (0.20 mass fraction). 
 
 
 Figure 5.7 is a simulation in which both the size range (80 – 100 fl) and the 
MCHC (0.33 mass fraction held constant) are within relevant physiological parameters.  
The first striking feature to notice is that the overall shape of the spectra looks similar to 
experimental spectra of red cells.  The n/n0 has increased to the point to where the whole 
particle scattering dominates the spectra.  This also accounts for the fact that the effect of 
the size change is dominant compared to the spectra in the previous two simulations.  The 
spectral flattening is evident on a larger scale as well.   
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Figure 5.7:  Simulated spectra of erythrocytes at varying MCV at constant MCHC (0.33 
mass fraction). 
 
 
Effect of Varying MCHCs on Red Cell Spectra 
 The simulation analysis of erythrocytes naturally progressed to the examination of 
trends due to varying mean corpuscular hemoglobin concentrations while holding the size 
constant.  In this case, the interdependent parameters such as size and hematocrit were 
not changing therefore an adjustment for particle number was not necessary.  Certain 
parameters were held constant as follows: 
Wavelength range for analysis:  190 1100 
Spectral resolution in nm:  1 
Blood concentration (g/ml) in cuvette:  1e-3 
Cell pathlength in cm:  1 
Erythrocyte volume fraction:  0.45 
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Erythrocyte average diameter (cm):  5.35e-4 
Erythrocyte density (g/ml):  1 
Number protein components:  1 
Property filename for component #1:  ophbo2.01 
Leukocyte volume fraction:  0 
Platelet volume fraction:  0 
Plasma volume fraction:  0 
 
The sole varying parameter was the MCHC (in mass fractions) which was examined at 
0.33, 0.20, 0.09, 0.5.  Figure 5.8 shows the result with the MCV set at 80 fl.  The most 
compelling trend to be noticed is that as the MCHC increases, there is an overall 
elevation of the spectra across the entire wavelength range due to the increase in light 
scattering.  At the low MCHC values (0.05 and 0.09), the characteristic hemoglobin 
singlet (417 nm) and the doublet (500~600 nm) are visible.  Even a small difference in 
mass fractions between 0.05 and 0.09 demonstrates a substantial scattering increase for 
the higher MCHC (evidenced by the elevation of the 0.09 spectrum).  At a hemoglobin 
mass fraction of 0.20, the shape of the spectrum is significantly different from that of 
0.09 with the hemoglobin peaks becoming less prominent due to the peaks being 
somewhat masked by the elevation of the scattering component.  A physiological MCHC 
(0.33 mass fraction) shows the absence of the hemoglobin peaks as they are completely 
masked by the scattered light.  The increase in the internal hemoglobin content increases 
the n/n0 contrast which contributes to the increase in whole particle scattering.  
Furthermore, the increase in hemoglobin density suggests that less of the chromophores 
are being sampled by the incident light, a phenomenon that would be less profound if the 
hemoglobin were free in solution.  Similar simulations done at constant sizes of 90 and 
100 fl yielded the same trend across the four MCHCs shown in Figure 5.8.   
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Figure 5.8:  Simulated spectra of erythrocytes at varying MCHC and constant MCV. 
 
Combined Effect of MCHC and MCV Changes 
 Once the individual effects of MCHC and MCV variations had been determined 
by the model, it was important to examine concomitant changes in both parameters.  The 
following simulation mimics a probable physiological event where the red cells are 
altered in size due to changes in the osmotic environment.  Associated with this change is 
a size-dependent alteration in concentration of the internal hemoglobin depending upon 
whether the cell is swelling or shrinking.  If the cells swell, the influx of water will dilute 
the hemoglobin concentration and vice versa.  As the cell volume (size) changed, the 
MCHC adjustments were calculated as follows: 
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Given:  MCHC = 33% at MCV = 90 fl 
  33% = 33 g/dl = 0.33 g/ml 
 
so, 0.33 g/ml x 90 x 10-12 ml = 2.97 x 10-11 g Hb 
 
Adjusting the MCHC in a cell volume of 95 fl: 
2.97 x 10-11 g Hb/95 x 10-12 ml = 0.31 g/ml 
 
Thus the diluted MCHC mass fraction is 0.31.   
 
The table included in Figure 5.9 shows the MCV changes and the corresponding 
MCHCs.  The hematocrit was held constant at 0.45 and the weight-based cell 
concentration in the cuvette was held at 1e-3 g/ml.  Similar to a previous simulation, the 
result was normalized (area under the curve method) to eliminate any cell number 
variation so that each spectra was expressed on a per cell basis.  The result was a direct 
comparison between cells of different sizes and their corresponding hemoglobin 
concentrations.   
 The swelling and shrinking of red cells even within physiological size constraints 
produced significant qualitative changes in the spectra.  The cell with the largest volume 
(100 fl) contained the most dilute hemoglobin (mass of hemoglobin held constant) and 
vice versa for the smallest volume cell.  Referring back to a previous simulation (Figure 
5.7) that examined only changes in the MCV, the trend in this current simulation (Figure 
5.9) shows an opposite effect.  That is, when changing only the MCV (Figure 5.7), the 
particle with the largest size (100 fl) but with the same hemoglobin content experienced 
the largest flattening of the spectrum.  However, in the case of swelling cells, the 
spectrum flattens when the MCV decreases and the MCHC increases.  This can be 
explained by the dominant spectral manifestation of increasing MCHC.  The effect of 
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increasing the MCHC (increase in n/n0) is evident in the dramatic changes in the spectra 
in Figure 5.8 and this is also responsible for the differences seen in Figure 5.9.  Hence, 
the effects of the hemoglobin concentration override the effects of size.   
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Figure 5.9:  Combined spectral effect of changes in RBC hemoglobin concentration and 
volume.   
 
 
5.2 Qualitative Analysis of Experimental Spectra 
In light of the theoretical studies presented in the previous section, the next step was 
to examine the outcome in an experimental system to see if the predicted trends shown by 
Mie theory hold true when compared to experimental values.  The concentration of 
hemoglobin in red blood cells was systematically altered by osmotic permeabilization, 
followed by restoration of the cells under physiologic osmolarity.  A variety of 
 150
concentrations and sizes were obtained by controlling the incubation time following the 
permeabilization step.  The sizes and concentrations were confirmed by using a Serono-
Baker hematology analyzer.    Each of these experimental sets was normalized using the 
area under the curve method from 230 – 900 nm.  All of the spectra were subjected to 
solvent (isotonic phosphate buffered saline) correction, thus subtracting the large, 
saturated saline peak below 230 nm renders this region unreliable for data extraction.  
The wavelength range of 900 – 1100 nm also occasionally showed errors in the way that 
the typically straight scattering region might tail downward due to instrumental 
uncertainty.  Hence, the 230 – 900 nm range encompassed the most consistent data.   
The following figures test the ability of the model to accurately simulate 
combinations of varying MCHC and MCV.  Figure 5.10 represents a group of 
experimental data selected over a range of MCHCs (0.048 – 0.336 mass fraction) each 
accompanied by varying MCV quantities.  The inset shows raw data with each sample 
diluted to a concentration of approximately 4000 cells/µl.  The large plot is normalized 
data designed to amplify the features of the spectra to facilitate visual qualitative 
comparisons.  As the MCHC increased, the overall optical density increased (inset).  The 
differences in the MCV provided a more subtle contribution to the spectra.  The 
normalized plot helped to show the emergence of the hemoglobin peaks as the 
encapsulated hemoglobin concentrations decrease.  The lowest MCHC sample (C4) 
showed the highest, most pronounced hemoglobin peaks whereas the highest MCHC 
sample (C1) exhibited a near absence of the characteristic peaks.  The observed behavior 
is expected and consistent with the scattering theory; as the concentration of hemoglobin 
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within the cell is decreased, so is the contrast of the particle relative to the suspending 
medium, which results in a decrease of the scattering contribution the.  
Figure 5.11 presents the simulations of the experimental spectra using the same 
MCHC and MCV values.  The empirical trends are evident in the simulated spectra:  1) 
there is a flattening in the curve with increasing MCHC, 2) the hemoglobin peaks become 
more apparent with decreasing MCHC, and 3) the inset plots show that with a constant 
cell count, the increase in MCHC generates a dramatic increase in the intensity of the  
 
Figure 5.10:  Experimental spectra of resealed cells with varying MCHC and MCV 
values.  The MCHC is expressed in mass fractions and the MCV in fl.  The inset 
represents the raw experimental data with each sample adjusted to a concentration of 
approximately 4000 cells/µl.  The large plot represents the normalized data where each 
raw data was divided through by the area under their respective curve.  The normalized 
plot amplifies the features of the curves to facilitate visual comparison. 
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overall spectrum.  The good agreements seen between the experimental and simulated 
spectra of the unmodified and hypotonically modified erythrocytes indicate the 
effectiveness of the scattering theory in describing the spectral features as functions of 
the size and the hemoglobin concentration. 
 
 
 
Figure 5.11:  Simulated spectra of resealed cells using the experimental MCHC and 
MCV values in Figure 5.20.  The MCHC is expressed in mass fractions and the MCV in 
fl.  The inset represents simulations of the raw experimental data.  The large plot 
represents the normalized data where each raw data was divided through by the area 
under the respective curves.  The normalized plot amplifies the features of the curves to 
facilitate visual comparison. 
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5.3  Conclusions 
 This chapter examined the effectiveness of the Mie theory based model to 
simulate the spectral features and trends of purified and hypotonically modified 
erythrocytes.  The acquisition of the experimental data of red cells possessing various 
MCHC and MCV values revealed features that were similar to the predictions made in 
the previous chapter.  Furthermore, simulations of experimental data using corresponding 
values of hematologic parameters obtained from the hematology analyzer provided good 
agreement of the overall features.  As two major parameters, MCHC and MCV, were 
changed, the trends of the spectra were modeled successfully to parallel those of the 
experimental spectra.  Increasing MCV (at constant MCHC) showed a slight decrease in 
the absorption region (<600 nm), however this effect was not as dramatic as changing 
MCHC at constant MCV.  In this latter case, increasing the MCHC drastically increased 
the whole particle scattering of the cell and this resulted in an elevation of the entire OD 
spectrum accompanied by the masking of the characteristic hemoglobin absorption peaks.  
Moreover, as the MCHC and MCV were both varied, the dominant parameter proved to 
be the MCHC in dictating the spectral trends.  Also, normalized spectra showed that as 
the cellular hemoglobin content increased, the absorption peak decreased, strongly 
indicating the presence of macroscopic hypochromism at higher hemoglobin 
concentrations.  This successful attempt to qualitatively simulate the purified and 
modified red cells allowed us to take the next step in our investigation:  to implement a 
Mie interpretation model for the quantification red cell suspensions.   
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Chapter 6:  Application of the Interpretation Model for the  
Quantitative Analysis of Erythrocytes 
 
 
  To this point, we have identified the presence of macroscopic 
hypochromicity as a scattering-related effect in the red cell spectra.  Moreover, the 
features and trends of experimentally modified red blood cells were successfully 
simulated using the mathematical model.  This chapter describes how the method was 
further extended to an interpretation model that permits the extraction of particle 
information from experimental spectrum including chemical composition, particle size, 
and particle number.  The quality of results from the interpretation provide strong 
evidence that molecular hypochromicity is negligible in the UV-visible spectrum of a red 
blood cell system.   
In Chapter 3 the concept of molecular hypochromicity was introduced.  Previous 
studies6,7 suggested the possibility of hypochromicity in red blood cells because of its 
high hemoglobin content.  Considering that hemoglobin is a strong chromophore and it 
exists in large concentration inside the red cell, testing for molecular hypochromicity is 
not a trivial issue.  If it exists, a hypochromicity correction would be required in addition 
to the implementation of a scattering and absorption model for the quantification of total 
hemoglobin in a red cell suspension.  This test for molecular hypochromicity was to 
determine whether the interpretation model that accounts for scattering can provide good 
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estimates of the total hemoglobin concentration.  The scattering model based on Mie 
theory simultaneously provides estimates of MCHC, MCV, and RBC counts, all 
parameters that can be measured independently.  The good agreement found herein 
between the spectroscopy-based estimates and the measured values provide further 
support to our conclusion that molecular hypochromicity is not significant for red blood 
cells.   
 
6.1  The Interpretation Model 
The kernel of the interpretation model is the turbidity equation based on Mie 
theory (as described extensively in Chapter 3) and it provides adequate estimations of the 
above-mentioned parameters for a given sample spectrum.  One of the big advantages to 
this method is its capability to efficiently analyze the spectrum across a broad wavelength 
range, providing a redundant mathematical check that increases the reliability of the 
estimated parameters.  This is in contrast to many other studies using one or only a few 
selected wavelengths for their estimations.79,80,81   
The general input-output format for the model is illustrated in the schematic 
diagram in Figure 6.1.  The two major inputs are the optical properties of the 
chromophore (hemoglobin) and the measured spectrum.  The computation consists of an 
iterative process to determine the best solution set for the output parameters which 
correspond to a good statistical fit of the spectrum.  The wavelength range used for 
analysis was 240 – 900 nm.  The range from 190 nm to 239 nm was omitted due to the 
solvent peak interfering with the sample spectra.  Figure 4.6 (Chapter 4) showed a 
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spectrum of the solvent (0.9% PBS) that showed a large saturated peak < 240 nm.  A 
background correction (subtraction of solvent spectrum from sample spectrum) of the 
sample spectrum would render this region unreliable for spectral interpretation.  The 
wavelength range of 901 – 1100 nm was omitted due to spectral perturbations seen in this 
range resulting from an inconsistent instrumental light source.  Although the diagnostics 
indicated that the lamp was producing intensities in this wavelength range within 
acceptable limits, some of the spectra showed dips below the baseline after background 
correction.  It should be noted, however, that this omission did not alter the estimated 
values for the following reason.  The “scattering only” region extends from 
approximately 620 nm to 1100 nm, a range that is largely linear.  Hence, analyzing 620 – 
900 nm is a good representation of the entire scattering wavelength range.   
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Figure 6.1:  Schematic diagram of the interpretation model.  Inputs consist of the optical 
properties of the chromophore and the experimentally measured spectrum.  The outputs 
include the particle count, average particle diameter (of an equivalent sphere), the mean 
corpuscular hemoglobin concentration, particle size distribution, and the spectral fit.   
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 Due to the multiple parameters composed in a solution set, regularization methods 
were implemented to confine the possible estimates and arrive at a reasonable solution 
while also limiting solutions to a statistically good fit of the spectrum.119  To achieve this, 
the discretization of the integrand of the turbidity equation can be written in a matrix 
form as a quadrature approximation 
   τ = Af + ε    (Eq. 6.1) 
where ε represents the sum of the measurement error (εm) and the quadrature error 
introduced in the discretization (εc).119,120  The least squares solution to the discretized 
model in terms of the particle size distribution (PSD) is defined as  
   τTTls AAAf 1)(ˆ −=    (Eq. 6.2) 
However, small errors in the quadrature or experimental measurements can translate into 
large errors for lsfˆ .  Regularization of this equation leads to a constrained solution 
defined by  
   τγ TTls AHAAf 1)(ˆ −+=   (Eq. 6.3) 
where γ is a regularization parameter and H is a covariance matrix that helps to narrow 
the possible solution sets that arise from the propagation of error.  There exists an 
acceptable value for γ such that the error of lsfˆ  is minimized.  This value is estimated 
using the Generalized Cross Validation (GCV) technique described by the equation 
{ }2
2
)]([
)]([
)( γ
τγγ
ZItrace
ZI
mV −
−=   (Eq. 6.4) 
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where Z(γ)=A(ATA+γI)-1AT.120  The variable m represents the number of turbidity 
measurements with respect to wavelength.117,121  The result of these equations is a reliable 
equivalent sphere particle size distribution for use with the turbidity equation in the 
interpretation model.   
Variants of the Interpretation Model 
 The interpretation model was modified in three ways to provide slightly different 
approaches to the interpretation of the resealed red cell system.69  Table 6.1 identifies and 
describes the three versions. 
 
Version Name  Description 
RBCHb01a  Choice of one encapsulated chromophore (oxyhemoglobin) 
  RBCHb01b               Choice of two encapsulated chromophores (oxy- and another 
hemoglobin derivative such as methemoglobin) 
  RBCHb02a               Choice of one chromophore but with the option to put a fraction of        
the chromophore outside of the cell in the medium 
 
Table 6.1:  The three versions of the interpretation models and the variations in their 
functions. 
 
 
 Version 01a is the simplest of the three with 01b and 02a introducing additional 
parameters for the prospect of elucidating the better solution set.  However, increasing 
the number of parameters adds more complexity to the calculations as well as amplifying 
the potential error in the solution set such that the ideal situation would be if RBCHb01a 
proved to be an adequate model for a majority of the measured data.  Therefore, the data 
was first analyzed with 01a while implementing the subsequent versions on an as-needed 
basis.   
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Corroboration of the Estimated Parameters 
 While the interpretation model is a powerful tool for extracting particle 
information from a single spectrum, its development requires validation of the observed 
parameters using separate analytical methods.  These methods were previously described 
in the Chapter 4.  Briefly, the hematology analyzer (Serono-Baker system) gives 
impedence-based values for the cell counts and the cell volume, with the volume being 
readily calculated to the equivalent sphere diameter using the equation for the volume of 
a sphere (v=4πr3/3).   
 The hemoglobin concentration can be calculated in two independent manners 
albeit both are based on the same Drabkin’s principle (discussed in Chapter 4).46,47  The 
first is the modified Drabkin’s assay automated by the hematology analyzer.  The second 
is the manual Drabkin’s assay, used as a verification tool for the values obtained via 
instrumental analysis.  Although the two methods share the same principle, their 
executions bring about a systematic offset that needs to be addressed.  Figure 6.2 is a 
scatter plot comparison of hemoglobin concentrations (HGB in g/dl) acquired from the 
two methods using an array of data points obtained throughout this study.  The solid line 
represents a 45 degree reference line where a perfect correlation between the two 
methods of measurement would put the data points on the reference line.  It is evident, 
however, that there is a relatively consistent bias in the data.  The offset shows the 
Drabkin’s values being slightly greater than the hematology analyzer values.  Using the 
Serono numbers as the reference, the calculated percent (%) offset for the large (~20 g/dl) 
and medium (~10 g/dl) hemoglobin concentrations are within 10%.  Although the best fit 
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line tapers towards the juxtaposed reference line at the lower values as expected, the 
numerical value for the % offset increases due to the decrease in the numerical values.  
Furthermore, the data points at the larger values (>20 g/dl) show a more pronounced 
deviation from the reference line.  The discrepancy in the two techniques can be 
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Figure 6.2:  Comparison of hemoglobin concentration (HGB) values (g/dl) measured by 
the Serono-Baker and the Drabkin’s assay.  The solid line is a 45 degree reference line, 
the scattered points represent the data points, and the dotted line is a linear regression of 
the data points. 
 
 
attributed to a systematic error which is not uncommon when comparing two such 
methods.122,123  As long as the bias is considered, the Drabkin’s method can still be used 
as a validation for the Serono-Baker and the estimated values from the interpretation 
model.   
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 The hemoglobin concentration values compared in Figure 6.2 are raw numbers 
obtained directly from the measured spectra.  In the case of both methods, the red cells 
are lysed, the optical density is taken at a predetermined wavelength and then translated 
into the hemoglobin concentration using a calibration curve.  Since the Serono-Baker is 
an automated system, the error associated with the HGB reading is minimized.  This is in 
contrast to the manual Drabkin’s method in which one must take into account the human  
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Figure 6.3:  Comparison of the mean corpuscular hemoglobin concentration (MCHC) 
values (mass fraction) measured by the Serono-Baker and the Drabkin’s assay.  The solid 
line is a 45 degree reference line, the scattered points represent the data points, and the 
dotted line is a linear regression of the data points. 
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pipetting error as well as instrumental errors.  The difference is illustrated in an analysis 
where six replicates of the same sample gave an error of 0.7% (standard deviation).  
Replicates of the Drabkin’s assay showed a higher error of 1.4%.   
The offset of the two methods can be further represented as a comparison of 
MCHC in Figure 6.3.  It must be considered, however, that the MCHC is a calculated 
value instead of a raw number like the HGB.  In the equation MCHC = HGB/HCT, it is 
evident that the computation introduces the hematocrit (HCT) value that is obtained by 
the Serono-Baker, an additional source of error.  Thus this error is introduced into the 
MCHC obtained via both analytical formats.  The plot shows that the data points at the 
lower MCHCs have a relatively tight fit to the linear regression whereas the higher 
MCHC values become slightly more scattered.   
 
Testing the Interpretation Model 
 Thirty-four samples of purified and resealed red blood cells were analyzed to give 
good estimates red cell parameters.  This section presents analyzed results for 
representative samples in the high, medium and low MCHC ranges.  In order to explain 
the inputs and outputs of the model, a specific example of a resealed red cell sample in 
the low range MCHC (sample ID: r41603g) will be used.  The program inputs for the 
RBCHb01a interpretation model with respect to this sample are as follows: 
Problem number:  1 
Cell pathlength (cm):  1 
Particle density (g/ml):  1 
Sample filename:  r41603g.dat 
Wavelength range for analysis (nm):  240 900 
Optical properties file or particles and suspending medium:  ophbo2.01 
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Enter filename for estimation results:  r41603g.txt 
Number of particle populations:  1 
Fraction of chromophores in particles:  0.05 
Estimate of Dn (nm):  4500 
Estimate of sigma:  0.1 
Enter filename for calculated PSD:  r41603g.psd 
Enter filename for calculated spectrum:  r41603g.clc 
 
 Some of the parameters are self-explanatory.  The optical properties file 
contains the absorption coefficient and the refractive index of oxyhemoglobin, and also 
the refractive index of the suspending medium (water).  The “particle population” refers 
to the particle size population defined by the mean, where up to three distributions are 
allowed by the program.  The majority of our analyses kept the population at one since 
this provided successful outcomes.  The fraction of chromophores field is an estimation 
of the hemoglobin mass fraction that provides a starting point for the model to facilitate 
convergence.  The value 0.05 was chosen as a round number close the Serono-Baker 
output (0.062).  Dn is the estimated number based diameter of the sphere which was 
chosen to be 4500 nm, slightly smaller than the equivalent sphere diameter of a cell of 
volume 80 fl (5350 nm).  The breadth of the variance (σ) for an equivalent lognormal 
size distribution was estimated to be 0.1.   
 The spectral output file is illustrated in Figure 6.4 along with some of the key 
estimated parameters.  The data includes the measured spectrum fitted to the calculated 
spectrum.  The residuals indicate the difference between the measured and calculated.  
The Beer-Lambert spectrum of the chromophore shows the absorption spectrum of 
oxyhemoglobin if the total mass of the encapsulated protein remained constant but 
existed free in solution in the same sample volume.  An important feature to note in the 
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calculated spectrum is its close fit to the measured data.  The scattering region (>600 
nm), devoid of any absorption effects, shows a near-perfect overlay.  Slight differences in 
the absorbing region of the spectrum may be attributed to either assumptions made in the 
modeling, or perhaps there are aspects of the biological system not being considered.  
Such issues will be discussed later in the chapter.   
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Figure 6.4:  Output of the spectral estimate by the RBCHb01a interpretation model for 
low range MCHC.  The measured and calculated spectra closely overlay each other.  The 
residuals represent the difference between the calculated and measured spectra, and the 
absorption of hemoglobin illustrates the absorption spectrum if the hemoglobin resided 
free in solution while keeping the protein mass and sample volume constant. 
 
 
 Figure 6.4 is representative of successful interpretations achieved for resealed 
cells with the MCHC in the low range (< 0.10 mass fraction).  In the case of the MCHC 
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value for this sample (r41603g), the measured quantity is reported to be 0.062 by the 
Serono-Baker (as shown in the figure) and 0.098 by the Drabkin’s assay.  The estimated 
value of 0.084 falls in the range between the two measured numbers.  The MCV value 
itself is estimated to be 85.2 fl, slightly different from the measured quantity of 79.8 fl.  
The difference could be related to the instrumental error of the measured value and/or the 
flexibility of the numerical solutions within the statistical tolerance of the interpretation 
model.  To elaborate this latter point, a few requirements need to be met to arrive at a 
reasonable solution:  1) the solution must provide a good fit to the empirical spectrum 
across the entire wavelength range of analysis, and 2) the values assigned to each of the 
important parameters (diameter, cell count, hemoglobin concentration, etc) must all make  
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Figure 6.5:  A representation of the algorithmic process of the interpretation model.   
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sense within physiologic constraints.  Figure 6.5 illustrates a simplified example where 
statistically viable solutions exist within the limits of the oblong ellipse defining the error 
tolerance along a reference line.  However, relevant solution sets reside within the 
smaller oval and the regularization technique narrows the possible solutions within these 
limits. 
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Figure 6.6:  Output of the spectral estimate by the RBCHb01a interpretation model for 
medium range MCHC.  The measured and calculated spectra resemble one another, 
particularly in the scattering region > 600 nm.  The residuals represent the difference 
between the calculated and measured spectra, and the absorption of hemoglobin 
illustrates the absorption spectrum if the hemoglobin resided free in solution while 
keeping the protein mass and sample volume constant.  The outputs for the hemoglobin 
concentration, size, and number parameters match well with the measured values. 
 
 
 Figure 6.6 is a representative result of a spectral interpretation by RBCHb01a 
for a resealed red cell population in the medium range of hemoglobin concentrations.  In 
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terms of protocol, the length of time the cells were subject to permeabilization in the 
hypotonic buffer was reduced to approximately one minute so that less hemoglobin was 
released.  The result was a higher encapsulated hemoglobin concentration compared to 
the data set represented by Figure 6.4.  Higher hemoglobin content raised the overall 
refractive index of the particle, hence increasing the scattering component of the particle.   
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Figure 6.7:  Output of the spectral estimate by the RBCHb01a interpretation model for 
physiological range MCHC.  The measured and calculated spectra resemble one another, 
particularly in the scattering region > 600 nm.  The residuals represent the difference 
between the calculated and measured spectra, and the absorption of hemoglobin 
illustrates the absorption spectrum if the hemoglobin resided free in solution while 
keeping the protein mass and sample volume constant.  The outputs for the hemoglobin 
concentration, size, and number parameters match well with the measured values. 
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Increase in the scattering pattern adds to the complexity of modeling the total spectrum, 
particularly in the wavelength range < 600 nm that contains significant absorption 
information.  This is reflected in the model’s difficulty in closely reproducing all of the 
detailed features of the experimental spectrum, especially at the lower wavelengths.  
From a quantitative perspective, however, the three major parameters, MCHC, 
diameter/volume, and cell count all yield good results.  Similar results were seen in 
samples with MCHC values in the physiological range (Figure 6.7).  Experimentally, 
these erythrocytes were isolated from the major components of whole blood with no 
modification to the erythrocytes themselves.  The interpreted spectral fit shows excellent 
correlation in the scattering-only region at wavelengths above 600 nm.  The estimated 
MCHC and the cell counts show remarkable correspondence.  The size values obtained 
from the experimental and calculated spectra were less similar, however, the calculated 
volume still falls within the physiological range (80 – 100 fl) and is a plausible value.   
 
6.2 Quantitative Results of the Interpretation Model 
 As mentioned previously, the turbidity equation depends on not only the 
optical properties of the erythrocytes, but also a number of important parameters 
describing the particles:  the cell size (equivalent sphere diameter/volume), the 
hemoglobin content, and the cell count.  Provided that the refractive index of the medium 
is properly accounted for,73 the interpretive results of the model generally showed 
satisfactory values for each of the parameters compared to their corroborative 
experimental values.   
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 The three different versions of the interpretation model listed in Table 6.1 
offered varying options in the way the data was evaluated.  Program version RBCHb01a 
simulated the simplest case, assuming that all of the hemoglobin was encapsulated inside 
the cells in the form of oxyhemoglobin.  We found that this version of the program 
converged to the most physiologically consistent solutions (43 of 59 samples analyzed 
converged to adequate values).  The other two versions of the interpretation model only  
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Figure 6.8:  Comparison of the calculated MCHC to the MCHC values measured by the 
hematology analyzer and the manual Drabkin’s assay.  The scatter plots were fitted with 
a linear regression curve.  Both methods show a high level of corroboration to the 
estimated data.  The separation of the two lines is attributed to the systematic offset 
inherent between the two methods of measurement.   
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improved the estimations in isolated cases.  The bulk of the results represented herein 
were obtained from RBCHb01a.   
 
Quantitative Results Obtained with RBCHb01a 
 The mean corpuscular hemoglobin concentration (MCHC) value was 
reported by the Serono-Baker hematology analyzer and estimated by the interpretation 
model.  Additionally, the MCHC was calculated from the hemoglobin concentration 
value obtained from the Drabkin’s assay.  Figure 6.8 shows a comparison of the 
estimated MCHC to those acquired from the two independent experimental procedures.   
 
Sample Serono-Baker Estimated Drabkin's 
6399a 0.036 0.050 0.065 
6399b 0.041 0.056 0.077 
6399c 0.043 0.045 0.074 
6399d 0.047 0.047 0.084 
6999a 0.048 0.051 0.077 
r5103d 0.084 0.084 0.125 
r5103e 0.090 0.083 0.111 
r41703d 0.095 0.128 0.168 
r51403c 0.199 0.241 0.226 
r6303b 0.228 0.241 0.247 
r51403d 0.229 0.251 0.246 
r6303a 0.238 0.251 0.271 
r6303g 0.306 0.333 0.355 
r41703a 0.333 0.335 0.365 
r51403a 0.343 0.358 0.372 
 
Table 6.2:  Table of estimated and measured values (g/dl) for representative erythrocyte 
samples containing various amounts of hemoglobin.  The calculated values generally fall 
between the two measured values with a few exceptions.   
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A perfect corroboration would be represented by a 45o line passing through the origin.  
The separation of the two best-fit lines is related to the systematic offset of the Drabkin’s 
assay and the Serono-Baker discussed earlier in the chapter (Figures 6.2 and 6.3).  Table 
6.2 offers an abbreviated look at some representative values plotted in Figure 6.8.  The 
estimated (calculated) values largely fall between the two measured values with a few 
exceptions, indicating a general consistency in the results of the model.  Interestingly, 
both measured data sets in Figure 6.8 show an increased scatter in the points as the  
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Figure 6.9:  Comparison of the calculated hemoglobin concentration (HGB) to the HGB 
values measured by the hematology analyzer and the manual Drabkin’s assay.  The 
scatter plots were fitted with a linear regression curve.  Both methods show a higher level 
of corroboration to the estimated values than the MCHC data.  The separation of the two 
lines is attributed to the systematic offset inherent between the two methods of 
measurement. 
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hemoglobin values become larger.  However, the same trend is seen in the direct 
comparison between the two physical methods in Figure 6.3 hence the increased scatter at 
the high hemoglobin concentrations is a result of measurement variability.    
 A similar comparison was made in terms of the total hemoglobin 
concentration (HGB) expressed in g/dl.  This term represents the hemoglobin 
concentration quantified as the cells in suspension were lysed and the hemoglobin was 
diluted into solution.47  The Drabkin’s assay was the standardized method for the 
acquisition of this parameter.  The hematology analyzer used a modified Drabkin’s assay 
to collect the same information.  The plot (Figure 6.9) illustrates a linear regression for 
both methods, each of which shows a high correlation with the calculated values.  
Consistent with the MCHC data, there is more scatter at the higher values than the low 
range.  The tighter distribution of the points in Figure 6.8 is suggestive of the HGB 
parameter’s unprocessed nature whereas MCHC is a value calculated from HGB and 
hematocrit (HCT) with an implied propagation of error.  Importantly, the estimation 
successfully accounted for the hemoglobin mass balance without the implementation 
of any correction for molecular hypochromism.   
 Furthermore, comparisons were made between measured and calculated sizes 
of the cells, both expressed as equivalent sphere diameter and volume.  The hematology 
analyzer provided the validation for the estimated sizes.  The equivalent sphere diameters 
estimated by the interpretation model seemed to be reasonable estimates of the measured 
values for a large proportion (43/59) of samples (Figure 6.10).   The calculated values for 
particle were close to or in the range of physiological values (5.35 – 5.76 µm).  Greater  
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Figure 6.10:  Calculated vs measured equivalent sphere diameters.  The measured values 
were obtained from the Serono-Baker hematology analyzer and the calculated values 
were estimated by the interpretation model.   
 
 
than 90% of the calculated estimates were within a 10% error of their measured 
counterparts.  When these values were translated into volumes, even small differences 
were magnified due to the exponent in the spherical volume equation (Figure 6.11).  
Nevertheless, the differences between the calculated and measured MCVs are 
proportionate to their counterparts reported in Figure 6.10.  Moreover, the phase contrast 
micrographs (Chapter 4) indicated that the sizes were consistent with both measured and 
estimated values.  Hence it can be generally stated that the estimated volumes for a 
majority of our 59 experimental samples are in or approaching the physiological range of 
the erythrocytes.   
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Figure 6.11:  Calculated vs measured cell volumes.  The measured values were obtained 
from the Serono-Baker hematology analyzer and the calculated values were estimated by 
the interpretation model.   
 
 Figure 6.12 illustrates the comparison between calculated and measured cell 
counts of purified and modified red cells.  Although some of the smaller counts show 
significant variability, there are many samples that show very good agreement similar to 
the comparisons of cell volume in the previous figure.  Of the 34 samples analyzed, the 
estimated values of approximately 70% of the samples were within 20% error of the 
measured values.  It is important to note that the measured MCV and the cell counts have 
instrument-associated error as defined in Table 4.2 (Chapter 4).  Moreover, the calculated 
values can fluctuate within the limits of acceptable solution sets as indicated previously 
in Figure 6.5.   
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Figure 6.12:  Calculated vs measured cell counts.  The measured values were obtained 
from the Serono-Baker hematology analyzer and the calculated values were estimated by 
the interpretation model.   
 
  To further explore the variability of the measured values of cell count and 
cell size in comparison to the calculated numbers, a Coulter Z2 counter was used.  
Although the counts were obtained using electrical impedence measurements like the 
Serono-Baker hematology analyzer, it still provided another level of corroboration to 
validate the interpreted numbers.  The counter is reported to give reproducible RBC 
counts within 5% and has an upper linearity limit of 8 x 106 cells/µl.124  Tables 6.3 
presents counts for six resealed cell samples measured on the Coulter and the Serono-
Baker, and their calculated counterparts.  Samples 1 – 3 were replicate samples of 
resealed cells prepared in parallel as were samples 4 – 6.  Within each sample set, the 
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counts and sizes were relatively consistent for each instrument.  Interestingly however, 
there were constant systematic offsets between the two impedance counters for each set 
of parameters.  The calculated values obtained from the interpretation model generally 
fell close to the range of both measured values, but the precision appeared sample-
related.  The first sample set (1 – 3) yielded calculated values for both parameters that 
were closer to the measured values than the second sample set (4 – 6).  The calculated 
equivalent sphere diameters (Table 6.4) showed better agreement to the experimental 
values.   
 
  Coulter (106/µl)      Serono-Baker (106/µl)    Calculated (106/µl) 
Sample 1          3.21      4.01        3.30 
Sample 2          3.59      4.08        3.38 
Sample 3          3.64      4.15        3.28  
Sample 4          1.73      2.23        2.74  
Sample 5          1.69      2.16        3.60 
Sample 6                 1.60      2.20        3.52 
 
Table 6.3:  Comparison of cell counts of resealed cells between measured (Coulter Z2 
and Serono-Baker 9110) and calculated values.   
 
 
 
  Coulter (µm)   Serono-Baker(µm)  Calculated(µm) 
Sample 1        5.18  5.27           5.06   
Sample 2        5.18  5.25           5.13 
Sample 3        5.32  5.23           5.16 
Sample 4        5.58  5.44           5.82 
Sample 5        5.58  5.44           5.50 
Sample 6        5.59  5.44           5.65 
 
Table 6.4:  Comparison of the equivalent sphere diameter (µm) of resealed cells between 
measured (Coulter Z2 and Serono-Baker 9110) and calculated values.   
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6.3 Discussion 
 It has long been debated over the last 50 years whether or not molecular 
hypochromism plays a role in the optical characteristics of encapsulated systems such as 
red blood cells and chloroplasts.6,85  Considering the success of the interpretation model, 
however, it can be stated with confidence that molecular hypochromism is insignificant 
in the spectral analysis of red blood cells, and most probably in similar systems.  The 
extension of Mie theory to accurately quantify the total hemoglobin concentration in a 
suspension of red cells is a large contribution to both fundamental and applied science.  
Moreover, the success in estimating other important red cell parameters including cell 
count, MCHC, MCV, and cell diameter strengthens the validity of the interpretation 
model.     
 When the interpretation model was subjected to multiple evaluations of the 
same red cell data, the algorithm consistently returned the same HGB value, although the 
MCHC and MCV fluctuated slightly and dependently between trials.  This can be 
explained by examining how the interpretation model calculates these values.  Consider 
the relationship 
Hbp f
DNHGB ρπ 


=
6
3
 
where the middle term in parentheses is the volume of a sphere, ρ is the density of the 
cell, and fHb is the mass fraction of hemoglobin.  The interpretation program first attempts 
to fit a normalized spectrum, hence the particle concentration (Np) is eliminated from the 
equation.  Therefore, the two estimated values are D and fHb.  These two parameters 
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fluctuate in accordance with each other to give a consistent HGB value that correlated 
well with the measured value.   
 Furthermore, the success of the estimated parameters was accompanied by 
good estimated fits of the measured spectra.  The fits were best across the entire 
wavelength range (the data was fitted from 240 to 900 nm) for the low MCHC values 
(~0.05 – 0.10 mass fraction).  This could be a result of one or more combined effects.  
First, the resealed cells appeared to take on a more spherical shape as evident in the phase 
contrast micrographs, thus approaching the spherical approximation used in Mie theory.  
Second, and perhaps more important, the lower contrast of resealed cells to medium due 
to the low hemoglobin concentration decreased whole particle scattering characteristics, 
simplifying the interpretation of the spectrum.  As the MCHC increased, the scattering 
component increased adding to the complexity of the spectrum.  At the wavelengths > 
600 nm where mainly the scattering component is represented, a good overlap between 
the measured and calculated spectra is seen.  At the low wavelengths, a combination of 
scattering and absorption components are represented.  Here, there are differences in 
estimated and calculated spectra, however, the areas under the curves are similar.  This 
appears to reflect a compensation for variations in spectral match that allows us to 
achieve relevant values for red cells.  The experimental spectrum of the high MCHC 
(Figure 6.7) shows a smoothed curve compared to the estimated spectrum.  This effect 
may be the result of distribution of cell orientations since it has been shown that a 
broadening of the distribution causes curve smoothening (unpublished work).69  Thus 
accounting for cell shape and orientation in the calculations should further improve the 
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interpretation model, which is already providing good estimates of red cell parameters.  
Additionally, there are other distributions that merit consideration.  The particle size 
distribution for the resealed cells could be slightly irregular compared to that of the 
unmodified red cells.  Microscopy pictures suggest that the sizes range in the 
approximate diameters from 4 to 8 µm.  In some cases, the distribution could be bimodal.  
Moreover, the MCHC distribution in the resealed cell samples could be heterogeneous, 
but to what degree remains to be seen.  Examination of such issues should further 
improve upon an already satisfactory interpretation model.  To conclude, in spite of the 
fact that we are using a simplified spherical approximation, the fact that there is good 
agreement between spectroscopy-based estimates and standard measurement strongly 
suggests that improvement of the scattering model is the right direction in completing the 
interpretation of the red blood cell.   
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Chapter 7:  Conclusions 
 Multiwavelength UV-visible spectrophotometry is a versatile method for the 
characterization of suspended particles of various sizes.  Optical analysis of particles such 
as red blood cells have been attempted on different levels (single wavelength or small 
wavelength range) and problems such as photometer design and the possibility of 
hypochromism have been identified.  However, this is the first body of work that 
addresses the full array of fundamental questions associated with macroscopic particle 
characterization and successfully implements a reliable interpretation model for the 
quantification of the important parameters of red blood cells.  The contributions are listed 
as follows. 
• The concept of hypochromicity was revised in the context of obtaining precise 
estimates of hemoglobin concentration in red blood cells from spectroscopic 
measurements.  Hypochromism (a decrease in the absorption spectrum with the 
increase in the concentration of a strong chromophore) in the past had only been 
defined as a phenomenon cause by electronic molecular interactions.  In order to 
characterize red blood cells using the light scattering theory, it was necessary to 
adjust the perception of hypochromicity. 
• Two levels of hypochromicity were established to better describe the optical behavior 
of macroscopic particles.  Molecular hypochromicity is the aforementioned effect due 
 181
to particle interactions on the molecular level.  Macroscopic hypochromicity is the 
attenuation of the absorption component as a result of increased light scattering as the 
refractive index of the particle increases.  Red blood cells with high physiological 
concentrations of hemoglobin exhibit a particularly pronounced macroscopic 
hypochromicity. 
• Instrumental configuration was shown to have a significant effect on the spectrum 
and the way it is interpreted.  In previous studies,6,7 the effect of photometer design 
(with respect to the angle of acceptance) on macroscopic particle spectra has been 
confused with molecular hypochromism.  This study examined the importance of the 
acceptance angle on the red cell spectrum and in the process, we established that a 
small angle transmission spectrum contained the best balance of absorption and 
scattering information. 
• A modified protocol for the hypotonic modification of red blood cells was developed, 
with the ability to control the resulting encapsulated hemoglobin concentration.   
The resealed cells were essential in the investigation of the optical behavior of red 
cells as the refractive index and the size of the particles changed.   
• The light scattering theory of electromagnetic radiation was used to successfully 
account for the scattering and absorption components of red cell spectra.  The 
capability to analyze both the scattering and absorption components of a large particle 
suspension allowed for the close examination of the two types of hypochromicity.   
• In the context of light scattering theory, the Mie theory was implemented and 
extended to account for chemical composition across the entire wavelength range 
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(190 – 1100 nm).  Although the theory assumes spherical particles, results showed its 
capability to reliably interpret red blood cell spectra in physiological and modified 
states. 
• Using the Mie theory, trends and features of experimental red cell spectra were 
successfully simulated.  Simulations were helpful in predicting the outcomes of 
experiments, and also to suggest the direction of future experiments.   
• The interpretation model based on the Mie theory yielded realistic values of MCHC, 
MCV, Np, and HGB for purified and resealed red cell samples. 
• The success of the interpretation model in giving reasonable values for the 
hematologic parameters, particularly the total hemoglobin concentration (HGB) 
indicated that there was no significant molecular hypochromic effect as suggested in 
previous studies. 
The implications of this work encompass the understanding of fundamental light 
scattering concepts and the possibilities of a rapid, inexpensive and reliable analysis of 
whole blood in a clinical setting.  Since the contributions of red blood cells dominate a 
spectrum of whole blood, a good characterization of red cells was necessary in order to 
examine the effects of lesser optical contributors such as platelets and leukocytes.  
Furthermore, since the basic ideas are in place, multiwavelength light scattering analysis 
can be applied to encapsulated particle systems similar to red blood cells.   
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Future Work 
 The spherical restriction of the Mie theory may have been the reason for our 
inability to perfectly fit all of the features of the red cell spectrum, particularly for the 
cells containing a high concentration of hemoglobin.  At high refractive indices of red 
cells, the scattering becomes more dominant and parameters such as shape and 
orientation could become important to the features of the spectrum.  Current work 
involves other members of the research group attempting to incorporate form factors into 
the analysis to examine the effects of shape and orientation on the spectrum.69,125 
 Moreover, with regards to the characterization of resealed cells, there were 
physical details of the cells that were not accounted for by inspecting the sample with the 
hematology analyzer.  For example, when the cells were permeabilized and resealed, the 
resulting MCHC most probably did not represent a uniform distribution of hemoglobin 
concentration across the entire population.   The Serono-Baker reports an average value 
and is incapable of accounting for multiple populations.  Simulations can be used to 
determine the impact of hypothetical distributions of hemoglobin concentrations.  If the 
calculated model suggests that it is significant, then the resealed cells could be subjected 
to density separations to better characterize the cell spectra.   
 Experimental model systems can be used to further validate the results of the 
resealed cells.  Liposomes were proposed in our studies as an alternative system, but 
results showed difficulty in producing unilamellar vesicles (Appendix C).  A different 
protocol should be chosen to refine the quality of the liposomes to facilitate their 
characterization.  Moreover, aggregation of proteins using high salt media provides 
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possibilities of mimicking encapsulated systems.  Preliminary work with the aggregation 
of serum albumin and hemoglobin (Appendix H) showed drastic spectral changes when 
comparing pre- and post-aggregation.  If the density and the size of the aggregates can be 
characterized, their spectra can be quantified.   
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Appendix A:  Mie Theory Formulae 
 
 It has been established that the Mie efficiency coefficient8,71,72 for extinction (Qext) 
is related to the optical density with the turbidity equation revisited below, 
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where Qext = Qsca + Qabs thus the turbidity equation is divided into its scattering and 
absorption components.  Other important parameters of the equation include the particle 
number (Np), the equivalent sphere diameter (D), the size distribution function (f(d)), the 
size parameter (α) and the complex refractive index (m).  The latter two parameters were 
defined in Chapter 3 as 
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where Qabs can be inferred from these two know values.  Mie scattering coefficients, an 
and bn are  
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ξn(z), ξ’n(z), ψn(z), and ψ’n(z) are Riccati-Bessel functions defined in terms of Bessel 
functions (Jn), 
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Appendix B:  Concentration-Related Instrumental Limitations of Hemoglobin and 
Erythrocytes 
 
 It is important to understand and to operate within the limitations of the 
instrument (Agilent 8453 UV-vis spectrophotometer) when analyzing data.  Two major 
concerns that required attention were both related to the concentration of the erythrocytes 
in the suspension:  linearity of the instrument and multiple scattering.  The former can be 
discussed in terms of the absorbance equation, A = log (I0/It).  If the recovered 
transmitted light is only 5% of the incident light intensity due to absorption, the value for 
A would be 1.3.  At 1% recovery, A would be 2.  Thus as absorption increases, the 
sensitivity of the detector is tested due to the decreasing light transmission.  We have 
chosen a conservative 1.2 optical density units as our upper limit to ensure the reliability 
of our data.  Figure B1 demonstrates the linearity of the optical density measurements as 
a function of concentration for a hemoglobin solution taken with a 1 cm pathlength 
cuvette.  The small peak at 540 nm stays below an OD of one and thus maintains good 
linearity over the observed concentrations.  The hemoglobin Soret band at 417 nm keeps 
linearity at higher OD and it can be inferred by the plot that the linearity breaks down 
between 2.5 and 3.0 OD.  Therefore, it can be seen that our self-imposed limit of 1.2 OD 
is well within the linear limits and will give reliable data.  Due to the high extinction 
coefficient of hemoglobin, the 417 nm band reaches and OD of 1.2 at a concentration of 
~1.3 mg/ml and the 540 nm band at a concentration of ~14 mg/ml.  These values are not 
remotely close to physiological encapsulated hemoglobin concentrations of 330 mg/ml.  
Thus it is easy to see the difficulty in examining the effect of molecular hypochromism in 
a free hemoglobin solution approaching physiological concentrations.  For suspensions of  
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red cells, it was determined experimentally that a concentration of 4000 cells/µl gives an 
OD of ~1.2. 
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
0 0.2 0.4 0.6 0.8 1 1.2
Concentration (mg/ml)
O
D
540 nm
417 nm
 
Figure B1:  Assessment of the optical density linearity limits of the Agilent 8453 
spectrophotometer as a function of hemoglobin (solution) concentration.  The 540 nm 
band maintains linearity due to its low optical density over the observed concentrations.  
The 417 nm band, however, loses its linearity between OD of 2.5 and 3.0.  
  
 
 Multiple scattering effects also need to be considered in a particle suspension.  
The Mie theory predicts light scattered by a single particle.  If the cells are concentrated 
enough to scatter light by multiple particles, the task of interpreting the spectra becomes 
complex.  Figure B2 examines if there are any multiple scattering effects at the working 
sample dilution of 4000 cells/µl with serial dilutions of whole blood.  The presence of  
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multiple scattering would manifest itself by deviating from linearity as the cell 
concentration increases.  According to our observations, the measurement at 
approximately 4000 cells/µl shows negligible deviations at wavelengths of 417 and 540 
nm.  Thus it can be concluded that multiple scattering effects are not a factor in our 
simulations and interpretations of spectra based on the Mie theory.   
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Figure B2:  Serial dilutions of whole blood for the examination of multiple scattering.  
The linearity of the spectrum at wavelengths of 417 and 540 nm imply negligible 
multiple scattering effects at 4000 cells/µl. 
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Appendix C:  Spectral Characterization of a Liposome Model System 
 
 Multiwavelength spectra of modified red blood cells were successfully 
characterized and interpreted in this dissertation.  As an alternate experimental model 
system parallel to the red cells, liposomes were used to encapsulate hemoglobin 
(hemosomes) and other model proteins.  The advantages to a good liposome model 
system are that they are easy to manipulate, a variety of model molecules can be 
encapsulated within the membrane, and their spherical nature fits well in the Mie 
framework.   
 Liposomes are lipid vesicles that enclose an aqueous volume.  When lipids are 
introduced to aqueous media at the appropriate concentrations, they form spontaneously 
into vesicles with the membrane in a bilayer structure similar to those of biological cells 
(Figure C1).126  Liposomes are typically made with common phospholipids such as 
phosphatidylcholine, phosphatidylserine and sphingomyelin in combination with 
cholesterol (~ 1:1 molar ratio of lipid:cholesterol).  The physical structure of the 
liposomes membranes can be unilamellar or multilamellar (multiple concentric 
membranes within the same liposome) depending on the manner in which they are 
prepared.126,127  Moreover, sizes of the liposomes can vary in the range of 0.02 – 20 µm 
in diameter.126,128  Liposome systems have different clinical and experimental 
applications such as artificial red blood cell substitutes,128,129,130,131 nucleic acid 
carriers,127,132 drug delivery systems,133 and systems observing enzymatic activity under 
encapsulated conditions.134 
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Figure C1:  Diagram of a liposome.  Like biological phospholipids bilayers, the 
membranes adopt tail-to-tail configuration and encapsulate an aqueous volume. 
 
 The objective of this research was to perform a multiwavelength UV-vis spectral 
analysis/chararacterization of liposomes encapsulating hemoglobin (hemosomes) to 
parallel our studies of the modified red cells.  Given that the properties of the hemosomes 
are accurately elucidated, it should be possible to interprete the spectra of the hemosomes, 
considering the success the modified red cell characterization.  The liposomes vary 
greatly in size, however this should not pose a problem with the interpretation since there 
are no size restrictions with the Mie theory.  Moreover, liposomes encapsulating albumin 
were examined due to the accessibility of the model protein. 
 
Materials and Methods: 
 For the preparation of the protein-encapsulated liposomes, a commonly described 
thin film method was used.128,135  Lyophilized egg yolk phosphatidylcholine (PC) 
(Sigma-Aldrich, MO) was reconstituted to a stock solution of  
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100 mg/ml with chloroform.  Using an approximate molecular weight of the PC (MW 
~768 Da) given by the manufacturer, a 1:1 molar ration of PC:cholesterol was calculated.  
In a 250 ml round-bottom flask, 200 ml of PC stock solution and 10 mg of cholesterol 
were measured and dissolved in approximately 3 ml of chloroform.  The flask was fitted 
to a rotary evaporator (Buchi Rotovapor R-3000 with a Buchi 461 water bath) and 
subjected to a vacuum with the water bath set to approximately 55oC, slightly lower than 
the boiling point of chloroform (61.5oC).  The flask was rotated until the chloroform was 
completely evaporated and a thin layer of lipid/cholesterol was distributed evenly on the 
bottom of the flask.   
 The proteins encapsulated were bovine serum albumin (Sigma-Aldrich MO) 
(typically ~ 5% concentration was used), and hemoglobin harvested from red blood cells 
(Figure C2).  For the hemoglobin, whole blood samples were obtained from the Florida 
Blood Services (St. Petersburg, FL).  The whole blood sample was washed by 
centrifugation in three cycles with isotonic PBS as previously described in Chapter 4.  
The washed cell sample was then lysed by a freeze-thaw method.  The cells were frozen 
in a -80oC freezer for approximately 10 minutes, then immediately thawed in a 56oC 
water bath.  The process was repeated three times until inversion of the sample in its 
holding tube no longer showed any turbidity of intact cells.  The sample was then 
centrifuged at 100,000 x g in a Beckman Optima TL ultracentrifuge with a TLA-100.4 
rotor to rid the suspension of cell debris.  The resulting hemoglobin solution was assayed 
for concentration using the Drabkin’s assay (Chapter 4).   
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 Next, the hemoglobin solution diluted to a desired concentration was measured 
(~10 ml) into the round-bottom flask containing the thin lipid/cholesterol layer and the 
mixture was sonicated for approximately 15 minutes at a frequency of 47 KHz (Branson 
5120 sonicator) (Figure C3).  The resulting liposomes were washed three times by 
centrifugation and resuspended with PBS to approximately 2 ml.  A spectrum of the  
 
Obtain blood samples Count on Serano Baker
Determine dilution
Take whole blood spec
Wash blood 4x by 
centrifugation
Resuspend cells with PBS
Freeze-thaw lyse 4x (-80/57oC) Spec of lysed suspension
Spin down cell debris
Determine concentration of Hb
solution with Drabkin’s assay
Dilute Hb solution to desired 
concentration (5%)**
Confirm concentration with 
Drabkin’s assay
 
Figure C2:  Flowchart of the method for hemoglobin harvesting prior to the production 
of hemoglobin-encapsulated liposomes (hemosomes). 
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Lecithin/cholesterol in chloroform 
(1:1 molar ratio)
Prepare thin lipid film in rotoevaporator
(vacuum dry)
Add prepared Hb solution (~10 ml)
Sonicate (15 min)
Wash hemosomes Spec of crude hemosomes
Small Medium Large0.22 µm 0.45 µm
 
Figure C3:  Protocol for the generation of hemoglobin-encapsulated liposomes 
(hemosomes).  Other model proteins such as albumin can be substituted for hemoglobin.   
 
crude sample suspension was obtained.  The suspension was then mechanically extruded 
with syringe filters (Whatman polyethersulfone disc filters for low protein adsorption) 
with pore sizes of 0.22 and 0.45 µm to narrow the size ranges of the liposomes for 
analysis.  Spectra were obtained for each size range. 
 
Results and Discussion 
 Figure C4 shows normalized spectra of the crude, filtered and free albumin 
spectra from a representative albumin liposome experiment.  The spectrum of the free 
albumin solution shows a clearly defined Soret band at ~280 nm but in contrast, none of  
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the liposome spectra show this peak.  This effect is a scattering-related effect comparable 
to the one seen with hemoglobin and red cells.  The crude sample, which represents the  
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Figure C4:  Normalized spectra of crude and filtered albumin liposomes compared to a 
spectrum of free albumin in solution. 
 
 
unfiltered liposomes, the spectrum seems to be dominated by the scattering properties of 
the larger liposomes, judging from the flattened spectrum.  This conjecture is further 
supported by the similarities of the crude spectrum to the that of the filtered liposomes 
containing sizes above 0.45 µm.  The low (< 0.22 µm) and medium (0.22 – 0.45 µm)  
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range sizes of liposomes show spectra that nearly overlap.  The small differences in the 
two spectra reflect a trend resulting from size disparities, consistent with our results from 
red cells.  That is, as the size increases, a region of the small wavelengths (< 300 nm) 
decreases and the spectral intensity increases at the larger wavelengths (> 300 nm).   
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Figure C5:  Normalized spectra of crude and filtered hemosomes compared to a 
spectrum of free hemoglobin in solution. 
 
 Figure C5 shows normalized spectra of crude and filtered hemosomes and free 
hemoglobin in solution.  The hemosomes were prepared using a hemoglobin solution 
with a concentration of ~10%.  The spectral characteristics of each of the samples are 
similar to those of the albumin-containing liposomes.  The spectrum for the low size  
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range (< 0.22 µm) showed a characteristic hemoglobin band at 417 nm.  This could be an 
indication of encapsulated hemoglobin, or free hemoglobin in solution outside the 
liposomes.  The latter case is more probable considering that if the hemoglobin were  
encapsulated, the 417 nm peak would be visible in the other filtered fractions to some 
degree as well.  For future reference, an additional step of centrifugation and inspection 
of the supernatant would verify this suspicion.   
 Both the albumin liposomes and hemosomes showed similar spectral qualities and 
trends.  Visual examination of the liposomes using light microscopy showed large 
variations in particle size.  Additionally, it was noted that the liposomes were 
multilamellar to varying degrees and tended to aggregate (Figure C6).  The lamellarity of 
the vesicles would change the optical properties of the particles in the context of spectral 
analysis.  It was therefore no surprise when the interpretation model did not give 
reasonable values for size and protein concentration for the albumin liposomes and the 
hemosomes.  In order to achieve a good characterization of the liposome system, a few 
issues must be considered:  1) lamellarity of the liposomes, 2) the particle size 
distribution, 3) how much of the protein was encapsulated. 
Recommendations for future work in this area should start with the refinement of 
the protocol to make liposomes.  Different methods have been reported that control the 
characteristics of the liposomes during production, such as lipid dispersion in water,136 
freeze-thaw method137 and emulsification.138  Furthermore, corroboration of particle  
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characteristics require analytical methods, such as electron microscopy139 and  photon 
correlation spectroscopy.140 
 
 
 
Figure C6:  Light microscope picture of albumin liposomes magnified to 400x.  Many of 
the liposomes are multilamellar and tend to aggregate.  Hemosome showed similar 
qualities.   
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Appendix D:  RBC Swelling 
 
 Under physiological conditions, red blood cells typically exist as biconcave disks.  
Changes in ionic strength can cause the cells to undergo morphological changes such as 
swelling, shrinking or crenating.  UV-visible spectrophotometry was used to examine 
whole blood in varying medium tonicities to observe how these changes are represented 
in the spectra.  Although whole blood was used, the red cells in particular act as the 
osmometers thus any changes in the spectra would reflect the changes in the red cells. 
 
Materials and Methods 
 Whole blood samples were obtained from the Florida Blood Services, Tampa, FL 
and the sample was diluted to a concentration of ~4000 cells/µl as described in Chapter 4.  
Two dilutions were performed with the first being a 1:50 using 0.9% PBS.  For the 
second dilution needed to achieve the final cell concentration, the ionic strengths of the 
media were varied.  The different tonicities of media were obtained by diluting the 0.9% 
stock PBS accordingly to obtain concentrations of 0.7%, 0.5%, and 0.4%.  When mixed 
with the blood cell sample, the final saline concentrations were calculated to be 0.899%, 
0.707%, 0.515%, and 0.419%.  OD spectra of the mixture was obtained as previously 
described.   
 
Results and Discussion 
 Figure D1 illustrates normalized spectra of red cells in the various tonicities of 
saline each after a 15 minute incubation time where decreasing the decreasing tonicity of  
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the PBS medium causes the cells to swell, and eventually burst.  The differences between 
the 0.899% and 0.707% curves are subtle.  The small changes are a result of the swelling 
of the cells in the 0.707% medium reflecting a slight increase in the volume (size) 
coupled with a small decrease in the hemoglobin concentration.  As the ionic strength of 
the medium is decreased to 0.515%, the slope of the linear portion of the spectrum (> 600 
nm) changes, denoting larger alterations in size.  Also, the emergence of a peak at 417 
nm denotes the lysis of a small population of cells and the presence of free hemoglobin in 
the medium.   Saline with a tonicity of 0.417% causes a more significant bursting of the 
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Figure D1:  Spectra of red cells in varying tonicities of PBS media.  As the tonicity 
decreases, the cells swell, eventually bursting and releasing hemoglobin into solution 
(0.419% curve).   
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cells.  This is evident as the spectrum is dominated mainly by the hemoglobin absorption 
spectrum.  There is indication of a population of intact cells because the spectrum is 
significantly elevated from the baseline across the entire wavelength range.  Thus it can 
be concluded that subtle changes in the swelling of the red cells can be detected 
experimentally.  This supports the swelling simulations shown in Chapter 5.  Moreover, 
UV-visible spectroscopic measurements can detect lysis of cells.  Further work should 
allow for the quantification of lysed cells, an application useful in clinical settings. 
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Appendix E:  Spiking Red Cell Suspensions with Hemoglobin 
 Within the scope of this study, it has become evident that free hemoglobin in the 
medium of the red cell suspension is detectable in the multiwavelength spectrum.  The 
spectral manifestation of the free hemoglobin in the suspension is most profound at the 
417 nm Soret band.  As a clinical application, simple spectroscopic detection can prove 
useful for the detection of disorders such as hemolytic anemia14 and the quantification of 
blood substitutes like polymerized hemoglobin.14  Herein, we show a preliminary study 
of free hemoglobin in a red cell suspension by artificial hemoglobin spiking and how it is 
spectrally represented. 
 
Materials and Methods 
 Human hemoglobin A0 was obtained from Sigma (cat. # H-0267) and it was 
reconstituted in PBS for a final concentration of approximately 0.5 g/dl.  A sample of 
purified red blood cells was diluted 1:50 (2.45 ml PBS, 0.05 ml cell suspension), then a 
second dilution was performed (2.95 ml PBS, 0.05 ml 1:50 suspension) to achieve an OD 
maximum of approximately 0.5.  To the 3 ml suspension, 10 µl of stock Hb solution was 
added and a spectrum was taken.  A subsequent spectrum was taken after the addition of 
another 10 µl of stock Hb.  The suspension was centrifuged for 10 minutes at 1500 x g 
and the supernatant was spectrophotometrically analyzed in an attempt to retrieve the 20 
µl of Hb added to the suspension.  As a control, 10 ml of hemoglobin stock was added 
twice to 3 ml of PBS and a spectrum was taken at each step.  The same procedure was  
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performed with a sample of resealed cells.  The hemoglobin concentrations were 
estimated using ε417 = 7786 cm2/g.   
 
Results 
 Figure E1 shows the control samples of free hemoglobin in 3 ml of PBS.  The 
addition of 10 µl and  20 µl of stock Hb to the PBS was quantified by the Drabkin’s assay 
to be 0.0178 mg/ml  and 0.0365 mg/ml.  Figure E2 illustrates spectra of purified red 
blood cells spiked with the same volumes of stock hemoglobin solution as the control.   
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Figure E1:  Spectrum of the control PBS spiked with two volumes of free hemoglobin.  
The concentrations were estimated using the extinction coefficient at 417 nm. 
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The increasing amounts of hemoglobin is represented with an increase in the intensity of 
the 417 nm peak.  The absorption characteristics of the free hemoglobin largely changes 
the spectrum in the absorption region < 600 nm.  The scattering region >600 nm shows a 
slight change.  Since this wavelength range is mostly affected by size and refractive index 
changes, perhaps there is some surface adsorption of the free hemoglobin on the outside 
of the cells, affecting the refractive index of the particle to a small extent.  Quantification 
of the Hb concentration in the supernatant gave a result of 0.0352 mg/ml, a value that is 
close to that of the control.   
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Figure E2:  Spectrum of a purified red cell suspension spiked with free hemoglobin.  The 
presence of the free hemoglobin is represented by the peak at 417.  The spectrum of the 
supernatant of the spiked cell sample was quantified for concentration using the 
extinction coefficient at 417 nm.   
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 Similar results are shown for a spiked resealed cell sample (Figure E3).  The 
MCHC of the resealed sample was reported to be 0.215 mass fraction (Serono-Baker).  
Once again, the 417 nm peak significantly increased with increasing free hemoglobin.  
The supernatant was quantified to be 0.0348 mg/ml, a value that is extremely close to that 
of the spiking experiment of the purified red cells above.  Both values are slightly smaller 
than the control, a fact that supports the hypothesis of surface adsorption.   
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Figure E3:  Spectrum of a resealed cell suspension spiked with free hemoglobin.  The 
presence of the free hemoglobin is represented by the peak at 417.  The spectrum of the 
supernatant of the spiked cell sample was quantified for concentration using the 
extinction coefficient at 417 nm.   
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Attempts to quantify the free hemoglobin for these samples using RBCHb02a.exe 
interpretation model (which takes into account free Hb) is covered in Appendix F.   
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Appendix F:  Detailed Examination of Experimental and Simulated Spectra of 
Resealed Cells 
 
 Chapter 5 showed a comparison of data between measured and simulated spectra 
of resealed red blood cells.  In this comparison, the simulation model proved to be 
successful at reproducing features and trends of the spectrum with changing MCHC and 
MCV.  This appendix further examines the effectiveness of the simulations in predicting 
the features and trends of measured spectra that are grouped into narrower MCHC ranges.   
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Figure F1:  Experimental data set of resealed red cells in the low MCHC range with 
varying MCV values.  The data set is normalized in the 230-900 nm range using the area 
under the curve method.  The MCHC is expressed in mass fractions and the MCV in fl.  
The free hemoglobin solution spectrum is included as a reference. 
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Figure F2:  Simulated spectra of the low MCHC range data set normalized on a per cell 
basis.  The MCHC is expressed in mass fractions and the MCV in fl.  The free 
hemoglobin solution spectrum is included as a reference. 
 
 Figures F1 and F2 are measured and simulated spectra respectively of resealed red 
cells.  Here, the theoretical model simulates the trends well.  The sample with the highest 
MCHC (0.117 mass fraction) shows the lowest 417 nm hemoglobin band and the lowest 
MCHC (0.084) has the highest 417 nm peak in both figures.  Although the samples vary 
in both MCHC and MCV, it has been shown in the simulations in Chapter 5 that the 
effect of MCHC changes is a more dominant one.   
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Figure F3:  Experimental data set of resealed red cells in the medium MCHC range with 
varying MCV values.  The data set is normalized in the 230-900 nm range using the area 
under the curve method.  The MCHC is expressed in mass fractions and the MCV in fl.  
The free hemoglobin solution spectrum is included as a reference. 
 
 Figures F3 and F4 represent measured and simulated data respectively for a 
medium range of MCHCs.  The calculated spectral features and trends in Figure F4 agree 
well with the experimental spectra from Figure F3.  The lowest MCHC (0.220 mass 
fraction) exhibits the highest spectral intensity at the lower wavelengths (<600 nm), a 
trend that is consistent in both figures.  There are small discrepancies in the features of  
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the measured and calculated spectra, however it must be noted that the simulation model 
does not take into account some details of the experimental red cell sample.  For example,  
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Figure F4:  Simulated spectra of the medium MCHC range data set normalized on a per 
cell basis.  The MCHC is expressed in mass fractions and the MCV in fl.  The free 
hemoglobin solution spectrum is included as a reference. 
 
the spherical approximation may pose limits on the simulation of the measured data.  
Furthermore, when the cells reseal, we are assuming a homogeneous distribution of 
MCHC which is probably not the case.  Despite such unanswered questions, the model  
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does a good job simulating spectra based on known parameters of the particle suspension 
(i.e. MCHC and MCV).   
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Figure F5:  Experimental data set of resealed red cells in the high MCHC range with 
varying MCV values.  The data set is normalized in the 230-900 nm range using the area 
under the curve method.  The MCHC is expressed in mass fractions and the MCV in fl.  
The free hemoglobin solution spectrum is included as a reference. 
 
 Figures F5 and F6 show measured and simulated spectra respectively in the high 
MCHC range.  Here, the simulated values show small changes in the spectra compared to 
the experimental spectra.  This can be attributed to the above mentioned issues of the 
spherical approximation, or the assumption of hemoglobin homogeneity.  At higher  
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hemoglobin concentrations, the refractive index of the particle increases, and scattering 
becomes prominent enough to exacerbate the effects of factors (such as shape) that may 
not have been a problem at lower refractive indices of the particle.   
 One peculiar sample in Figures F5 and F6 was the spectrum with an MCHC of 
0.329.  Upon close examination of experimental notes, it was evident that the sample 
used was approximately 10 days old.  This was in stark contrast to the rest of the samples 
(50+ samples) which were used within 24-48 hours post-donation.  It has been  
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Figure F6:  Simulated spectra of the high MCHC range data set normalized on a per cell 
basis.  The MCHC is expressed in mass fractions and the MCV in fl.  The free 
hemoglobin solution spectrum is included as a reference. 
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demonstrated by another project member that the aging of red cells in storage resulted in 
morphologic changes that translated into significant alterations of spectral features 
(unpublished data).108  Over time, the morphology of the cells turned into a spherical 
crenated form.  An examination of the sample under a light microscope at 100x 
magnification did indeed reveal a significant population of crenated cells.  Such 
alterations manifested in the spectra could explain the irregularity of this particular 
sample. 
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Appendix G:  Alternate Versions of the Interpretation Model 
 In Chapter 6, two alternate versions of the interpretation model were introduced:  
RBCHb01b and RBCHb02a.  The kernels of both models are identical to that of 
RBCHb01a (the version used for the main analysis in this work), all functioning on the 
basis of the Mie theory-based turbidity calculations.  Small alterations in the program 
design allow RBCHb01b to account for the presence of two derivatives of hemoglobin 
(typically oxyhemoglobin and methemoglobin in the case of resealed cells), and 
RBCHb02a introduces the capability to quantify any free hemoglobin existing in the 
medium outside the cells.  The main scheme of this investigation used an interpretation 
model that did not consider such details included in the alternate versions because the 
simplified interpretation model generally yielded good results.  However, when 
scrutinized on an individual basis, some samples were identified that were better suited to 
be interpreted using the alternate versions.  Some examples are cited in this appendix.   
 A comparison of the results of RBCHb01a and RBCHb01b generally yielded 
similar results in the values of parameters such as cell number, cell size and cell 
hemoglobin concentration.  However, there were a few select samples where the 
interpreted values improved with the use of RBCHb01b, accounting for the presence of 
methemoglobin.  The inputs for this version were similar to those of RBCHb01a (as 
described in Chapter 6) with the major difference being the designation of the optical 
properties file of a second hemoglobin derivative (ophbfe3.01 file containing the complex 
refractive index of methemoglobin and the refractive index of water).  In an example of a 
comparison of the two versions, Figure G1 shows a resealed cell with low MCHC  
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evaluated with RBCHb01a.  The MCHC is estimated well, however, the cell counts and 
the MCV values do not agree well with the measured.  The same data interpreted with 
RBCHb01b (incorporating methemoglobin) shows improved estimations of both counts 
and MCV (Figure G2).  The sample containing a low MCHC could very well have 
elevated amounts of oxidized hemoglobin compared to those of higher MCHC 
considering the manner in which it is prepared.  After permeabilizing the cells by way of 
hypotonic shock, the  
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Figure G1:  Resealed cell data interpreted using RBCHb01a interpretation model.  The 
MCV is estimated to be substantially higher than the measured value. 
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suspension is equilibrated for an extended period before restoration (see Chapter 4 for 
details).  This subjects the oxyhemoglobin to a highly oxygenated medium increasing the 
chances of conversion to methemoglobin.   
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Figure G2:  Data of same resealed sample as Figure A1 interpreted with RBCHb01b, 
accounting for the presence of methemoglobin.  The MCV and cell count estimations are 
closer to the measured values. 
 
 
 Analysis of data using RBCHb02a is a work in progress.  This version of the 
interpretation model accounts for any free hemoglobin in the medium, outside of the red 
cells.  The test sample is a suspension of purified red cells spiked with a known amount 
of free hemoglobin (as described in Appendix E).  Figure G3 shows that the estimated fit 
of the spectrum is not accurate although the estimated values are relatively close to the  
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measured values.  The calculated spectrum also does not reflect the large amount of free 
hemoglobin with a peak at 417 nm.  The data shown represents work that has not been 
completed, and further improvement of this model will provide us with the capability to 
detect small amounts of lysis in red cell suspensions and whole blood.   
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Figure G3:  An RBCHb02a interpretation of a purified red cell suspension spiked with 
free hemoglobin.  The fit of the curve is not good although the estimated values compare 
well with the measured values.   
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Appendix H:  UV-Visible Analysis of Molecular Aggregates 
 The focus of the encapsulated systems mentioned in this work (resealed red cells, 
liposomes) was to achieve a spectral understanding of the effects of changing chemical 
composition.  A similar model system for the optical characterization of macroscopic 
particles is molecular aggregates.  For example, a comparison of hemoglobin in solution 
and hemoglobin in an aggregated state should show drastic changes in the spectral profile.  
Light scattering characteristics of the aggregated form should approach the optical 
properties of encapsulated systems containing similar concentrations of hemoglobin.  
Provided that there are good corroborative methods of analyzing the physical properties 
of the aggregates, a reliable interpretation of the spectral data is sure to be achieved.   
 Large molecules on the order of proteins can be salted out at high salt 
concentrations by taking advantage of their hydrophobicity.141,142  At low salt 
concentrations, water molecules become ordered around hydrophobic patches on the 
protein, a thermodynamically unstable situation.  With the addition of a salt, the hydrated 
ions of the salt disrupt the ordered water molecules, exposing the hydrophobic patches 
and allowing the proteins to aggregate.  The concentration of salt required to salt out a 
protein depends on the amount of hydrophobic residues residing on the protein of interest.  
The most effective salts are ones containing multivalent anions and possess a high 
solubility, such as ammonium sulfate [(NH4)2SO4].142  Alternate precipitation methods 
use water miscible organic solvents (ethanol, actone) or a soluble high molecular weight 
organic polymer (polyethylene glycol) to decrease the solvation power of the water 
thereby aggregating the protein.   
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Our preliminary studies on protein aggregation were performed on purified 
human hemoglobin A0 (Sigma-Aldrich) and bovine serum albumin (Sigma-Aldrich).  The 
latter was chosen because it was readily available and it had been previously 
characterized spectrally.  Ammonium sulfate was used as the precipitating agent and the 
concentrations (percent saturation) required to aggregate the proteins were 
experimentally determined.  The spectral characteristics of the proteins were compared in 
their dissolved and precipitated states for any detectable differences.   
 
Materials and Methods 
 The buffer used in these experiments was a standard 0.2 M phosphate recipe.141  
The ionic strength of the buffer is not much of an issue here as it is when preparing the 
hypotonic shock phosphate buffer (0.007 M) for the resealing experiments.  Briefly, 100 
ml of 0.2 M solutions of monobasic sodium phosphate and dibasic sodium phosphate 
were prepared separately.  To obtain a final pH of 7.4, 19.0 ml of the monobasic and 81.0 
ml of the dibasic solutions were combined and the final volume was brought up to 200 ml.   
 For the preparation of the ammonium sulfate solutions, the % saturation was 
calculated by the equation 
2
12
3.0100
)(533
S
SSg −
−=  
where S1 and S2 are the initial and final saturation percentages and g is grams of 
ammonium sulfate to be added to 1 L of water or buffer at 20o C.142  Different saturation 
levels of the ammonium sulfate were test at 10% increments to determine the  
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concentration at which hemoglobin and albumin aggregated.  Incubation times were 
typically around 2 minutes.  The concentration of the stock solution of the commercial 
hemoglobin sample was 20 mg/ml and the albumin stock was 10 mg/ml with both 
proteins being reconstituted with phosphate buffer.   
 An example of concentration calculations for the hemoglobin sample is as follows 
(with albumin concentrations being calculated in the same manner).  Here, the desired 
concentration for the sample to be measured was 0.1 mg/ml hemoglobin in 80% saturated 
ammonium sulfate.  With the final sample volume to be 2 ml, 0.01 ml of the 20 mg/ml 
stock solution was added to 1.99 ml of 80% phosphate buffered ammonium sulfate 
solution (PB/AMS).  If the PB/AMS was 80% saturated at the time of addition, the final 
saturation would be 79.6%, which is a negligible difference for our purposes.   
 
Results 
 For both albumin and hemoglobin, it was determined that 90% ammonium sulfate 
saturation was needed to maximize precipitation of the proteins.  Figure H1 shows a 
precipitation experiment of a 0.2 mg/ml albumin solution.  The dashed line represents the 
albumin solution prior to aggregation.  The spectrum shows a characteristic peak at 280 
nm with a low baseline at the wavelengths > 300 nm indicating a lack of macroscopic 
scattering.  When the albumin is subjected to a 90% AMS solution, there is an 
appreciable elevation in the entire wavelength range suggesting the formation of  
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aggregates.  Centrifugation (15,000 x g) to isolate the supernatant shows no significant 
presence of free albumin as evident by the lack of a 280 nm peak.   
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Figure H1:  Ammonium sulfate precipitation of bovine serum albumin.  There is a 
noticeable difference in the spectra between free albumin and aggregated albumin.  The 
aggregated suspension shows considerable scattering with an elevated OD spectrum.  The 
supernatant spectrum after centrifugation shows no indication of an albumin peak, 
indicating the absence of a significant amount of non-aggretated albumin. 
 
 
 Figure H2 shows a precipitation of a 0.10 mg/ml solution of hemoglobin.  Much 
like the encapsulated form of hemoglobin, the aggregated form exhibits significant 
scattering elements marked by the elevation of the OD spectrum.  The preliminary data 
indicates that an aggregated system can be used as another model system to support the 
results of the resealed cells.  Contrary to the liposomes, there is no need to worry about  
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multiple membrane layers changing the refractive index of the aggregates, since there is 
no membrane.  Hence it seems that the interpretation model could be successfully 
implemented as it was with the resealed cells.  It will however be necessary to 
corroborate the size distribution and hemoglobin content of the aggregates.   
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Figure H2:  Ammonium sulfate precipitation of 0.10 mg/ml hemoglobin.  Upon 
aggregation, the spectrum shows larger scattering elements. 
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